Rhode Island Hospital: drugs
Schedule G of this filing lists 973 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.
The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.
- 973drugs listed
- $357,096,076.09 (Schedule G, printed total, page 37 of the filing PDF)Total as filed
- 982,072 (Schedule G, printed claims total, page 37 of the filing PDF)Claims total as filed
- 109rows show “fewer than 6” for claims. What this means
All 973 drug rows
| Line | Drug | Amount as filed | Claims as filed |
|---|---|---|---|
| 1 | Keytruda 100 mg SDV 4 mL00006302602Listed by the FDA as Keytrudapembrolizumab25 mg/mLinjection, solutionMerck Sharp & Dohme LLC | 32,042,093.78 (Schedule G, line 1, page 11 of the filing PDF) | 4,641 |
| 2 | Darzalex Faspro 1,800 mg SDV 15 mL57894050301Listed by the FDA as Darzalex Fasprodaratumumab and hyaluronidase-fihj (human recombinant)1,800 mg/15 mL; 30,000 units/15 mLinjectionJanssen Biotech, Inc. | 13,989,522.71 (Schedule G, line 2, page 11 of the filing PDF) | 1,545 |
| 3 | Vyndamax 61 mg caps 3x1000069873030Listed by the FDA as Vyndamaxtafamidis61 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc | 11,268,756.45 (Schedule G, line 3, page 11 of the filing PDF) | 632 |
| 4 | Opdivo 240 mg VL 24 mL00003373413Listed by the FDA as Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C. | 8,983,854.58 (Schedule G, line 4, page 11 of the filing PDF) | 903 |
| 5 | Imfinzi 500 mg SDV 10 mL00310461150Listed by the FDA as Imfinzidurvalumab500 mg/10 mLinjection, solutionAstraZeneca Pharmaceuticals LP | 5,812,396.86 (Schedule G, line 5, page 11 of the filing PDF) | 615 |
| 6 | Trikafta 150 mg tab 4x2151167033101Listed by the FDA as Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated | 5,721,598.74 (Schedule G, line 6, page 11 of the filing PDF) | 364 |
| 7 | Tagrisso 80 mg tab 3000310135030Listed by the FDA as Tagrissoosimertinib80 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 5,280,189.01 (Schedule G, line 7, page 11 of the filing PDF) | 409 |
| 8 | Entyvio 300 mg SDV64764030020Listed by the FDA as Entyviovedolizumab300 mg/5 mLinjection, powder, lyophilized, for solutionTakeda Pharmaceuticals America, Inc. | 4,784,502.23 (Schedule G, line 8, page 11 of the filing PDF) | 801 |
| 9 | Hemlibra 105 mg SDV 0.7 mL50242092201Listed by the FDA as Hemlibraemicizumab105 mg/0.7 mLinjection, solutionGenentech, Inc. | 4,336,357.33 (Schedule G, line 9, page 11 of the filing PDF) | 159 |
| 10 | Amvuttra 25 mg/0.5 mL PFS71336100301Listed by the FDA as Amvuttravutrisiran25 mg/0.5 mLinjectionAlnylam Pharmaceuticals, Inc. | 4,112,254.59 (Schedule G, line 10, page 11 of the filing PDF) | 31 |
| 11 | Dupixent 300 mg PFP 2x2 mL00024591502Listed by the FDA as Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC | 3,560,670.59 (Schedule G, line 11, page 11 of the filing PDF) | 1,367 |
| 12 | Pluvicto69488001061 | 3,559,810.00 (Schedule G, line 12, page 11 of the filing PDF) | 103 |
| 13 | Enhertu 100 mg SDV65597040601Listed by the FDA as Enhertufam-trastuzumab deruxtecan-nxki100 mg/5 mLinjection, powder, lyophilized, for solutionDaiichi Sankyo Inc. | 3,538,492.55 (Schedule G, line 13, page 11 of the filing PDF) | 610 |
| 14 | Tecentriq 1,200 mg SDV 20 mL50242091701Listed by the FDA as Tecentriqatezolizumab1,200 mg/20 mLinjection, solutionGenentech, Inc. | 3,418,700.21 (Schedule G, line 14, page 11 of the filing PDF) | 345 |
| 15 | Stelara 90 mg PFS 1 mL57894006103Listed by the FDA as Stelaraustekinumab90 mg/mLinjection, solutionJanssen Biotech, Inc. | 3,278,776.15 (Schedule G, line 15, page 11 of the filing PDF) | 366 |
| 16 | Calquence 100 mg tab 6000310351260Listed by the FDA as Calquenceacalabrutinib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 3,247,570.71 (Schedule G, line 16, page 11 of the filing PDF) | 296 |
| 17 | Brukinsa 80 mg cap 12072579001102Listed by the FDA as Brukinsazanubrutinib80 mgcapsuleBeOne Medicines USA, Inc. | 3,202,500.95 (Schedule G, line 17, page 11 of the filing PDF) | 335 |
| 18 | Inflectra 100 mg VL00069080901Listed by the FDA as Inflectrainfliximab-dyyb100 mg/10 mLinjection, powder, lyophilized, for solutionPfizer Laboratories Div Pfizer Inc | 3,196,296.59 (Schedule G, line 18, page 11 of the filing PDF) | 4,382 |
| 19 | Padcev 20 mg SDV51144002001Listed by the FDA as Padcev EJFVenfortumab vedotin20 mg/2 mLinjection, powder, lyophilized, for solutionSeagen Inc. | 3,181,274.23 (Schedule G, line 19, page 11 of the filing PDF) | 957 |
| 20 | Yervoy 50 mg VL 10 mL00003232711Listed by the FDA as Yervoyipilimumab5 mg/mLinjectionE.R. Squibb & Sons, L.L.C. | 3,086,327.24 (Schedule G, line 20, page 12 of the filing PDF) | 218 |
| 21 | Xtandi 40 mg tab 12000469062599Listed by the FDA as Xtandienzalutamide40 mgtabletAstellas Pharma US, Inc. | 3,009,730.12 (Schedule G, line 21, page 12 of the filing PDF) | 553 |
| 22 | Asparlas inj 3750/5 mL72694051501Listed by the FDA as Asparlascalaspargase pegol750 units/mLinjection, solutionServier Pharmaceuticals LLC | 2,995,940.39 (Schedule G, line 22, page 12 of the filing PDF) | 107 |
| 23 | Opdualag 240/80 mg SDV 20 mL00003712511Listed by the FDA as Opdualagnivolumab and relatlimab-rmbw12 mg/mL; 4 mg/mLinjectionE.R. Squibb & Sons, L.L.C. | 2,995,022.38 (Schedule G, line 23, page 12 of the filing PDF) | 107 |
| 24 | Vyndaqel 20 mg caps 4x3000069197540Listed by the FDA as Vyndaqeltafamidis meglumine20 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc | 2,882,319.72 (Schedule G, line 24, page 12 of the filing PDF) | 169 |
| 25 | Nubeqa 300 mg tab 12050419039501Listed by the FDA as Nubeqadarolutamide300 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc. | 2,813,033.97 (Schedule G, line 25, page 12 of the filing PDF) | 332 |
| 26 | Hemgenix 111-115 kg00053023023Listed by the FDA as Hemgenixetranacogene dezaparvoveckitCSL Behring | 2,691,500.00 (Schedule G, line 26, page 12 of the filing PDF) | fewer than 6 (the count is not shown) |
| 27 | Rinvoq 15 mg ER tab 3000074230630Listed by the FDA as Rinvoqupadacitinib15 mgtablet, extended releaseAbbVie Inc. | 2,677,670.30 (Schedule G, line 27, page 12 of the filing PDF) | 716 |
| 28 | Blincyto 35 mcg kit55513016001Listed by the FDA as BlincytoblinatumomabkitAmgen, Inc | 2,674,633.89 (Schedule G, line 28, page 12 of the filing PDF) | 476 |
| 29 | Ilaris 150 mg VL00078073461Listed by the FDA as Ilariscanakinumab150 mg/mLinjection, solutionNovartis Pharmaceuticals Corporation | 2,637,281.05 (Schedule G, line 29, page 12 of the filing PDF) | 94 |
| 30 | Gammagard liq 30 g VL 300 mL Nonret00944270007Listed by the FDA as Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc. | 2,625,371.30 (Schedule G, line 30, page 12 of the filing PDF) | 784 |
| 31 | Venclexta 100 mg tab 12000074057622Listed by the FDA as Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc. | 2,521,058.23 (Schedule G, line 31, page 12 of the filing PDF) | 409 |
| 32 | Skyrizi 360 mg kit00074107001Listed by the FDA as Skyrizirisankizumab-rzaakitAbbVie Inc. | 2,447,993.63 (Schedule G, line 32, page 12 of the filing PDF) | 240 |
| 33 | Hemlibra 60 mg SDV 0.4 mL50242092101Listed by the FDA as Hemlibraemicizumab60 mg/0.4 mLinjection, solutionGenentech, Inc. | 2,427,512.64 (Schedule G, line 33, page 12 of the filing PDF) | 119 |
| 34 | Skyrizi pen 150 mg PFS 1 mL00074210001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc. | 2,424,814.65 (Schedule G, line 34, page 12 of the filing PDF) | 228 |
| 35 | Reblozyl 75 mg SDV59572077501Listed by the FDA as Reblozylluspatercept75 mginjection, powder, lyophilized, for solutionCelgene Corporation | 2,382,443.03 (Schedule G, line 35, page 12 of the filing PDF) | 254 |
| 36 | Attruby 356 mg tab 112 (4x28) BP82228071228Listed by the FDA as Attrubyacoramidis hydrochloride356 mgtablet, film coatedBridgeBio Pharma, Inc. | 2,345,998.47 (Schedule G, line 36, page 12 of the filing PDF) | 131 |
| 37 | Imdelltra 10 mg VL55513007701Listed by the FDA as Imdelltra (AMG757)tarlatamab-dllekitAmgen, Inc | 2,276,513.40 (Schedule G, line 37, page 12 of the filing PDF) | 146 |
| 38 | Taltz 80 mg/mL auto inj 1 mL00002144511Listed by the FDA as Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company | 2,186,382.48 (Schedule G, line 38, page 12 of the filing PDF) | 649 |
| 39 | Nplate 250 mcg SDV 0.5 mL55513022101Listed by the FDA as Nplateromiplostim250 mcg/0.5 mLinjection, powder, lyophilized, for solutionAmgen, Inc | 2,182,659.19 (Schedule G, line 39, page 12 of the filing PDF) | 1,669 |
| 40 | Hemlibra 150 mg SDV 1 mL50242092301Listed by the FDA as Hemlibraemicizumab150 mg/mLinjection, solutionGenentech, Inc. | 2,147,248.82 (Schedule G, line 40, page 12 of the filing PDF) | 61 |
| 41 | Ultomiris 300 mg/3 mL VL DS25682002501Listed by the FDA as Ultomirisravulizumab300 mg/3 mLsolution, concentrateAlexion Pharmaceuticals Inc. | 2,093,059.31 (Schedule G, line 41, page 12 of the filing PDF) | 32 |
| 42 | Humira CF 40 mg-0.4 mL PFP kit 200074055402Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 2,015,282.13 (Schedule G, line 42, page 12 of the filing PDF) | 1,535 |
| 43 | Erbitux 100 mg SDV 50 mL66733094823Listed by the FDA as Erbituxcetuximab2 mg/mLsolutionImClone LLC | 1,894,761.70 (Schedule G, line 43, page 12 of the filing PDF) | 374 |
| 44 | Lutathera69488000301Listed by the FDA as Lutatheralutetium lu 177 dotatate10 mCi/mLinjectionAdvanced Accelerator Applications USA, Inc | 1,870,166.00 (Schedule G, line 44, page 12 of the filing PDF) | 42 |
| 45 | Kyprolis 60 mg pwd LYO SDV76075010101Listed by the FDA as Kyproliscarfilzomib60 mg/30 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc. | 1,794,151.77 (Schedule G, line 45, page 12 of the filing PDF) | 581 |
| 46 | Kisqali 200 mg tab 3x21 REF00078087463Listed by the FDA as Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 1,773,345.39 (Schedule G, line 46, page 12 of the filing PDF) | 183 |
| 47 | Kisqali 200 mg tab 3x14 REF00078086742Listed by the FDA as Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 1,717,562.65 (Schedule G, line 47, page 12 of the filing PDF) | 218 |
| 48 | Rybrevant 350 mg SDV 7 mL57894050101Listed by the FDA as Rybrevantamivantamab-vmjw350 mginjectionJanssen Biotech, Inc. | 1,713,993.78 (Schedule G, line 48, page 12 of the filing PDF) | 149 |
| 49 | Botox Therapeutic 100 units VL DS00023114501Listed by the FDA as BotoxonabotulinumtoxinA100 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc. | 1,710,348.68 (Schedule G, line 49, page 12 of the filing PDF) | 1,872 |
| 50 | Tecvayli 153 mg SDV 1.7 mL SD57894045001Listed by the FDA as Tecvayliteclistamab-cqyv90 mg/mLinjectionJanssen Biotech, Inc. | 1,671,022.98 (Schedule G, line 50, page 12 of the filing PDF) | 311 |
| 51 | Verzenio 100 mg tab 1400002481554Listed by the FDA as Verzenioabemaciclib100 mgtabletEli Lilly and Company | 1,667,901.00 (Schedule G, line 51, page 12 of the filing PDF) | 166 |
| 52 | Gammagard liq 20 g 200 mL Nonret00944270006Listed by the FDA as Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc. | 1,636,051.82 (Schedule G, line 52, page 12 of the filing PDF) | 863 |
| 53 | Hemlibra 300 mg SDV 2 mL50242093001Listed by the FDA as Hemlibraemicizumab300 mg/2 mLinjection, solutionGenentech, Inc. | 1,620,840.11 (Schedule G, line 53, page 12 of the filing PDF) | 44 |
| 54 | Perjeta 420 mg SDV 14 mL50242014501Listed by the FDA as Perjetapertuzumab30 mg/mLinjection, solution, concentrateGenentech, Inc. | 1,585,692.18 (Schedule G, line 54, page 12 of the filing PDF) | 286 |
| 55 | Polivy 140 mg SDV50242010501Listed by the FDA as Polivypolatuzumab vedotin140 mg/7.52 mLinjection, powder, lyophilized, for solutionGenentech, Inc. | 1,522,579.69 (Schedule G, line 55, page 12 of the filing PDF) | 110 |
| 56 | Verzenio 150 mg tab 1400002533754Listed by the FDA as Verzenioabemaciclib150 mgtabletEli Lilly and Company | 1,468,896.00 (Schedule G, line 56, page 12 of the filing PDF) | 146 |
| 57 | Imbruvica 420 mg tab 2857962042028Listed by the FDA as Imbruvicaibrutinib420 mgtablet, film coatedPharmacyclics LLC | 1,440,465.70 (Schedule G, line 57, page 12 of the filing PDF) | 140 |
| 58 | Cabometyx 40 mg tab 3042388002546Listed by the FDA as Cabometyxcabozantinib40 mgtabletExelixis, Inc. | 1,402,827.81 (Schedule G, line 58, page 13 of the filing PDF) | 153 |
| 59 | Fabrazyme vial 35 mg D/S58468004001Listed by the FDA as Fabrazymeagalsidase beta5 mg/mLinjection, powder, lyophilized, for solutionGenzyme Corporation | 1,363,847.54 (Schedule G, line 59, page 13 of the filing PDF) | 182 |
| 60 | Privigen 40 g SDV 400 mL44206043940Listed by the FDA as Privigenhuman immunoglobulin G40 g/400 mLliquidCSL Behring AG | 1,343,127.39 (Schedule G, line 60, page 13 of the filing PDF) | 322 |
| 61 | Tretten 2,496 IU SDV00169701301Listed by the FDA as Trettencoagulation factor XIII A-subunit (recombinant)kitNovo Nordisk | 1,341,015.12 (Schedule G, line 61, page 13 of the filing PDF) | 26 |
| 62 | Dupixent 300 mg PFS 2x2 mL00024591401Listed by the FDA as Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC | 1,318,247.66 (Schedule G, line 62, page 13 of the filing PDF) | 517 |
| 63 | Evenity 105 mg PFS 1.17 mL 2 PK55513099802Listed by the FDA as Evenityromosozumab-aqqg105 mg/1.17 mLinjection, solutionAmgen, Inc | 1,310,269.07 (Schedule G, line 63, page 13 of the filing PDF) | 591 |
| 64 | Alecensa 150 mg cap 24050242013001Listed by the FDA as Alecensaalectinib hydrochloride150 mgcapsuleGenentech, Inc. | 1,305,450.09 (Schedule G, line 64, page 13 of the filing PDF) | 122 |
| 65 | Columvi 10 mg SDV 10 mL50242012701Listed by the FDA as Columviglofitamab10 mg/10 mLconcentrateGenentech, Inc. | 1,239,274.72 (Schedule G, line 65, page 13 of the filing PDF) | 55 |
| 66 | Invega Trinza 819 mg SYG 2.63 mL50458060901Listed by the FDA as Invega Trinzapaliperidone palmitate819 mg/2.63 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc | 1,227,319.97 (Schedule G, line 66, page 13 of the filing PDF) | 240 |
| 67 | Orencia 250 mg VL00003218713Listed by the FDA as Orenciaabatacept250 mg/15 mLinjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C. | 1,222,395.74 (Schedule G, line 67, page 13 of the filing PDF) | 661 |
| 68 | Soliris 300 mg/30 mL non-return DS25682000101Listed by the FDA as Soliriseculizumab300 mg/30 mLinjection, solution, concentrateAlexion Pharmaceuticals Inc. | 1,189,617.23 (Schedule G, line 68, page 13 of the filing PDF) | 56 |
| 69 | Privigen 20 g SDV 200 mL44206043820Listed by the FDA as Privigenhuman immunoglobulin G20 g/200 mLliquidCSL Behring AG | 1,126,956.36 (Schedule G, line 69, page 13 of the filing PDF) | 713 |
| 70 | Truqap 200 mg tab 6400310950101Listed by the FDA as Truqapcapivasertib200 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 1,117,956.52 (Schedule G, line 70, page 13 of the filing PDF) | 55 |
| 71 | Nexviazyme 100 mg/10 mL58468042601Listed by the FDA as Nexviazymeavalglucosidase alfa-ngpt100 mg/10 mLinjection, powder, lyophilized, for solutionGenzyme Corporation | 1,112,966.55 (Schedule G, line 71, page 13 of the filing PDF) | 465 |
| 72 | Benlysta 200 mg inj 449401008835Listed by the FDA as Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC | 1,110,340.74 (Schedule G, line 72, page 13 of the filing PDF) | 309 |
| 73 | Opdivo 40 mg VL 4 mL00003377211Listed by the FDA as Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C. | 1,105,654.93 (Schedule G, line 73, page 13 of the filing PDF) | 397 |
| 74 | Ibrance 100 mg tab 2100069048603Listed by the FDA as Ibrancepalbociclib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 1,085,057.98 (Schedule G, line 74, page 13 of the filing PDF) | 115 |
| 75 | Cerezyme inj 400 units58468466301Listed by the FDA as Cerezymeimiglucerase40 units/mLinjection, powder, lyophilized, for solutionGenzyme Corporation | 1,073,665.99 (Schedule G, line 75, page 13 of the filing PDF) | 777 |
| 76 | Invega Susten 234 mg SYG 1.5 mL50458056401Listed by the FDA as Invega Sustennapaliperidone palmitate234 mg/1.5 mLinjectionJanssen Pharmaceuticals, Inc. | 1,042,132.62 (Schedule G, line 76, page 13 of the filing PDF) | 848 |
| 77 | Orgovyx 120 mg tab 3072974012001Listed by the FDA as Orgovyxrelugolix120 mgtablet, film coatedSumitomo Pharma America, Inc. | 1,037,852.10 (Schedule G, line 77, page 13 of the filing PDF) | 532 |
| 78 | Infliximab 100 mg SDV 20 mL57894016001Listed by the FDA as Infliximab100 mg/10 mLinjection, powder, lyophilized, for solutionJanssen Biotech, Inc. | 1,022,201.02 (Schedule G, line 78, page 13 of the filing PDF) | 901 |
| 79 | Polivy 30 mg SDV50242010301Listed by the FDA as Polivypolatuzumab vedotin30 mg/1.88 mLinjection, powder, lyophilized, for solutionGenentech, Inc. | 1,013,173.51 (Schedule G, line 79, page 13 of the filing PDF) | 191 |
| 80 | Prolia 60 mg PFS 1 mL55513071021Listed by the FDA as Proliadenosumab60 mg/mLinjectionAmgen, Inc | 1,008,064.76 (Schedule G, line 80, page 13 of the filing PDF) | 1,012 |
| 81 | Ibrance 125 mg tab 2100069068803Listed by the FDA as Ibrancepalbociclib125 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 999,470.69 (Schedule G, line 81, page 13 of the filing PDF) | 105 |
| 82 | Tibsovo 250 mg tab 6072694061760Listed by the FDA as Tibsovoivosidenib250 mgtablet, film coatedServier Pharmaceutical LLC | 983,042.82 (Schedule G, line 82, page 13 of the filing PDF) | 37 |
| 83 | Elahere 100 mg SDV 20 mL72903085301Listed by the FDA as Elaheremirvetuximab soravtansine5 mg/mLinjection, solutionImmunoGen, Inc. | 967,847.27 (Schedule G, line 83, page 13 of the filing PDF) | 71 |
| 84 | Ofev 150 mg gel cap 6000597014560Listed by the FDA as Ofevnintedanib150 mgcapsuleBoehringer Ingelheim Pharmaceuticals, Inc. | 966,705.00 (Schedule G, line 84, page 13 of the filing PDF) | 134 |
| 85 | Cosentyx Unoready 300 mg PFP 2 mL00078107068Listed by the FDA as Cosentyxsecukinumab300 mg/2 mLinjectionNovartis Pharmaceuticals Corporation | 948,474.97 (Schedule G, line 85, page 13 of the filing PDF) | 427 |
| 86 | Bridion inj 200 mg SDV 10x2 mL00006542312Listed by the FDA as Bridionsugammadex100 mg/mLinjection, solutionMerck Sharp & Dohme LLC | 930,879.73 (Schedule G, line 86, page 13 of the filing PDF) | 7,067 |
| 87 | Kadcyla 100 mg SDV 15 mL50242008801Listed by the FDA as Kadcylaado-trastuzumab emtansine20 mg/mLinjection, powder, lyophilized, for solutionGenentech, Inc. | 928,686.35 (Schedule G, line 87, page 13 of the filing PDF) | 150 |
| 88 | Skyrizi 600 mg SDV 10 mL SD00074501501Listed by the FDA as Skyrizirisankizumab-rzaa600 mg/10 mLinjectionAbbVie Inc. | 924,156.25 (Schedule G, line 88, page 13 of the filing PDF) | 126 |
| 89 | Vyondys 53 100 mg/2 mL SDV60923046502Listed by the FDA as Vyondys 53golodirsen50 mg/mLinjectionSarepta Therapeutics, Inc. | 909,585.61 (Schedule G, line 89, page 13 of the filing PDF) | 37 |
| 90 | Brukinsa 160 mg tab 6072579012201Listed by the FDA as Brukinsazanubrutinib160 mgtablet, film coatedBeOne Medicines USA, Inc. | 893,689.12 (Schedule G, line 90, page 13 of the filing PDF) | 88 |
| 91 | Libtayo 350 mg SDV 7 mL61755000801Listed by the FDA as Libtayocemiplimab-rwlc50 mg/mLinjectionRegeneron Pharmaceuticals, Inc. | 890,555.79 (Schedule G, line 91, page 13 of the filing PDF) | 90 |
| 92 | Ruxience 500 mg SDV 50 mL00069024901Listed by the FDA as Ruxiencerituximab-pvvr500 mg/50 mLinjection, solutionPfizer Laboratories Div Pfizer Inc | 878,571.33 (Schedule G, line 92, page 13 of the filing PDF) | 936 |
| 93 | Kimmtrak 100 mcg SDV 0.5 mL80446040101Listed by the FDA as Kimmtraktebentafusp100 mcg/0.5 mLinjection, solution, concentrateImmunocore Commercial LLC | 876,500.75 (Schedule G, line 93, page 13 of the filing PDF) | 80 |
| 94 | Verzenio 50 mg tab 1400002448354Listed by the FDA as Verzenioabemaciclib50 mgtabletEli Lilly and Company | 857,828.07 (Schedule G, line 94, page 13 of the filing PDF) | 64 |
| 95 | Talvey 40 mg SDV 1 mL57894047001Listed by the FDA as Talveytalquetamab-tgvs40 mg/mLinjectionJanssen Biotech, Inc. | 842,081.14 (Schedule G, line 95, page 13 of the filing PDF) | 75 |
| 96 | Hadlima Pushtouch 40 mg auto inj 2x0.4 mL78206018701Listed by the FDA as Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC | 836,913.90 (Schedule G, line 96, page 14 of the filing PDF) | 1,072 |
| 97 | Ocrevus 300 mg SDV 10 mL50242015001Listed by the FDA as Ocrevusocrelizumab300 mg/10 mLinjectionGenentech, Inc. | 831,622.78 (Schedule G, line 97, page 14 of the filing PDF) | 30 |
| 98 | Sandostatin LAR Depot 30 mg kit00078082581Listed by the FDA as Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation | 822,357.28 (Schedule G, line 98, page 14 of the filing PDF) | 457 |
| 99 | Doptelet 20 mg tab 3071369002030Listed by the FDA as Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc. | 771,861.13 (Schedule G, line 99, page 14 of the filing PDF) | 71 |
| 100 | Kanjinti 420 mg MDV55513013201Listed by the FDA as Kanjintitrastuzumab-anns420 mg/20 mLinjection, powder, lyophilized, for solutionAmgen, Inc | 770,650.64 (Schedule G, line 100, page 14 of the filing PDF) | 785 |
| 101 | Cabometyx 20 mg tab 3042388002446Listed by the FDA as Cabometyxcabozantinib20 mgtabletExelixis, Inc. | 766,301.30 (Schedule G, line 101, page 14 of the filing PDF) | 71 |
| 102 | Epidiolex 100 mg/mL sol kit 100 mL70127010010Listed by the FDA as Epidiolexcannabidiol100 mg/mLsolutionJazz Pharmaceuticals, Inc. | 762,519.41 (Schedule G, line 102, page 14 of the filing PDF) | 432 |
| 103 | Adcetris 50 mg SDV51144005001Listed by the FDA as Adcetrisbrentuximab vedotin50 mg/10.5 mLinjection, powder, lyophilized, for solutionSeagen Inc. | 758,224.38 (Schedule G, line 103, page 14 of the filing PDF) | 173 |
| 104 | Somatuline Depot 120 mg PFS 0.5 mL15054112004Listed by the FDA as Somatuline Depotlanreotide acetate120 mg/0.5 mLinjectionIpsen Biopharmaceuticals, Inc. | 750,430.04 (Schedule G, line 104, page 14 of the filing PDF) | 179 |
| 105 | Mvasi 400 mg SDV 16 mL55513020701Listed by the FDA as Mvasibevacizumab-awwb400 mg/16 mLinjection, solutionAmgen, Inc | 743,007.00 (Schedule G, line 105, page 14 of the filing PDF) | 783 |
| 106 | Tafinlar 75 mg cap 12000078068166Listed by the FDA as Tafinlardabrafenib75 mgcapsuleNovartis Pharmaceuticals Corporation | 740,989.22 (Schedule G, line 106, page 14 of the filing PDF) | 96 |
| 107 | Paclitaxel Protein-Bound 100 mg SDV00517430001Listed by the FDA as Paclitaxel Protein Bound Particles Albumin Boundpaclitaxel100 mg/20 mLinjection, powder, lyophilized, for suspensionAmerican Regent, Inc. | 736,064.90 (Schedule G, line 107, page 14 of the filing PDF) | 709 |
| 108 | Poteligeo inj 20 mg/5 mL42747076101Listed by the FDA as Poteligeomogamulizumab-kpkc4 mg/mLinjectionKyowa Kirin, Inc. | 734,698.82 (Schedule G, line 108, page 14 of the filing PDF) | 150 |
| 109 | Kevzara 200 mg PFP 2x1.14 mL00024592201Listed by the FDA as Kevzarasarilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC | 731,148.51 (Schedule G, line 109, page 14 of the filing PDF) | 329 |
| 110 | Crysvita inj 30 mg/mL42747030401Listed by the FDA as Crysvitaburosumab30 mg/mLinjectionKyowa Kirin, Inc. | 719,549.66 (Schedule G, line 110, page 14 of the filing PDF) | 44 |
| 111 | Dupixent 200 mg PFP 2x1.14 mL00024591902Listed by the FDA as Dupixentdupilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC | 714,963.69 (Schedule G, line 111, page 14 of the filing PDF) | 301 |
| 112 | Mekinist 2 mg tab 3000078111215Listed by the FDA as Mekinisttrametinib2 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 700,443.30 (Schedule G, line 112, page 14 of the filing PDF) | 88 |
| 113 | Lumizyme 50 mg vial DS58468016001Listed by the FDA as Lumizymealglucosidase alfa5 mg/mLinjection, powder, for solutionGenzyme Corporation | 698,760.14 (Schedule G, line 113, page 14 of the filing PDF) | 132 |
| 114 | Lynparza 150 mg tab 12000310067912Listed by the FDA as Lynparzaolaparib150 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 694,370.82 (Schedule G, line 114, page 14 of the filing PDF) | 71 |
| 115 | INFeD 100 mg SDV 10x2 mL00023608210Listed by the FDA as INFeDiron dextran50 mg/mLinjectionAllergan, Inc. | 690,110.91 (Schedule G, line 115, page 14 of the filing PDF) | 2,355 |
| 116 | Tagrisso 40 mg tab 3000310134930Listed by the FDA as Tagrissoosimertinib40 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 689,798.03 (Schedule G, line 116, page 14 of the filing PDF) | 49 |
| 117 | Imfinzi 120 mg SDV 2.4 mL00310450012Listed by the FDA as Imfinzidurvalumab120 mg/2.4 mLinjection, solutionAstraZeneca Pharmaceuticals LP | 683,826.13 (Schedule G, line 117, page 14 of the filing PDF) | 344 |
| 118 | Eloctate kit 4,000 IU VL71104080801Listed by the FDA as Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc. | 676,912.09 (Schedule G, line 118, page 14 of the filing PDF) | 13 |
| 119 | Bimzelx 320 mg auto inj 2 mL50474078284Listed by the FDA as Bimzelxbimekizumab320 mg/2 mLinjection, solutionUCB, Inc. | 670,938.34 (Schedule G, line 119, page 14 of the filing PDF) | 64 |
| 120 | Krazati 200 mg tab 18080739081218Listed by the FDA as Krazatiadagrasib200 mgtablet, coatedMirati Therapeutics, Inc | 666,128.93 (Schedule G, line 120, page 14 of the filing PDF) | 63 |
| 121 | Voranigo 40 mg tab 3072694072840Listed by the FDA as Voranigovorasidenib40 mgtablet, film coatedServier Pharmaceuticals LLC | 663,429.10 (Schedule G, line 121, page 14 of the filing PDF) | 27 |
| 122 | Actemra ACTPen 162 mg inj 0.9 mL50242014301Listed by the FDA as Actemra ACTPentocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc. | 660,622.94 (Schedule G, line 122, page 14 of the filing PDF) | 390 |
| 123 | Spinraza inj 12 mg/5 mL64406005801Listed by the FDA as Spinrazanusinersen2.4 mg/mLinjection, solutionBiogen Inc. | 647,624.74 (Schedule G, line 123, page 14 of the filing PDF) | 6 |
| 124 | Ogsiveo 150 mg tab 1482448015014Listed by the FDA as Ogsiveonirogacestat150 mgtablet, film coatedSpringWorks Therapeutics, Inc. | 646,562.96 (Schedule G, line 124, page 14 of the filing PDF) | 34 |
| 125 | Supprelin LA 50 mg kit DS67979000201Listed by the FDA as Supprelin LAhistrelin acetate50 mgimplantEndo USA, Inc. | 645,411.87 (Schedule G, line 125, page 14 of the filing PDF) | 42 |
| 126 | Tremfya 100 mg inj 1 mL57894064011Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc. | 640,872.04 (Schedule G, line 126, page 14 of the filing PDF) | 152 |
| 127 | Scemblix 40 mg tab 6000078109820Listed by the FDA as Scemblixasciminib40 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 639,851.18 (Schedule G, line 127, page 14 of the filing PDF) | 44 |
| 128 | Trodelvy 180 mg SDV55135013201Listed by the FDA as Trodelvysacituzumab govitecan180 mgpowder, for solutionGilead Sciences, Inc. | 634,730.92 (Schedule G, line 128, page 14 of the filing PDF) | 145 |
| 129 | Voranigo 10 mg tab 3072694087910Listed by the FDA as Voranigovorasidenib10 mgtablet, film coatedServier Pharmaceuticals LLC | 632,925.04 (Schedule G, line 129, page 14 of the filing PDF) | 21 |
| 130 | Gazyva 1,000 mg VL 40 mL50242007001Listed by the FDA as Gazyvaobinutuzumab1,000 mg/40 mLinjection, solution, concentrateGenentech, Inc. | 627,742.81 (Schedule G, line 130, page 14 of the filing PDF) | 91 |
| 131 | Trikafta 75 mg tab 4x2151167010602Listed by the FDA as Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated | 625,428.50 (Schedule G, line 131, page 14 of the filing PDF) | 45 |
| 132 | Ilumya 100 mg/mL PFS 1 mL47335017795Listed by the FDA as Ilumyatildrakizumab-asmn100 mg/mLinjection, solutionSun Pharmaceutical Industries, Inc. | 620,736.39 (Schedule G, line 132, page 14 of the filing PDF) | 58 |
| 133 | Neulasta 6 mg PFS 0.6 mL 340B55513019001Listed by the FDA as Neulastapegfilgrastim6 mg/0.6 mLinjectionAmgen, Inc | 618,794.27 (Schedule G, line 133, page 14 of the filing PDF) | 931 |
| 134 | Rytelo 188 mg SDV82959011101Listed by the FDA as Ryteloimetelstat sodium188 mginjection, powder, lyophilized, for solutionGeron Corporation | 614,217.57 (Schedule G, line 134, page 15 of the filing PDF) | 31 |
| 135 | Cosentyx SYG 150 mg/mL 2 Sensoready pen00078063941Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation | 607,841.57 (Schedule G, line 135, page 15 of the filing PDF) | 416 |
| 136 | Nulojix 250 mg VL00003037113Listed by the FDA as Nulojixbelatacept250 mginjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C. | 603,531.00 (Schedule G, line 136, page 15 of the filing PDF) | 609 |
| 137 | Abraxane 100 mg SDV68817013450Listed by the FDA as Abraxanepaclitaxel100 mg/20 mLinjection, powder, lyophilized, for suspensionAbraxis BioScience, LLC | 592,682.20 (Schedule G, line 137, page 15 of the filing PDF) | 597 |
| 138 | Tepezza 500 mg SDV75987013015Listed by the FDA as Tepezzateprotumumab500 mginjection, powder, lyophilized, for solutionHorizon Therapeutics USA, Inc. | 583,450.64 (Schedule G, line 138, page 15 of the filing PDF) | 26 |
| 139 | Jevtana W/DIL 60 mg SDV 1.5 mL00024582411Listed by the FDA as JevtanacabazitaxelkitSanofi-Aventis U.S. LLC | 581,105.40 (Schedule G, line 139, page 15 of the filing PDF) | 116 |
| 140 | Jemperli 500 mg SDV 10 mL00173089803Listed by the FDA as Jemperlidostarlimab50 mg/mLinjectionGlaxoSmithKline LLC | 579,790.44 (Schedule G, line 140, page 15 of the filing PDF) | 28 |
| 141 | Altuviiio 4,000 IU LFP VL71104098401Listed by the FDA as Altuviiioantihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlkitBioverativ Therapeutics Inc. | 567,323.70 (Schedule G, line 141, page 15 of the filing PDF) | 12 |
| 142 | Gattex Ancillary 5 mg kit 3068875010201Listed by the FDA as GattexteduglutidekitTakeda Pharmaceuticals America, Inc. | 561,227.62 (Schedule G, line 142, page 15 of the filing PDF) | 25 |
| 143 | Sarclisa 500 mg SDV 25 mL00024065601Listed by the FDA as Sarclisaisatuximab500 mg/25 mLinjection, solution, concentrateSanofi-Aventis U.S. LLC | 555,977.77 (Schedule G, line 143, page 15 of the filing PDF) | 111 |
| 144 | Imjudo 300 mg SDV 15 mL00310453530Listed by the FDA as Imjudotremelimumab300 mg/15 mLinjection, solutionAstraZeneca Pharmaceuticals LP | 546,518.52 (Schedule G, line 144, page 15 of the filing PDF) | 14 |
| 145 | Ibrance 75 mg tab 2100069028403Listed by the FDA as Ibrancepalbociclib75 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 546,194.58 (Schedule G, line 145, page 15 of the filing PDF) | 46 |
| 146 | Venclexta 100 mg tab 2800074057630Listed by the FDA as Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc. | 545,313.00 (Schedule G, line 146, page 15 of the filing PDF) | 85 |
| 147 | Besponsa 0.9 mg SDV00008010001Listed by the FDA as Besponsainotuzumab ozogamicin0.25 mg/mLinjection, powder, lyophilized, for solutionWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 544,435.78 (Schedule G, line 147, page 15 of the filing PDF) | 19 |
| 148 | Welireg 40 mg tab 9000006533101Listed by the FDA as Weliregbelzutifan40 mgtablet, film coatedMerck Sharp & Dohme LLC | 541,540.74 (Schedule G, line 148, page 15 of the filing PDF) | 28 |
| 149 | Zynlonta 10 mg VL DS79952011001Listed by the FDA as Zynlontaloncastuximab tesirine10 mg/2 mLinjection, powder, lyophilized, for solutionADC Therapeutics America, Inc. | 516,744.67 (Schedule G, line 149, page 15 of the filing PDF) | 42 |
| 150 | Rinvoq 30 mg ER tab 3000074231030Listed by the FDA as Rinvoqupadacitinib30 mgtablet, extended releaseAbbVie Inc. | 514,925.64 (Schedule G, line 150, page 15 of the filing PDF) | 161 |
| 151 | Bimzelx 160 mg inj 2x1 mL50474078185Listed by the FDA as Bimzelxbimekizumab160 mg/mLinjection, solutionUCB, Inc. | 514,892.89 (Schedule G, line 151, page 15 of the filing PDF) | 68 |
| 152 | Reblozyl 25 mg SDV59572071101Listed by the FDA as Reblozylluspatercept25 mginjection, powder, lyophilized, for solutionCelgene Corporation | 510,252.98 (Schedule G, line 152, page 15 of the filing PDF) | 161 |
| 153 | Monjuvi 200 mg SDV50881001303Listed by the FDA as Monjuvitafasitamab-cxix200 mg/5 mLinjection, powder, lyophilized, for solutionIncyte Corporation | 510,169.65 (Schedule G, line 153, page 15 of the filing PDF) | 120 |
| 154 | Dupixent 200 mg PFS 2x1.14 mL00024591801Listed by the FDA as Dupixentdupilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC | 508,169.78 (Schedule G, line 154, page 15 of the filing PDF) | 200 |
| 155 | Actemra 400 mg SDV 20 mL50242013701Listed by the FDA as Actemratocilizumab400 mg/20 mLinjection, solution, concentrateGenentech, Inc. | 506,448.75 (Schedule G, line 155, page 15 of the filing PDF) | 276 |
| 156 | Pomalyst DS 4 mg cap 2159572050421Listed by the FDA as Pomalystpomalidomide4 mgcapsuleCelgene Corporation | 498,136.96 (Schedule G, line 156, page 15 of the filing PDF) | fewer than 6 (the count is not shown) |
| 157 | Epkinly 48 mg SDV 0.8 mL82705001001Listed by the FDA as Epkinlyepcoritamab-bysp48 mg/0.8 mLinjection, solutionGenmab US, Inc. | 493,545.78 (Schedule G, line 157, page 15 of the filing PDF) | 36 |
| 158 | Privigen 10 g SDV 100 mL44206043710Listed by the FDA as Privigenhuman immunoglobulin G10 g/100 mLliquidCSL Behring AG | 476,636.39 (Schedule G, line 158, page 15 of the filing PDF) | 563 |
| 159 | Vectibix 100 mg SDV 5 mL55513095401Listed by the FDA as Vectibixpanitumumab100 mg/5 mLsolutionAmgen, Inc | 470,044.62 (Schedule G, line 159, page 15 of the filing PDF) | 150 |
| 160 | Rituxan 500 mg SDV 50 mL50242005306Listed by the FDA as Rituxanrituximab10 mg/mLinjection, solutionGenentech, Inc. | 459,079.69 (Schedule G, line 160, page 15 of the filing PDF) | 80 |
| 161 | Rinvoq 45 mg ER tab 2800074104328Listed by the FDA as Rinvoqupadacitinib45 mgtablet, extended releaseAbbVie Inc. | 458,813.90 (Schedule G, line 161, page 15 of the filing PDF) | 91 |
| 162 | Jaypirca 100 mg tab 6000002702660Listed by the FDA as Jaypircapirtobrutinib100 mgtablet, coatedEli Lilly and Company | 453,007.86 (Schedule G, line 162, page 15 of the filing PDF) | 38 |
| 163 | Cyramza 100 mg SDV 10 mL00002766901Listed by the FDA as Cyramzaramucirumab10 mg/mLsolutionEli Lilly and Company | 447,953.73 (Schedule G, line 163, page 15 of the filing PDF) | 65 |
| 164 | Repatha 140 mg/mL auto inj 2PK72511076002Listed by the FDA as Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc. | 442,470.03 (Schedule G, line 164, page 15 of the filing PDF) | 0 |
| 165 | Zepzelca 4 mg SDV68727071201Listed by the FDA as Zepzelcalurbinectedin0.5 mg/mLinjection, powder, lyophilized, for solutionJazz Pharmaceuticals, Inc. | 441,838.89 (Schedule G, line 165, page 15 of the filing PDF) | 50 |
| 166 | Qinlock 50 mg tab 9073207010130Listed by the FDA as Qinlockripretinib50 mgtabletDeciphera Pharmaceuticals, LLC | 439,745.13 (Schedule G, line 166, page 15 of the filing PDF) | 7 |
| 167 | Lumakras 320 mg tab 9055513050450Listed by the FDA as Lumakrassotorasib320 mgtablet, coatedAmgen, Inc | 438,465.47 (Schedule G, line 167, page 15 of the filing PDF) | 39 |
| 168 | Benlysta 400 mg SDV49401010201Listed by the FDA as Benlystabelimumab400 mg/5 mLinjection, powder, lyophilized, for solutionGlaxoSmithKline LLC | 436,387.73 (Schedule G, line 168, page 15 of the filing PDF) | 116 |
| 169 | Stelara 45 mg PFS 0.5 mL57894006003Listed by the FDA as Stelaraustekinumab45 mg/0.5 mLinjection, solutionJanssen Biotech, Inc. | 430,958.21 (Schedule G, line 169, page 15 of the filing PDF) | 102 |
| 170 | Eligard PSS 22.5 mg 3 month Rplcment kit62935022710Listed by the FDA as Eligardleuprolide acetate22.5 mg/0.375 mLinjection, suspension, extended releaseTOLMAR Inc. | 426,311.86 (Schedule G, line 170, page 15 of the filing PDF) | 1,279 |
| 171 | Saphnelo 300 mg SDV 2 mL00310304000Listed by the FDA as Saphneloanifrolumab-fnia300 mg/2 mLinjection, solutionAstraZeneca Pharmaceuticals LP | 421,710.59 (Schedule G, line 171, page 15 of the filing PDF) | 82 |
| 172 | Abilify Maintena 400 mg kit59148024512Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc. | 417,827.54 (Schedule G, line 172, page 16 of the filing PDF) | 267 |
| 173 | Fasenra 30 mg PFS00310173030Listed by the FDA as Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP | 414,085.24 (Schedule G, line 173, page 16 of the filing PDF) | 98 |
| 174 | Norditropin Flex Pro 10 mg PFP 1.5 mL00169770521Listed by the FDA as Norditropinsomatropin10 mg/1.5 mLinjection, solutionNovo Nordisk | 409,237.93 (Schedule G, line 174, page 16 of the filing PDF) | 754 |
| 175 | Vyvgart 400 mg SDV 20 mL DS73475304105Listed by the FDA as Vyvgartefgartigimod alfa20 mg/mLinjectionargenx US | 394,761.90 (Schedule G, line 175, page 16 of the filing PDF) | 45 |
| 176 | Fulphila 6 mg PFS 0.6 mL83257000541Listed by the FDA as Fulphilapegfilgrastim-jmdb6 mg/0.6 mLinjectionBiocon Biologics Inc. | 393,619.18 (Schedule G, line 176, page 16 of the filing PDF) | 637 |
| 177 | Advate Baxject III 5 mL 2,401- 3,600 IU00944304610Listed by the FDA as Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 387,578.40 (Schedule G, line 177, page 16 of the filing PDF) | 31 |
| 178 | Tremfya 200 mg SDV 20 mL57894065002Listed by the FDA as Tremfyaguselkumab200 mg/20 mLinjectionJanssen Biotech, Inc. | 385,849.12 (Schedule G, line 178, page 16 of the filing PDF) | 25 |
| 179 | Qalsody sol 100/15 mL64406010901Listed by the FDA as Qalsodytofersen100 mg/15 mLinjectionBiogen Inc. | 385,600.09 (Schedule G, line 179, page 16 of the filing PDF) | 214 |
| 180 | Kesimpta 20 mg PFP 0.4 mL00078100768Listed by the FDA as Kesimptaofatumumab20 mg/0.4 mLinjection, solutionNovartis Pharmaceuticals Corporation | 384,002.56 (Schedule G, line 180, page 16 of the filing PDF) | 65 |
| 181 | Prolastin-C inj 1,000 mg13533070501Listed by the FDA as Prolastin-C Liquidalpha1-proteinase inhibitor (human)1,000 mg/20 mLinjection, solutionGrifols USA, LLC | 379,334.73 (Schedule G, line 181, page 16 of the filing PDF) | 1,027 |
| 182 | Rylaze 10 mg SDV 3x0.5 mL68727090003Listed by the FDA as Rylazeasparaginase erwinia chrysanthemi (recombinant)-rywn20 mg/mLinjectionJazz Pharmaceuticals, Inc. | 371,404.08 (Schedule G, line 182, page 16 of the filing PDF) | 36 |
| 183 | Zoladex 3.6 mg PFS DS70720095036Listed by the FDA as Zoladexgoserelin3.6 mgimplantTerSera Therapeutics LLC | 368,714.21 (Schedule G, line 183, page 16 of the filing PDF) | 371 |
| 184 | Nucala PFS 100 mg/mL00173089242Listed by the FDA as Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC | 367,366.49 (Schedule G, line 184, page 16 of the filing PDF) | 87 |
| 185 | Lenvima 14 mg cap 6062856071430Listed by the FDA as LenvimalenvatinibkitEisai Inc. | 366,604.18 (Schedule G, line 185, page 16 of the filing PDF) | 34 |
| 186 | Imbruvica 140 mg cap 9057962014009Listed by the FDA as Imbruvicaibrutinib140 mgcapsulePharmacyclics LLC | 362,555.08 (Schedule G, line 186, page 16 of the filing PDF) | 37 |
| 187 | Tabrecta 200 mg tab 5600078071656Listed by the FDA as Tabrectacapmatinib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 356,001.56 (Schedule G, line 187, page 16 of the filing PDF) | 22 |
| 188 | Adalimumab-adaz 40 mg PFP 2x0.4 mL61314032720Listed by the FDA as Adalimumabadalimumab-adaz40 mg/0.4 mLinjection, solutionSandoz Inc | 348,590.79 (Schedule G, line 188, page 16 of the filing PDF) | 518 |
| 189 | Yondelis 1 mg pwd SDV59676061001Listed by the FDA as Yondelistrabectedin0.05 mg/mLinjection, powder, lyophilized, for solutionJanssen Products, LP | 343,573.34 (Schedule G, line 189, page 16 of the filing PDF) | 71 |
| 190 | Empliciti 300 mg SDV LYO00003229111Listed by the FDA as Emplicitielotuzumab300 mginjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C. | 341,900.37 (Schedule G, line 190, page 16 of the filing PDF) | 65 |
| 191 | Truxima 500 mg SDV 50 mL63459010450Listed by the FDA as Truximarituximab-abbs10 mg/mLinjection, solutionCephalon, Inc. | 334,600.21 (Schedule G, line 191, page 16 of the filing PDF) | 135 |
| 192 | Ogsiveo 100 mg tab 1482448010014Listed by the FDA as Ogsiveonirogacestat100 mgtablet, film coatedSpringWorks Therapeutics, Inc. | 333,104.44 (Schedule G, line 192, page 16 of the filing PDF) | 18 |
| 193 | Erleada 60 mg tab 12059676060012Listed by the FDA as Erleadaapalutamide60 mgtablet, film coatedJanssen Products, LP | 332,979.87 (Schedule G, line 193, page 16 of the filing PDF) | 33 |
| 194 | Talzenna 0.5 mg SGC 3000069054630Listed by the FDA as Talzennatalazoparib0.5 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc | 332,051.43 (Schedule G, line 194, page 16 of the filing PDF) | 24 |
| 195 | Sublocade 300 mg SDV 1.5 mL12496030001Listed by the FDA as Sublocadebuprenorphine300 mgsolutionIndivior Inc. | 329,831.92 (Schedule G, line 195, page 16 of the filing PDF) | 199 |
| 196 | Phesgo 600 mg-600 mg SDV 10 mL50242026001Listed by the FDA as Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf600 mg/10 mL; 600 mg/10 mL; 20,000 units/10 mLinjection, solutionGenentech, Inc. | 325,000.00 (Schedule G, line 196, page 16 of the filing PDF) | 51 |
| 197 | Lunsumio 30 mg SDV 30 mL50242014201Listed by the FDA as Lunsumiomosunetuzumab30 mg/30 mLconcentrateGenentech, Inc. | 324,523.30 (Schedule G, line 197, page 16 of the filing PDF) | 16 |
| 198 | Idhifa 100 mg tab 3059572071030Listed by the FDA as Idhifaenasidenib mesylate100 mgtablet, film coatedCelgene Corporation | 323,544.77 (Schedule G, line 198, page 16 of the filing PDF) | 15 |
| 199 | Parsabiv 5 mg SDV 10x1 mL55513074110Listed by the FDA as Parsabivetelcalcetide5 mg/mLinjection, solutionAmgen, Inc | 323,210.42 (Schedule G, line 199, page 16 of the filing PDF) | 2,145 |
| 200 | Entyvio 108 mg PFP 0.68 mL64764010821Listed by the FDA as Entyvio Penvedolizumab108 mg/0.68 mLinjection, solutionTakeda Pharmaceuticals America, Inc. | 319,055.26 (Schedule G, line 200, page 16 of the filing PDF) | 87 |
| 201 | Ingrezza S72 40 mg cap 3070370204001Listed by the FDA as Ingrezzavalbenazine40 mgcapsuleNeurocrine Biosciences, Inc. | 318,876.70 (Schedule G, line 201, page 16 of the filing PDF) | 55 |
| 202 | Repatha 140 mg auto inj 2x1 mL L/F72511039302Listed by the FDA as Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc. | 318,412.86 (Schedule G, line 202, page 16 of the filing PDF) | 925 |
| 203 | Invega Hafyera 1,560 mg ER PFS 5 mL50458061201Listed by the FDA as Invega Hafyerapaliperidone palmitate1,560 mg/5 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc | 316,164.39 (Schedule G, line 203, page 16 of the filing PDF) | 25 |
| 204 | Scemblix 20 mg tab 6000078109120Listed by the FDA as Scemblixasciminib20 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 315,129.03 (Schedule G, line 204, page 16 of the filing PDF) | 22 |
| 205 | Lynparza 100 mg tab 12000310066812Listed by the FDA as Lynparzaolaparib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 315,078.02 (Schedule G, line 205, page 16 of the filing PDF) | 24 |
| 206 | Crysvita inj 20 mg/mL42747020301Listed by the FDA as Crysvitaburosumab20 mg/mLinjectionKyowa Kirin, Inc. | 313,127.65 (Schedule G, line 206, page 16 of the filing PDF) | 32 |
| 207 | Lonsurf 20 mg tab 2064842102001Listed by the FDA as Lonsurftrifluridine and tipiracil20 mg; 8.19 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd. | 310,459.94 (Schedule G, line 207, page 16 of the filing PDF) | 30 |
| 208 | Cosentyx SYG 150 mg/mL Sensoready pen00078063968Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation | 306,389.07 (Schedule G, line 208, page 16 of the filing PDF) | 438 |
| 209 | Xgeva SDV 120 mg/1.7 mL 155513073001Listed by the FDA as Xgevadenosumab120 mg/1.7 mLinjectionAmgen, Inc | 304,748.52 (Schedule G, line 209, page 16 of the filing PDF) | 158 |
| 210 | Gamunex-C 10% 10 g VL 100 mL13533080071Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC | 302,050.80 (Schedule G, line 210, page 17 of the filing PDF) | 191 |
| 211 | Simlandi 40 mg-0.4 mL auto inj kit 251759040202Listed by the FDA as Simlandiadalimumab-ryvkkitTeva Pharmaceuticals USA, Inc. | 293,096.67 (Schedule G, line 211, page 17 of the filing PDF) | 447 |
| 212 | Gammagard 10% 5 g VL 50 mL DS00944270004Listed by the FDA as Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc. | 291,195.24 (Schedule G, line 212, page 17 of the filing PDF) | 711 |
| 213 | Truqap 160 mg tab 64 (4x16) BP00310950002Listed by the FDA as Truqapcapivasertib160 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 288,302.64 (Schedule G, line 213, page 17 of the filing PDF) | 14 |
| 214 | Fasenra Autoinj 30 mg/mL00310183030Listed by the FDA as Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP | 287,312.64 (Schedule G, line 214, page 17 of the filing PDF) | 72 |
| 215 | Epidiolex 100 mg/mL sol kit 60 mL70127010060Listed by the FDA as Epidiolexcannabidiol100 mg/mLsolutionJazz Pharmaceuticals, Inc. | 287,073.29 (Schedule G, line 215, page 17 of the filing PDF) | 136 |
| 216 | Braftovi 75 mg 2x60 cap 120 BTL70255002503Listed by the FDA as Braftoviencorafenib75 mgcapsuleArray BioPharma Inc. | 285,867.05 (Schedule G, line 216, page 17 of the filing PDF) | 45 |
| 217 | Taltz 80 mg/mL auto inj 2x1 mL00002144527Listed by the FDA as Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company | 279,623.07 (Schedule G, line 217, page 17 of the filing PDF) | 45 |
| 218 | Skyrizi 150 mg PFS 1 mL00074105001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc. | 279,598.18 (Schedule G, line 218, page 17 of the filing PDF) | 28 |
| 219 | Vivitrol 380 mg sus65757030001Listed by the FDA as VivitrolnaltrexonekitAlkermes, Inc. | 276,498.80 (Schedule G, line 219, page 17 of the filing PDF) | 392 |
| 220 | Benlysta 120 mg SDV49401010101Listed by the FDA as Benlystabelimumab120 mg/1.5 mLinjection, powder, lyophilized, for solutionGlaxoSmithKline LLC | 272,750.17 (Schedule G, line 220, page 17 of the filing PDF) | 216 |
| 221 | Trikafta 80/40/60 oral51167044501Listed by the FDA as Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated | 272,625.48 (Schedule G, line 221, page 17 of the filing PDF) | 14 |
| 222 | Istodax 10 mg SDV kit59572098401Listed by the FDA as IstodaxromidepsinkitCelgene Corporation | 270,077.93 (Schedule G, line 222, page 17 of the filing PDF) | 117 |
| 223 | Jakafi 5 mg tab 6050881000560Listed by the FDA as Jakafiruxolitinib5 mgtabletIncyte Corporation | 263,048.11 (Schedule G, line 223, page 17 of the filing PDF) | 41 |
| 224 | Zepbound 15 mg PFP 4x0.5 mL00002245780Listed by the FDA as Zepboundtirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company | 262,702.75 (Schedule G, line 224, page 17 of the filing PDF) | 257 |
| 225 | HyperRAB 300 IU VL 1 mL13533031801Listed by the FDA as HyperRABrabies immune globulin (human)300 IU/mLinjection, solutionGrifols USA, LLC | 257,767.94 (Schedule G, line 225, page 17 of the filing PDF) | 117 |
| 226 | Cosentyx 125 mg SDV 5 mL00078116861Listed by the FDA as Cosentyxsecukinumab25 mg/mLinjection, solution, concentrateNovartis Pharmaceuticals Corporation | 255,343.94 (Schedule G, line 226, page 17 of the filing PDF) | 69 |
| 227 | Ojjaara 200 mg tab 3081864010130Listed by the FDA as Ojjaaramomelotinib200 mgtabletGlaxoSmithKline LLC | 251,636.06 (Schedule G, line 227, page 17 of the filing PDF) | 12 |
| 228 | Invega Trinza 546 mg SYG 1.75 mL50458060801Listed by the FDA as Invega Trinzapaliperidone palmitate546 mg/1.75 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc | 249,621.53 (Schedule G, line 228, page 17 of the filing PDF) | 68 |
| 229 | Gavreto 100 mg cap 6071332000660Listed by the FDA as Gavretopralsetinib100 mgcapsuleRigel Pharmaceuticals, Inc. | 247,485.01 (Schedule G, line 229, page 17 of the filing PDF) | 24 |
| 230 | Lenvima 8 mg cap 6062856070830Listed by the FDA as Lenvimalenvatinib4 mgcapsuleEisai Inc. | 243,998.77 (Schedule G, line 230, page 17 of the filing PDF) | 26 |
| 231 | Ruxience 100 mg SDV 10 mL00069023801Listed by the FDA as Ruxiencerituximab-pvvr100 mg/10 mLinjection, solutionPfizer Laboratories Div Pfizer Inc | 241,966.10 (Schedule G, line 231, page 17 of the filing PDF) | 882 |
| 232 | Fabrazyme vial 5 mg D/S58468004101Listed by the FDA as Fabrazymeagalsidase beta5 mg/mLinjection, powder, lyophilized, for solutionGenzyme Corporation | 240,447.90 (Schedule G, line 232, page 17 of the filing PDF) | 262 |
| 233 | Kalydeco 150 mg tab 5651167020001Listed by the FDA as Kalydecoivacaftor150 mgtablet, film coatedVertex Pharmaceuticals Incorporated | 240,067.20 (Schedule G, line 233, page 17 of the filing PDF) | 11 |
| 234 | Xospata 40 mg tab 9000469142590Listed by the FDA as Xospatagilteritinib40 mgtabletAstellas Pharma US, Inc. | 239,577.56 (Schedule G, line 234, page 17 of the filing PDF) | 10 |
| 235 | Alyftrek 10/50/125 tab 5651167012101Listed by the FDA as Alyftrekvanzacaftor, tezacaftor, and deutivacaftor10 mg; 50 mg; 125 mgtablet, film coatedVertex Pharmaceuticals Incorporated | 238,523.91 (Schedule G, line 235, page 17 of the filing PDF) | 10 |
| 236 | Bizengri 375 mg SDV 2x18.75 mL DS71837100002Listed by the FDA as Bizengrizenocutuzumab20 mg/mLinjectionPartner Therapeutics, Inc. | 237,428.75 (Schedule G, line 236, page 17 of the filing PDF) | fewer than 6 (the count is not shown) |
| 237 | Lazcluze 240 mg tab 3057894024030Listed by the FDA as Lazcluzelazertinib240 mgtablet, film coatedJanssen Biotech, Inc. | 236,630.80 (Schedule G, line 237, page 17 of the filing PDF) | 17 |
| 238 | Advate Baxject III 5 mL 1,801-2,400 IU00944304510Listed by the FDA as Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 235,923.31 (Schedule G, line 238, page 17 of the filing PDF) | 13 |
| 239 | Eloctate kit 1,679 IU VL71104080501Listed by the FDA as Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc. | 232,822.38 (Schedule G, line 239, page 17 of the filing PDF) | 0 |
| 240 | Aristada 882 mg SYG 3.2 mL65757040303Listed by the FDA as Aristadaaripiprazole lauroxil882 mg/3.2 mLinjection, suspension, extended releaseAlkermes, Inc. | 232,397.01 (Schedule G, line 240, page 17 of the filing PDF) | 104 |
| 241 | Olumiant 2 mg tab 3000002418230Listed by the FDA as Olumiantbaricitinib2 mgtablet, film coatedEli Lilly and Company | 231,990.31 (Schedule G, line 241, page 17 of the filing PDF) | 74 |
| 242 | Nucala PFS auto 100 mg inj mL00173089201Listed by the FDA as Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC | 231,956.56 (Schedule G, line 242, page 17 of the filing PDF) | 41 |
| 243 | Kcentra 511 IU SDV63833038602Listed by the FDA as Kcentraprothrombin, coagulation factor VII human, coagulation factor IX human, coagulation factor X human, protein C, protein S human, and waterkitCSL Behring GmbH | 231,849.91 (Schedule G, line 243, page 17 of the filing PDF) | 246 |
| 244 | Actemra 200 mg SDV 10 mL50242013601Listed by the FDA as Actemratocilizumab200 mg/10 mLinjection, solution, concentrateGenentech, Inc. | 229,400.83 (Schedule G, line 244, page 17 of the filing PDF) | 217 |
| 245 | Wegovy 2.4 mg PFP 4x0.75 mL00169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 229,175.33 (Schedule G, line 245, page 17 of the filing PDF) | 380 |
| 246 | Biktarvy 50 mg/200 mg/25 mg tab 3061958250101Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc. | 228,677.82 (Schedule G, line 246, page 17 of the filing PDF) | 77 |
| 247 | Sublocade 100 mg SDV 0.5 mL12496010001Listed by the FDA as Sublocadebuprenorphine100 mgsolutionIndivior Inc. | 227,109.54 (Schedule G, line 247, page 17 of the filing PDF) | 150 |
| 248 | Humira CF 40 mg-0.4 mL PFS kit 200074024302Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 225,946.94 (Schedule G, line 248, page 18 of the filing PDF) | 117 |
| 249 | Ofev 100 mg gel cap 6000597014360Listed by the FDA as Ofevnintedanib100 mgcapsuleBoehringer Ingelheim Pharmaceuticals, Inc. | 222,732.65 (Schedule G, line 249, page 18 of the filing PDF) | 25 |
| 250 | Pulmozyme amp 30x2.5 mL50242010040Listed by the FDA as Pulmozymedornase alfa1 mg/mLsolutionGenentech, Inc. | 222,670.96 (Schedule G, line 250, page 18 of the filing PDF) | 428 |
| 251 | Onureg 300 mg tab 759572074007Listed by the FDA as Onuregazacitidine300 mgtablet, film coatedCelgene Corporation | 221,268.53 (Schedule G, line 251, page 18 of the filing PDF) | 17 |
| 252 | Skyrizi 180 mg kit00074106501Listed by the FDA as Skyrizirisankizumab-rzaakitAbbVie Inc. | 218,476.10 (Schedule G, line 252, page 18 of the filing PDF) | 13 |
| 253 | Gamunex-C 20 g/200 mL13533080024Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC | 216,884.98 (Schedule G, line 253, page 18 of the filing PDF) | 79 |
| 254 | Folotyn 40 mg VL 2 mL72893000501Listed by the FDA as Folotynpralatrexate40 mg/2 mLinjectionAcrotech Biopharma Inc | 214,922.25 (Schedule G, line 254, page 18 of the filing PDF) | 6 |
| 255 | Lorbrena 25 mg tab 3000069022701Listed by the FDA as Lorbrenalorlatinib25 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 214,487.36 (Schedule G, line 255, page 18 of the filing PDF) | 25 |
| 256 | Lorbrena 100 mg tab 3000069023101Listed by the FDA as Lorbrenalorlatinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 213,731.50 (Schedule G, line 256, page 18 of the filing PDF) | 13 |
| 257 | Jivi Factor FVIII 3,383 IU VL00026394825Listed by the FDA as Jiviantihemophilic factor (recombinant) pegylated-auclkitBayer HealthCare LLC | 212,773.34 (Schedule G, line 257, page 18 of the filing PDF) | fewer than 6 (the count is not shown) |
| 258 | Mavyret 100/40 mg tab 8400074262528Listed by the FDA as Mavyretglecaprevir and pibrentasvir40 mg; 100 mgtablet, film coatedAbbVie Inc. | 211,664.50 (Schedule G, line 258, page 18 of the filing PDF) | 23 |
| 259 | Remicade 100 mg SDV57894003001Listed by the FDA as Remicadeinfliximab100 mg/10 mLinjection, powder, lyophilized, for solutionJanssen Biotech, Inc. | 211,340.60 (Schedule G, line 259, page 18 of the filing PDF) | 237 |
| 260 | Bavencio 200 mg VL 10 mL44087353501Listed by the FDA as Bavencioavelumab20 mg/mLinjection, solution, concentrateEMD Serono, Inc. | 210,487.74 (Schedule G, line 260, page 18 of the filing PDF) | 21 |
| 261 | Cimzia 2x200 mg/mL SDV kit50474070062Listed by the FDA as Cimziacertolizumab pegolkitUCB, Inc. | 206,739.49 (Schedule G, line 261, page 18 of the filing PDF) | 117 |
| 262 | Brixadi 128 mg ER PFS kit 0.36 mL58284022801Listed by the FDA as Brixadibuprenorphine128 mg/0.36 mLinjectionBraeburn Inc. | 204,277.67 (Schedule G, line 262, page 18 of the filing PDF) | 177 |
| 263 | Inqovi 35 mg/100 mg tab 564842072709Listed by the FDA as Inqovicedazuridine and decitabine100 mg; 35 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd. | 203,864.66 (Schedule G, line 263, page 18 of the filing PDF) | 30 |
| 264 | Actemra 80 mg SDV 4 mL50242013501Listed by the FDA as Actemratocilizumab80 mg/4 mLinjection, solution, concentrateGenentech, Inc. | 199,847.58 (Schedule G, line 264, page 18 of the filing PDF) | 527 |
| 265 | Lenvima 10 mg cap 3062856071030Listed by the FDA as Lenvimalenvatinib10 mgcapsuleEisai Inc. | 199,628.82 (Schedule G, line 265, page 18 of the filing PDF) | 18 |
| 266 | Pomalyst DS 3 mg cap 2159572050321Listed by the FDA as Pomalystpomalidomide3 mgcapsuleCelgene Corporation | 195,257.48 (Schedule G, line 266, page 18 of the filing PDF) | 17 |
| 267 | Aranesp 200 mcg PFS 0.4 mL55513002801Listed by the FDA as Aranespdarbepoetin alfa200 mcg/0.4 mLinjection, solutionAmgen, Inc | 193,120.00 (Schedule G, line 267, page 18 of the filing PDF) | 426 |
| 268 | Tasigna 150 mg cap 112 (4x28)00078059287Listed by the FDA as Tasignanilotinib150 mgcapsuleNovartis Pharmaceuticals Corporation | 192,884.78 (Schedule G, line 268, page 18 of the filing PDF) | 59 |
| 269 | Jivi Factor FVIII 1,999 IU VL00026394625Listed by the FDA as Jiviantihemophilic factor (recombinant) pegylated-auclkitBayer HealthCare LLC | 192,092.20 (Schedule G, line 269, page 18 of the filing PDF) | 7 |
| 270 | Udenyca 6 mg PFS 0.6 mL70114010101Listed by the FDA as Udenycapegfilgrastim-cbqv6 mg/0.6 mLinjection, solutionCoherus Oncology, Inc. | 191,458.63 (Schedule G, line 270, page 18 of the filing PDF) | 292 |
| 271 | Cablivi 11 mg LYP pwd SDV kit58468022501Listed by the FDA as CablivicaplacizumabkitGenzyme Corporation | 188,395.50 (Schedule G, line 271, page 18 of the filing PDF) | fewer than 6 (the count is not shown) |
| 272 | Tremfya 200 mg PFP 2 mL57894065102Listed by the FDA as Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc. | 188,164.30 (Schedule G, line 272, page 18 of the filing PDF) | 43 |
| 273 | Tezspire 210 mg PFS 1.91 mL55513011201Listed by the FDA as Tezspiretezepelumab-ekko210 mg/1.9 mLinjection, solutionAmgen Inc | 188,042.43 (Schedule G, line 273, page 18 of the filing PDF) | 55 |
| 274 | Ozempic 0.25/0.5 mg PFP 3 mL00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 186,028.34 (Schedule G, line 274, page 18 of the filing PDF) | 521 |
| 275 | Abilify Maint 400 mg kit59148001971 | 184,165.74 (Schedule G, line 275, page 18 of the filing PDF) | 147 |
| 276 | Ingrezza 80 mg cap 3070370108001Listed by the FDA as Ingrezzavalbenazine80 mgcapsuleNeurocrine Biosciences, Inc. | 183,721.00 (Schedule G, line 276, page 18 of the filing PDF) | 33 |
| 277 | Mounjaro 7.5 mg PFP 4x0.5 mL00002148480Listed by the FDA as Mounjarotirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 183,185.50 (Schedule G, line 277, page 18 of the filing PDF) | 242 |
| 278 | Doptelet 20 mg tab 1071369002010Listed by the FDA as Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc. | 182,442.57 (Schedule G, line 278, page 18 of the filing PDF) | 38 |
| 279 | TNKase 50 mg SDV50242012047Listed by the FDA as TNKasetenecteplasekitGenentech, Inc. | 181,672.74 (Schedule G, line 279, page 18 of the filing PDF) | 207 |
| 280 | Pomalyst DS 2 mg cap 2159572050221Listed by the FDA as Pomalystpomalidomide2 mgcapsuleCelgene Corporation | 177,736.29 (Schedule G, line 280, page 18 of the filing PDF) | 10 |
| 281 | Mounjaro 5 mg PFP 4x0.5 mL00002149580Listed by the FDA as Mounjarotirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company | 176,918.44 (Schedule G, line 281, page 18 of the filing PDF) | 265 |
| 282 | Procrit 40 MU SDV 4x1 mL59676034001Listed by the FDA as Procriterythropoietin40,000 IU/mLinjection, solutionJanssen Products, LP | 175,216.41 (Schedule G, line 282, page 18 of the filing PDF) | 512 |
| 283 | Xpovio 60 mg once wkly tab (60 mg x 4) BP72237010401Listed by the FDA as Xpovioselinexor60 mgtablet, film coatedKaryopharm Therapeutics Inc. | 174,760.63 (Schedule G, line 283, page 18 of the filing PDF) | 8 |
| 284 | Trulicity 3 mg PFP 4x0.5 mL00002223680Listed by the FDA as Trulicitydulaglutide3 mg/0.5 mLinjection, solutionEli Lilly and Company | 174,570.83 (Schedule G, line 284, page 18 of the filing PDF) | 204 |
| 285 | Tezspire 210 mg PFP 1.91 mL55513012301Listed by the FDA as Tezspiretezepelumab-ekko210 mg/1.9 mLinjection, solutionAmgen Inc | 174,013.36 (Schedule G, line 285, page 18 of the filing PDF) | 61 |
| 286 | Tepmetko 225 mg tab 60 (6x10) DS44087500006Listed by the FDA as Tepmetkotepotinib hydrochloride225 mgtabletEMD Serono, Inc. | 170,527.29 (Schedule G, line 286, page 19 of the filing PDF) | 13 |
| 287 | Simponi Aria 50 mg SDV 4 mL57894035001Listed by the FDA as Simponi Ariagolimumab50 mg/4 mLsolutionJanssen Biotech, Inc. | 169,842.59 (Schedule G, line 287, page 19 of the filing PDF) | 180 |
| 288 | Mvasi 100 mg SDV 4 mL55513020601Listed by the FDA as Mvasibevacizumab-awwb100 mg/4 mLinjection, solutionAmgen, Inc | 169,469.59 (Schedule G, line 288, page 19 of the filing PDF) | 741 |
| 289 | Trikafta 100/50/75 oral51167044601Listed by the FDA as Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated | 168,661.68 (Schedule G, line 289, page 19 of the filing PDF) | 7 |
| 290 | Tyenne 400 mg SDV 20 mL65219059420Listed by the FDA as Tyennetocilizumab-aazg400 mg/20 mLinjection, solution, concentrateFresenius Kabi USA, LLC | 168,535.44 (Schedule G, line 290, page 19 of the filing PDF) | 123 |
| 291 | Promacta 25 mg tab 3000078068515Listed by the FDA as Promactaeltrombopag olamine25 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 166,617.34 (Schedule G, line 291, page 19 of the filing PDF) | 132 |
| 292 | Vyloy 100 mg SDV00469342510Listed by the FDA as Vyloyzolbetuximab20 mg/mLinjection, powder, for suspensionAstellas Pharma US, Inc. | 163,453.43 (Schedule G, line 292, page 19 of the filing PDF) | 12 |
| 293 | Invega Susten 156 mg PFS 1 mL50458056301Listed by the FDA as Invega Sustennapaliperidone palmitate156 mg/mLinjectionJanssen Pharmaceuticals, Inc. | 162,867.93 (Schedule G, line 293, page 19 of the filing PDF) | 183 |
| 294 | Xolair 150 mg/mL PFS 1 mL50242021501Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.the product is listed, not this package | 162,698.92 (Schedule G, line 294, page 19 of the filing PDF) | 119 |
| 295 | Ibrance 125 mg cap 2100069018921Listed by the FDA as Ibrancepalbociclib125 mgcapsulePfizer Laboratories Div Pfizer Inc | 160,787.33 (Schedule G, line 295, page 19 of the filing PDF) | 17 |
| 296 | Pomalyst DS 1 mg cap 2159572050121Listed by the FDA as Pomalystpomalidomide1 mgcapsuleCelgene Corporation | 159,677.74 (Schedule G, line 296, page 19 of the filing PDF) | 18 |
| 297 | Itovebi 9 mg tab 2850242007908Listed by the FDA as Itovebiinavolisib9 mgtablet, film coatedGenentech, Inc. | 157,110.01 (Schedule G, line 297, page 19 of the filing PDF) | 10 |
| 298 | Xolair 300 mg PFS 2 mL50242022701Listed by the FDA as Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc. | 155,221.87 (Schedule G, line 298, page 19 of the filing PDF) | 50 |
| 299 | Praluent 75 mg/mL PFP 261755002002Listed by the FDA as Praluentalirocumab75 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc. | 153,224.00 (Schedule G, line 299, page 19 of the filing PDF) | 374 |
| 300 | Altuviiio 2,000 IU LFP VL71104098201Listed by the FDA as Altuviiioantihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlkitBioverativ Therapeutics Inc. | 152,739.96 (Schedule G, line 300, page 19 of the filing PDF) | 6 |
| 301 | Austedo 12 mg tab 6068546017260Listed by the FDA as Austedodeutetrabenazine12 mgtablet, coatedTeva Neuroscience, Inc. | 152,708.19 (Schedule G, line 301, page 19 of the filing PDF) | 34 |
| 302 | Parsabiv 2.5 mg SDV 10x0.5 mL55513074010Listed by the FDA as Parsabivetelcalcetide2.5 mg/0.5 mLinjection, solutionAmgen, Inc | 152,266.09 (Schedule G, line 302, page 19 of the filing PDF) | 1,140 |
| 303 | Mounjaro 15 mg PFP 4x0.5 mL00002145780Listed by the FDA as Mounjarotirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company | 152,049.52 (Schedule G, line 303, page 19 of the filing PDF) | 227 |
| 304 | Tzield inj 2 mg/2 mL73650031614Listed by the FDA as Tzieldteplizumab-mzwv1 mg/mLinjectionProvention Bio, Inc.the product is listed, not this package | 151,638.56 (Schedule G, line 304, page 19 of the filing PDF) | fewer than 6 (the count is not shown) |
| 305 | Zynyz 500 mg SDV 20 mL50881000603Listed by the FDA as Zynyzretifanlimab-dlwr25 mg/mLinjectionIncyte Corporation | 151,115.99 (Schedule G, line 305, page 19 of the filing PDF) | 19 |
| 306 | Kalydeco PED gran 50 mg 5651167030001Listed by the FDA as Kalydecoivacaftor50 mggranuleVertex Pharmaceuticals Incorporated | 150,965.50 (Schedule G, line 306, page 19 of the filing PDF) | 7 |
| 307 | Eloctate kit 2,000 IU VL71104080601Listed by the FDA as Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc. | 150,655.00 (Schedule G, line 307, page 19 of the filing PDF) | 6 |
| 308 | Kisqali 200 mg tab 21 REF00078086001Listed by the FDA as Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 150,279.32 (Schedule G, line 308, page 19 of the filing PDF) | 43 |
| 309 | Xtandi 40 mg cap 12000469012599Listed by the FDA as Xtandienzalutamide40 mgcapsuleAstellas Pharma US, Inc. | 149,866.21 (Schedule G, line 309, page 19 of the filing PDF) | 34 |
| 310 | Xolair 150 mg PFS 1 mL50242021503Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc. | 149,750.00 (Schedule G, line 310, page 19 of the filing PDF) | 99 |
| 311 | Ozempic 2 mg/0.75 mL PFP 3 mL00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 148,986.70 (Schedule G, line 311, page 19 of the filing PDF) | 434 |
| 312 | TNKase 50 mg SDV50242017601Listed by the FDA as TNKasetenecteplasekitGenentech, Inc. | 147,584.93 (Schedule G, line 312, page 19 of the filing PDF) | 79 |
| 313 | Inlyta 5 mg tab 6000069015111Listed by the FDA as Inlytaaxitinib5 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 146,759.46 (Schedule G, line 313, page 19 of the filing PDF) | 19 |
| 314 | Votrient 200 mg tab 12000078107766Listed by the FDA as Votrientpazopanib hydrochloride200 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 146,121.03 (Schedule G, line 314, page 19 of the filing PDF) | 18 |
| 315 | Jivi Factor FVIII 4,110 IU VL00026395050Listed by the FDA as Jiviantihemophilic factor (recombinant) pegylated-auclkitBayer HealthCare LLC | 145,645.32 (Schedule G, line 315, page 19 of the filing PDF) | fewer than 6 (the count is not shown) |
| 316 | Sandostatin LAR Depot 20 mg kit00078081881Listed by the FDA as Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation | 145,199.88 (Schedule G, line 316, page 19 of the filing PDF) | 89 |
| 317 | Lenvima 4 mg cap 3062856070430Listed by the FDA as Lenvimalenvatinib4 mgcapsuleEisai Inc. | 144,985.51 (Schedule G, line 317, page 19 of the filing PDF) | 12 |
| 318 | Xolair 150 mg Psvfree Lypoh SDV50242004062Listed by the FDA as Xolairomalizumab150 mg/1.2 mLinjection, solutionGenentech, Inc. | 143,293.50 (Schedule G, line 318, page 19 of the filing PDF) | 52 |
| 319 | Ibrance 75 mg cap 2100069018721Listed by the FDA as Ibrancepalbociclib75 mgcapsulePfizer Laboratories Div Pfizer Inc | 141,725.26 (Schedule G, line 319, page 19 of the filing PDF) | 21 |
| 320 | Aranesp 40 mcg SYG 4x0.4 mL55513002104Listed by the FDA as Aranespdarbepoetin alfa40 mcg/0.4 mLinjection, solutionAmgen, Inc | 140,786.67 (Schedule G, line 320, page 19 of the filing PDF) | 1,176 |
| 321 | Aranesp 100 mcg PFS 4x0.5 mL55513002504Listed by the FDA as Aranespdarbepoetin alfa100 mcg/0.5 mLinjection, solutionAmgen, Inc | 140,518.83 (Schedule G, line 321, page 19 of the filing PDF) | 536 |
| 322 | Ozempic 1 mg/0.75 mL PFP 3 mL00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 136,825.78 (Schedule G, line 322, page 19 of the filing PDF) | 399 |
| 323 | Imbruvica 280 mg tab 2857962028028Listed by the FDA as Imbruvicaibrutinib280 mgtablet, film coatedPharmacyclics LLC | 136,716.24 (Schedule G, line 323, page 19 of the filing PDF) | 11 |
| 324 | Olumiant 4 mg tab 3000002447930Listed by the FDA as Olumiantbaricitinib4 mgtablet, film coatedEli Lilly and Company | 135,871.39 (Schedule G, line 324, page 20 of the filing PDF) | 33 |
| 325 | Adakveo 100 mg SDV 10 mL00078088361Listed by the FDA as Adakveocrizanlizumab10 mg/mLinjectionNovartis Pharmaceuticals Corporation | 135,267.34 (Schedule G, line 325, page 20 of the filing PDF) | 36 |
| 326 | Privigen 5 g SDV 50 mL44206043605Listed by the FDA as Privigenhuman immunoglobulin G5 g/50 mLliquidCSL Behring AG | 134,952.18 (Schedule G, line 326, page 20 of the filing PDF) | 465 |
| 327 | Jakafi 15 mg tab 6050881001560Listed by the FDA as Jakafiruxolitinib15 mgtabletIncyte Corporation | 134,466.91 (Schedule G, line 327, page 20 of the filing PDF) | 22 |
| 328 | Mounjaro 2.5 mg PFP 4x0.5 mL00002150680Listed by the FDA as Mounjarotirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 134,244.17 (Schedule G, line 328, page 20 of the filing PDF) | 206 |
| 329 | Mounjaro 10 mg PFP 4x0.5 mL00002147180Listed by the FDA as Mounjarotirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company | 133,243.03 (Schedule G, line 329, page 20 of the filing PDF) | 169 |
| 330 | Gammagard 10% 10 g VL 100 mL DS00944270005Listed by the FDA as Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc. | 133,015.43 (Schedule G, line 330, page 20 of the filing PDF) | 176 |
| 331 | Spevigo 150 mg PFS 2x1 mL00597062020Listed by the FDA as Spevigospesolimab-sbzo150 mginjectionBoehringer Ingelheim Pharmaceuticals, Inc. | 132,987.70 (Schedule G, line 331, page 20 of the filing PDF) | 8 |
| 332 | Afinitor 5 mg tab 4x700078056651Listed by the FDA as Afinitoreverolimus5 mgtabletNovartis Pharmaceuticals Corporation | 131,368.50 (Schedule G, line 332, page 20 of the filing PDF) | 25 |
| 333 | Jakafi 10 mg tab 6050881001060Listed by the FDA as Jakafiruxolitinib10 mgtabletIncyte Corporation | 128,691.97 (Schedule G, line 333, page 20 of the filing PDF) | 31 |
| 334 | Vpriv 400 units SDV54092070104Listed by the FDA as Vprivvelaglucerase alfa2.5 mg/mLinjection, powder, lyophilized, for solutionTakeda Pharmaceuticals America, Inc. | 128,637.43 (Schedule G, line 334, page 20 of the filing PDF) | 9 |
| 335 | Ibrance 100 mg cap 2100069018821Listed by the FDA as Ibrancepalbociclib100 mgcapsulePfizer Laboratories Div Pfizer Inc | 127,703.16 (Schedule G, line 335, page 20 of the filing PDF) | 13 |
| 336 | Dysport 500 units SDV15054050001Listed by the FDA as Dysportbotulinum toxin type A500 unitsinjection, powder, lyophilized, for solutionIpsen Biopharmaceuticals, Inc. | 126,105.00 (Schedule G, line 336, page 20 of the filing PDF) | 116 |
| 337 | Zepbound 10 mg PFP 4x0.5 mL00002247180Listed by the FDA as Zepboundtirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company | 125,800.78 (Schedule G, line 337, page 20 of the filing PDF) | 162 |
| 338 | Sarclisa 100 mg SDV 5 mL00024065401Listed by the FDA as Sarclisaisatuximab100 mg/5 mLinjection, solution, concentrateSanofi-Aventis U.S. LLC | 122,332.49 (Schedule G, line 338, page 20 of the filing PDF) | 98 |
| 339 | Venofer 100 mg SDV 10x5 mL00517234010Listed by the FDA as Venoferiron sucrose20 mg/mLinjection, solutionAmerican Regent, Inc. | 122,092.35 (Schedule G, line 339, page 20 of the filing PDF) | 1,660 |
| 340 | Actemra SUBQ 162 mg PFS 0.9 mL50242013801Listed by the FDA as Actemratocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc. | 120,926.37 (Schedule G, line 340, page 20 of the filing PDF) | 93 |
| 341 | Gablofen 2,000 mcg/mL PFS 20 mL DS66794015701Listed by the FDA as Gablofenbaclofen injection2,000 mcg/mLinjection, solutionPiramal Critical Care Inc | 120,840.00 (Schedule G, line 341, page 20 of the filing PDF) | 120 |
| 342 | Firmagon 80 mg kit55566830301Listed by the FDA as FirmagondegarelixkitFerring Pharmaceuticals Inc. | 120,102.73 (Schedule G, line 342, page 20 of the filing PDF) | 415 |
| 343 | Braftovi 75 mg 2x90 cap 180 BTL70255002501Listed by the FDA as Braftoviencorafenib75 mgcapsuleArray BioPharma Inc. | 118,079.30 (Schedule G, line 343, page 20 of the filing PDF) | 17 |
| 344 | Wegovy 1.7 mg PFP 4x0.75 mL00169451714Listed by the FDA as Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 117,674.61 (Schedule G, line 344, page 20 of the filing PDF) | 200 |
| 345 | Zepbound 5 mg PFP 4x0.5 mL00002249580Listed by the FDA as Zepboundtirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company | 116,820.55 (Schedule G, line 345, page 20 of the filing PDF) | 166 |
| 346 | Imbruvica 70 mg-mL sol 108 mL57962000712Listed by the FDA as Imbruvicaibrutinib70 mg/mLsuspensionPharmacyclics LLC | 116,493.56 (Schedule G, line 346, page 20 of the filing PDF) | 8 |
| 347 | Otulfi 90 mg PFS 1 mL65219082626Listed by the FDA as Otulfiustekinumab-aauz90 mg/mLinjection, solutionFresenius Kabi USA, LLC | 114,967.76 (Schedule G, line 347, page 20 of the filing PDF) | 57 |
| 348 | Herceptin 150 mg SDV50242013201Listed by the FDA as Herceptintrastuzumab150 mg/7.4 mLinjection, powder, lyophilized, for solutionGenentech, Inc. | 113,769.56 (Schedule G, line 348, page 20 of the filing PDF) | 37 |
| 349 | Radicava ORS 105 mg/5 mL sus kit 50 mL70510232201Listed by the FDA as Radicava ORSedaravonekitShionogi Inc. | 113,432.64 (Schedule G, line 349, page 20 of the filing PDF) | 12 |
| 350 | Tymlos 80 mcg PF Multi-dose pen70539000102Listed by the FDA as Tymlosabaloparatide3.12 mg/1.56 mLinjection, solutionRadius Health, Inc. | 112,528.68 (Schedule G, line 350, page 20 of the filing PDF) | 83 |
| 351 | Valtoco 10 mg nasal SPY 5 (5x10 mg) BP72252051005Listed by the FDA as Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc | 112,059.92 (Schedule G, line 351, page 20 of the filing PDF) | 127 |
| 352 | Datroway 100 mg SDV65597080101Listed by the FDA as Datrowaydatopotamab deruxtecan100 mg/5 mLinjection, powder, lyophilized, for solutionDaiichi Sankyo Inc. | 112,006.20 (Schedule G, line 352, page 20 of the filing PDF) | fewer than 6 (the count is not shown) |
| 353 | Zepbound 7.5 mg PFP 4x0.5 mL00002248480Listed by the FDA as Zepboundtirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 110,771.54 (Schedule G, line 353, page 20 of the filing PDF) | 154 |
| 354 | Imbruvica 140 mg tab 2857962001428Listed by the FDA as Imbruvicaibrutinib140 mgtablet, film coatedPharmacyclics LLC | 109,540.80 (Schedule G, line 354, page 20 of the filing PDF) | 12 |
| 355 | Aranesp 500 mcg PFS 1 mL55513003201Listed by the FDA as Aranespdarbepoetin alfa500 mcg/mLinjection, solutionAmgen, Inc | 109,289.17 (Schedule G, line 355, page 20 of the filing PDF) | 92 |
| 356 | Tyenne 80 mg SDV 4 mL65219059004Listed by the FDA as Tyennetocilizumab-aazg80 mg/4 mLinjection, solution, concentrateFresenius Kabi USA, LLC | 108,897.87 (Schedule G, line 356, page 20 of the filing PDF) | 307 |
| 357 | Abilify Maintena 300 mg kit59148023212Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc. | 108,561.54 (Schedule G, line 357, page 20 of the filing PDF) | 83 |
| 358 | Humira 80 mg-0.8 mL PFP kit 200074012402Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 106,105.10 (Schedule G, line 358, page 20 of the filing PDF) | 22 |
| 359 | Neulasta Onpro kit 6 mg PFS 0.6 mL 340B55513019201Listed by the FDA as NeulastapegfilgrastimkitAmgen, Inc | 105,895.78 (Schedule G, line 359, page 20 of the filing PDF) | 532 |
| 360 | Xromi 100 mg-mL oral sol 148 mL62484001505Listed by the FDA as Xromihydroxyurea100 mg/mLsolutionNova Laboratories, Ltd. | 105,520.68 (Schedule G, line 360, page 20 of the filing PDF) | 160 |
| 361 | Austedo 9 mg tab 6068546017160Listed by the FDA as Austedodeutetrabenazine9 mgtablet, coatedTeva Neuroscience, Inc. | 105,256.36 (Schedule G, line 361, page 20 of the filing PDF) | 17 |
| 362 | Orencia Clickject 125 mg/mL inj 400003218851Listed by the FDA as Orenciaabatacept125 mg/mLinjection, solutionE.R. Squibb & Sons, L.L.C. | 105,041.64 (Schedule G, line 362, page 21 of the filing PDF) | 418 |
| 363 | BESREMi 500 mcg PFS 1 mL73536050001Listed by the FDA as BESREMiropeginterferon alfa-2b500 mcg/mLinjectionPharmaEssentia USA | 103,614.34 (Schedule G, line 363, page 21 of the filing PDF) | 10 |
| 364 | Eloctate kit 744 IU VL71104080301Listed by the FDA as Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc. | 102,528.09 (Schedule G, line 364, page 21 of the filing PDF) | 0 |
| 365 | Vumerity 231 mg Bottle 120 cap64406002003Listed by the FDA as Vumeritydiroximel fumarate231 mgcapsuleBiogen Inc. | 102,238.37 (Schedule G, line 365, page 21 of the filing PDF) | 26 |
| 366 | Winrevair 60 mg pwd kit00006509101Listed by the FDA as Winrevairsotatercept-csrkkitMerck Sharp & Dohme LLC | 101,147.24 (Schedule G, line 366, page 21 of the filing PDF) | 9 |
| 367 | Promacta 75 mg tab 3000078068715Listed by the FDA as Promactaeltrombopag olamine75 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 100,882.64 (Schedule G, line 367, page 21 of the filing PDF) | 30 |
| 368 | Promacta 25 mg pak 3000078069761Listed by the FDA as Promactaeltrombopag olamine25 mgpowder, for suspensionNovartis Pharmaceuticals Corporation | 97,643.06 (Schedule G, line 368, page 21 of the filing PDF) | 21 |
| 369 | Afstyla 2,768 IU SDV69911048102Listed by the FDA as Afstyla Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinantkitCSL Behring Lengnau AG | 95,911.20 (Schedule G, line 369, page 21 of the filing PDF) | fewer than 6 (the count is not shown) |
| 370 | Promacta 50 mg tab 3000078068615Listed by the FDA as Promactaeltrombopag olamine50 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 95,455.56 (Schedule G, line 370, page 21 of the filing PDF) | 22 |
| 371 | Risperidone 50 mg ER inj sus kit00480145308Listed by the FDA as RisperidonekitTeva Pharmaceuticals, Inc. | 95,203.29 (Schedule G, line 371, page 21 of the filing PDF) | 121 |
| 372 | Sprycel 100 mg tab 3000003085222Listed by the FDA as Spryceldasatinib100 mgtabletE.R. Squibb & Sons, L.L.C. | 94,497.86 (Schedule G, line 372, page 21 of the filing PDF) | 114 |
| 373 | Tyenne 162 mg auto inj 0.9 mL65219058401Listed by the FDA as Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC | 93,219.87 (Schedule G, line 373, page 21 of the filing PDF) | 73 |
| 374 | Venclexta 1 X 100 mg tab00074057611Listed by the FDA as Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc. | 92,698.62 (Schedule G, line 374, page 21 of the filing PDF) | 45 |
| 375 | Adzynma 1,664 units 1 EA64764014505Listed by the FDA as Adzynmaapadamtase alfakitTakeda Pharmaceuticals America, Inc. | 92,684.80 (Schedule G, line 375, page 21 of the filing PDF) | 14 |
| 376 | Mektovi 15 mg tab 18070255001002Listed by the FDA as Mektovibinimetinib15 mgtablet, film coatedArray BioPharma Inc. | 92,380.45 (Schedule G, line 376, page 21 of the filing PDF) | 7 |
| 377 | Tavalisse 100 mg tab 6071332000101Listed by the FDA as Tavalissefostamatinib100 mgtabletRigel Pharmaceuticals, Inc. | 92,133.10 (Schedule G, line 377, page 21 of the filing PDF) | 15 |
| 378 | Lynparza 100 mg tab 6000310066860Listed by the FDA as Lynparzaolaparib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 91,790.84 (Schedule G, line 378, page 21 of the filing PDF) | 16 |
| 379 | Tukysa 150 mg tab 6051144000260Listed by the FDA as Tukysatucatinib150 mgtabletSeagen Inc. | 90,969.17 (Schedule G, line 379, page 21 of the filing PDF) | 6 |
| 380 | Halaven 1 mg SDV 2 mL62856038901Listed by the FDA as Halaveneribulin mesylate0.5 mg/mLinjectionEisai Inc. | 90,303.86 (Schedule G, line 380, page 21 of the filing PDF) | 78 |
| 381 | Tabrecta 150 mg tab 5600078070956Listed by the FDA as Tabrectacapmatinib150 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 90,001.30 (Schedule G, line 381, page 21 of the filing PDF) | 7 |
| 382 | Glucagon 1 mg VL 10x3 mL63323059613Listed by the FDA as Glucagon1 mg/mLinjection, powder, lyophilized, for solutionFresenius Kabi USA, LLC | 89,251.68 (Schedule G, line 382, page 21 of the filing PDF) | 354 |
| 383 | Zenpep 20,000 units DR cap 10073562011201Listed by the FDA as Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase20,000 USP units; 63,000 USP units; 84,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc. | 89,060.62 (Schedule G, line 383, page 21 of the filing PDF) | 33 |
| 384 | Entresto FCT 24/ 26 mg tab 6000078065920Listed by the FDA as Entrestosacubitril and valsartan24 mg; 26 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 88,381.79 (Schedule G, line 384, page 21 of the filing PDF) | 603 |
| 385 | Xolair 300 mg auto inj 2 mL50242022755Listed by the FDA as Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc. | 88,079.72 (Schedule G, line 385, page 21 of the filing PDF) | 38 |
| 386 | Invega Hafyera 1,092 mg PFS 3.5 mL50458061101Listed by the FDA as Invega Hafyerapaliperidone palmitate1,092 mg/3.5 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc | 87,817.69 (Schedule G, line 386, page 21 of the filing PDF) | 12 |
| 387 | Mounjaro 12.5 mg PFP 4x0.5 mL00002146080Listed by the FDA as Mounjarotirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 87,629.90 (Schedule G, line 387, page 21 of the filing PDF) | 121 |
| 388 | Invega Trinza 410 mg SYG 1.32 mL50458060701Listed by the FDA as Invega Trinzapaliperidone palmitate410 mg/1.32 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc | 86,607.64 (Schedule G, line 388, page 21 of the filing PDF) | 34 |
| 389 | Tafinlar 50 mg cap 12000078068266Listed by the FDA as Tafinlardabrafenib50 mgcapsuleNovartis Pharmaceuticals Corporation | 86,038.73 (Schedule G, line 389, page 21 of the filing PDF) | 19 |
| 390 | Baqsimi 3 mg pwd 200548835202Listed by the FDA as Baqsimiglucagon3 mgpowderAmphastar Pharmaceuticals, Inc. | 85,196.97 (Schedule G, line 390, page 21 of the filing PDF) | 239 |
| 391 | Aranesp 60 mcg PFS 4x0.3 mL55513002304Listed by the FDA as Aranespdarbepoetin alfa60 mcg/0.3 mLinjection, solutionAmgen, Inc | 85,009.18 (Schedule G, line 391, page 21 of the filing PDF) | 668 |
| 392 | Gleevec 400 mg tab 30 (3x10) BP00078064913Listed by the FDA as Gleevecimatinib mesylate400 mgtabletNovartis Pharmaceuticals Corporation | 84,672.95 (Schedule G, line 392, page 21 of the filing PDF) | 22 |
| 393 | Recothrom 5,000 IU kit00338032201Listed by the FDA as Recothromthrombin topical recombinantkitBaxter Healthcare Corporation | 84,269.15 (Schedule G, line 393, page 21 of the filing PDF) | 1,194 |
| 394 | Humira CF 20 mg-0.2 mL PFS kit 200074061602Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 83,808.22 (Schedule G, line 394, page 21 of the filing PDF) | 53 |
| 395 | Tyenne 200 mg SDV 10 mL65219059210Listed by the FDA as Tyennetocilizumab-aazg200 mg/10 mLinjection, solution, concentrateFresenius Kabi USA, LLC | 83,733.79 (Schedule G, line 395, page 21 of the filing PDF) | 99 |
| 396 | BeneFIX-RT PDS 3,100 IU VL58394063703Listed by the FDA as BeneFIXcoagulation factor ix (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 82,864.74 (Schedule G, line 396, page 21 of the filing PDF) | fewer than 6 (the count is not shown) |
| 397 | Trulicity pen inj 1.5 mg 4x0.5 mL00002143480Listed by the FDA as Trulicitydulaglutide1.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 82,132.53 (Schedule G, line 397, page 21 of the filing PDF) | 226 |
| 398 | Talzenna 0.5 mg cap 3000069150130Listed by the FDA as Talzennatalazoparib0.5 mgcapsulePfizer Laboratories Div Pfizer Inc | 81,422.52 (Schedule G, line 398, page 21 of the filing PDF) | fewer than 6 (the count is not shown) |
| 399 | Aranesp 300 mcg PFS 0.6 mL55513011101Listed by the FDA as Aranespdarbepoetin alfa300 mcg/0.6 mLinjection, solutionAmgen, Inc | 80,350.74 (Schedule G, line 399, page 21 of the filing PDF) | 118 |
| 400 | Firmagon 240 mg kit55566840301Listed by the FDA as FirmagondegarelixkitFerring Pharmaceuticals Inc. | 80,102.17 (Schedule G, line 400, page 22 of the filing PDF) | 99 |
| 401 | Erivedge 150 mg cap 2850242014001Listed by the FDA as Erivedgevismodegib150 mgcapsuleGenentech, Inc. | 80,088.20 (Schedule G, line 401, page 22 of the filing PDF) | 17 |
| 402 | Norditropin Flex Pro 15 mg PFP 1.5 mL00169770821Listed by the FDA as Norditropinsomatropin15 mg/1.5 mLinjection, solutionNovo Nordisk | 79,614.12 (Schedule G, line 402, page 22 of the filing PDF) | 565 |
| 403 | Avsola 100 mg SDV55513067001Listed by the FDA as Avsolainfliximab-axxq100 mg/10 mLinjection, powder, lyophilized, for solutionAmgen, Inc | 79,471.11 (Schedule G, line 403, page 22 of the filing PDF) | 110 |
| 404 | Pertzye 24 MU DR cap 20059767002402Listed by the FDA as Pertzyepancrelipase24,000 USP units; 90,750 USP units; 86,250 USP unitscapsule, delayed releaseDigestive Care, Inc. | 79,152.40 (Schedule G, line 404, page 22 of the filing PDF) | 14 |
| 405 | Erleada 240 mg tab 3059676060430Listed by the FDA as Erleadaapalutamide240 mgtablet, film coatedJanssen Products, LP | 79,137.16 (Schedule G, line 405, page 22 of the filing PDF) | 11 |
| 406 | Basaglar 100 units/mL PFP 5x3 mL00002771559Listed by the FDA as Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company | 78,808.24 (Schedule G, line 406, page 22 of the filing PDF) | 348 |
| 407 | Lenvima 12 mg cap 9062856071230Listed by the FDA as Lenvimalenvatinib4 mgcapsuleEisai Inc. | 77,309.34 (Schedule G, line 407, page 22 of the filing PDF) | 7 |
| 408 | Trulicity 4.5 mg PFP 4x0.5 mL00002318280Listed by the FDA as Trulicitydulaglutide4.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 76,761.40 (Schedule G, line 408, page 22 of the filing PDF) | 91 |
| 409 | Cresemba 186 mg cap 1400469052002Listed by the FDA as Cresembaisavuconazonium sulfate100 mgcapsuleAstellas Pharma US, Inc. | 76,425.35 (Schedule G, line 409, page 22 of the filing PDF) | 31 |
| 410 | Botox DS 200 units VL00023392102Listed by the FDA as BotoxonabotulinumtoxinA200 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc. | 76,111.63 (Schedule G, line 410, page 22 of the filing PDF) | 43 |
| 411 | Genvoya 150/150/200/10 mg tab 3061958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc. | 76,033.28 (Schedule G, line 411, page 22 of the filing PDF) | 46 |
| 412 | Retacrit 40,000 units/mL VL 4x1 mL00069130904Listed by the FDA as Retacritepoetin alfa-epbx40,000 IU/mLinjection, solutionPfizer Laboratories Div Pfizer Inc | 75,556.37 (Schedule G, line 412, page 22 of the filing PDF) | 415 |
| 413 | Skytrofa 9.1 mg HGH 1x4BX73362000901Listed by the FDA as Skytrofalonapegsomatropin-tcgd9.1 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc. | 75,539.72 (Schedule G, line 413, page 22 of the filing PDF) | 30 |
| 414 | Brixadi 96 mg ER PFS kit 0.27 mL58284029601Listed by the FDA as Brixadibuprenorphine96 mg/0.27 mLinjectionBraeburn Inc. | 75,496.83 (Schedule G, line 414, page 22 of the filing PDF) | 61 |
| 415 | Humate-P 2,400 RCOF 1,000 IU FVIII63833061702Listed by the FDA as Humate-Pantihemophilic factor/von willebrand factor complex (human)kitCSL Behring GmbH | 75,243.51 (Schedule G, line 415, page 22 of the filing PDF) | 19 |
| 416 | Jascayd 18 mg tab 6000597731321Listed by the FDA as Jascaydnerandomilast18 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc. | 74,650.50 (Schedule G, line 416, page 22 of the filing PDF) | 6 |
| 417 | Cayston 75 mg 28day kit GIL61958090101Listed by the FDA as CaystonaztreonamkitGilead Sciences, Inc. | 74,248.76 (Schedule G, line 417, page 22 of the filing PDF) | 21 |
| 418 | Abilify Asimtufii 960 mg ER PFS 3.2 mL59148011480Listed by the FDA as Abilify Asimtufiiaripiprazole960 mg/3.2 mLinjection, suspension, extended releaseOtsuka America Pharmaceutical, Inc | 74,157.53 (Schedule G, line 418, page 22 of the filing PDF) | 17 |
| 419 | Cyclophosphamide 1 g SDV10019095601Listed by the FDA as Cyclophosphamide1 g/50 mLinjection, powder, for solutionBaxter Healthcare Company | 73,795.60 (Schedule G, line 419, page 22 of the filing PDF) | 731 |
| 420 | Onivyde 43 mg SDV 10 mL15054004301Listed by the FDA as Onivydeirinotecan hydrochloride4.3 mg/mLinjection, powder, for solutionIpsen Biopharmaceuticals, Inc. | 73,757.10 (Schedule G, line 420, page 22 of the filing PDF) | 22 |
| 421 | Leqvio 284 mg PFS 1.5 mL00078100060Listed by the FDA as Leqvioinclisiran284 mg/1.5 mLinjection, solutionNovartis Pharmaceuticals Corporation | 73,701.79 (Schedule G, line 421, page 22 of the filing PDF) | 23 |
| 422 | Litfulo 50 mg cap 2800069033428Listed by the FDA as Litfuloritlecitinib50 mgcapsulePfizer Laboratories Div Pfizer Inc | 73,197.31 (Schedule G, line 422, page 22 of the filing PDF) | 29 |
| 423 | Afstyla 3,347 IU SDV69911047802Listed by the FDA as Afstyla Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinantkitCSL Behring Lengnau AG | 72,161.32 (Schedule G, line 423, page 22 of the filing PDF) | fewer than 6 (the count is not shown) |
| 424 | Gammagard SD inj 10 g HU00944265804Listed by the FDA as Gammagard S/Dimmune globulin intravenous (human)kitTakeda Pharmaceuticals America, Inc. | 70,895.35 (Schedule G, line 424, page 22 of the filing PDF) | 234 |
| 425 | Zepbound 2.5 mg PFP 4x0.5 mL00002250680Listed by the FDA as Zepboundtirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 70,564.32 (Schedule G, line 425, page 22 of the filing PDF) | 101 |
| 426 | Dapagliflozin 10 mg tab 3066993045730Listed by the FDA as Dapagliflozin10 mgtablet, film coatedPrasco Laboratories | 69,769.79 (Schedule G, line 426, page 22 of the filing PDF) | 246 |
| 427 | Vosevi 400/100/100 mg tab 2861958240101Listed by the FDA as Vosevisofosbuvir, velpatasvir, and voxilaprevir400 mg; 100 mg; 100 mgtablet, film coatedGilead Sciences, Inc. | 69,446.46 (Schedule G, line 427, page 22 of the filing PDF) | fewer than 6 (the count is not shown) |
| 428 | Idhifa 50 mg tab 3059572070530Listed by the FDA as Idhifaenasidenib mesylate50 mgtablet, film coatedCelgene Corporation | 68,749.73 (Schedule G, line 428, page 22 of the filing PDF) | fewer than 6 (the count is not shown) |
| 429 | Ibtrozi 200 mg cap 90 (3x30)84651020093Listed by the FDA as Ibtrozitaletrectinib272 mgcapsuleNuvation Bio Inc. | 67,858.74 (Schedule G, line 429, page 22 of the filing PDF) | fewer than 6 (the count is not shown) |
| 430 | Tivicay 50 mg tab 3049702022813Listed by the FDA as Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company | 67,468.53 (Schedule G, line 430, page 22 of the filing PDF) | 190 |
| 431 | Zejula 200 mg tab 3000173091213Listed by the FDA as Zejulaniraparib200 mgtablet, film coatedGlaxoSmithKline LLC | 67,313.38 (Schedule G, line 431, page 22 of the filing PDF) | fewer than 6 (the count is not shown) |
| 432 | Genotropin 12 mg CRT00013264681Listed by the FDA as GenotropinsomatropinkitPfizer Laboratories Div Pfizer Inc | 67,269.56 (Schedule G, line 432, page 22 of the filing PDF) | 88 |
| 433 | Revlimid DS 10 mg cap 2859572041028Listed by the FDA as Revlimidlenalidomide10 mgcapsuleCelgene Corporation | 67,266.48 (Schedule G, line 433, page 22 of the filing PDF) | 17 |
| 434 | Winrevair 120 mg pwd kit 200006508801Listed by the FDA as Winrevairsotatercept-csrkkitMerck Sharp & Dohme LLC | 67,238.58 (Schedule G, line 434, page 22 of the filing PDF) | fewer than 6 (the count is not shown) |
| 435 | Envarsus 4 mg tab 10068992304001Listed by the FDA as Envarsus XRtacrolimus4 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc | 66,056.53 (Schedule G, line 435, page 22 of the filing PDF) | 434 |
| 436 | Bosulif 100 mg tab 12000069013501Listed by the FDA as Bosulifbosutinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 64,711.15 (Schedule G, line 436, page 22 of the filing PDF) | 19 |
| 437 | Avastin 400 mg SDV 16 mL50242006101Listed by the FDA as Avastinbevacizumab400 mg/16 mLinjection, solutionGenentech, Inc. | 64,614.75 (Schedule G, line 437, page 22 of the filing PDF) | 23 |
| 438 | Invega Susten 117 mg SYG 0.75 mL50458056201Listed by the FDA as Invega Sustennapaliperidone palmitate117 mg/0.75 mLinjectionJanssen Pharmaceuticals, Inc. | 64,081.75 (Schedule G, line 438, page 23 of the filing PDF) | 107 |
| 439 | TOBI Podhaler 28 mg cap 4x5649502040124Listed by the FDA as TOBI Podhalertobramycin28 mgcapsuleViatris Specialty LLC | 63,444.78 (Schedule G, line 439, page 23 of the filing PDF) | 15 |
| 440 | Konvomep 2-84 mg-mL kit 300 mL65628027210Listed by the FDA as Konvomepomeprazole and sodium bicarbonatekitAzurity Pharmaceuticals, Inc. | 63,244.16 (Schedule G, line 440, page 23 of the filing PDF) | 205 |
| 441 | Adzynma 0500 units 1 EA64764014005Listed by the FDA as Adzynmaapadamtase alfakitTakeda Pharmaceuticals America, Inc. | 62,647.80 (Schedule G, line 441, page 23 of the filing PDF) | 14 |
| 442 | Trulicity pen inj 0.75 mg 4x0.5 mL00002143380Listed by the FDA as Trulicitydulaglutide0.75 mg/0.5 mLinjection, solutionEli Lilly and Company | 61,780.72 (Schedule G, line 442, page 23 of the filing PDF) | 161 |
| 443 | Austedo XR 24 mg ER tab 3068546047256Listed by the FDA as Austedo XRdeutetrabenazine24 mgtablet, film coated, extended releaseTeva Neuroscience, Inc. | 61,611.86 (Schedule G, line 443, page 23 of the filing PDF) | 14 |
| 444 | Lupron Depot 3 mo 11.25 mg kit00074366303Listed by the FDA as Lupron Depotleuprolide acetatekitAbbVie Inc. | 61,228.64 (Schedule G, line 444, page 23 of the filing PDF) | 61 |
| 445 | Zepbound 12.5 mg PFP 4x0.5 mL00002246080Listed by the FDA as Zepboundtirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 61,092.31 (Schedule G, line 445, page 23 of the filing PDF) | 81 |
| 446 | Tavneos 10 mg cap 18073556016801Listed by the FDA as Tavneosavacopan10 mgcapsuleChemoCentryx, Inc. | 60,668.31 (Schedule G, line 446, page 23 of the filing PDF) | fewer than 6 (the count is not shown) |
| 447 | Wegovy 1 mg PFP 4x0.5 mL00169450114Listed by the FDA as Wegovysemaglutide1 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 60,392.75 (Schedule G, line 447, page 23 of the filing PDF) | 108 |
| 448 | Vanflyta 17.7 mg tab 1465597050404Listed by the FDA as Vanflytaquizartinib17.7 mgtablet, film coatedDaiichi Sankyo Inc. | 59,738.62 (Schedule G, line 448, page 23 of the filing PDF) | 6 |
| 449 | Kuvan tab 100 mg 120 DS68135030002Listed by the FDA as Kuvansapropterin dihydrochloride100 mgtabletBioMarin Pharmaceutical Inc. | 59,072.75 (Schedule G, line 449, page 23 of the filing PDF) | 11 |
| 450 | Vyepti 100 mg/mL SDV67386013051Listed by the FDA as Vyeptieptinezumab-jjmr100 mg/mLinjectionLundbeck Pharmaceuticals LLC | 58,764.16 (Schedule G, line 450, page 23 of the filing PDF) | 16 |
| 451 | Belrapzo 100 mg MDV 4 mL42367052125Listed by the FDA as Belrapzobendamustine hydrochloride100 mg/4 mLinjectionEagle Pharmaceuticals, Inc | 58,610.51 (Schedule G, line 451, page 23 of the filing PDF) | 46 |
| 452 | Fruzaqla 5 mg cap 2163020022521Listed by the FDA as Fruzaqlafruquintinib5 mgcapsuleTakeda Pharmaceuticals America, Inc. | 58,571.22 (Schedule G, line 452, page 23 of the filing PDF) | fewer than 6 (the count is not shown) |
| 453 | Jakafi 25 mg tab 6050881002560Listed by the FDA as Jakafiruxolitinib25 mgtabletIncyte Corporation | 58,470.40 (Schedule G, line 453, page 23 of the filing PDF) | 9 |
| 454 | Entresto FCT 49/ 51 mg tab 6000078077720Listed by the FDA as Entrestosacubitril and valsartan49 mg; 51 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 58,375.39 (Schedule G, line 454, page 23 of the filing PDF) | 237 |
| 455 | Zymfentra 120 mg auto inj kit72606002501Listed by the FDA as Zymfentrainfliximab-dyybkitCELLTRION USA Inc. | 57,673.58 (Schedule G, line 455, page 23 of the filing PDF) | 31 |
| 456 | Palynziq PFS 20 mg/mL 10 DS68135067345Listed by the FDA as Palynziqpegvaliase-pqpz20 mg/mLinjection, solutionBioMarin Pharmaceutical Inc. | 56,801.94 (Schedule G, line 456, page 23 of the filing PDF) | fewer than 6 (the count is not shown) |
| 457 | Orkambi 75/94 mg pack 5651167012201Listed by the FDA as Orkambilumacaftor and ivacaftor75 mg; 94 mggranuleVertex Pharmaceuticals Incorporated | 56,639.43 (Schedule G, line 457, page 23 of the filing PDF) | fewer than 6 (the count is not shown) |
| 458 | Gemcitabine 1 g SDV71288011450Listed by the FDA as Gemcitabinegemcitabine hydrochloride1 ginjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc. | 56,330.79 (Schedule G, line 458, page 23 of the filing PDF) | 1,743 |
| 459 | Akovaz 25 mg PFS 10x5 mL51754425003Listed by the FDA as Akovazephedrine sulfate5 mg/mLinjectionExela Pharma Sciences, LLC | 56,136.65 (Schedule G, line 459, page 23 of the filing PDF) | 5,515 |
| 460 | Isosulfan Blue 1% SDV 6x5 mL67457022005Listed by the FDA as Isosulfan Blue10 mg/mLinjection, solutionMylan Institutional LLC | 54,993.75 (Schedule G, line 460, page 23 of the filing PDF) | 90 |
| 461 | Sandostatin LAR Depot 10 mg VL00078081181Listed by the FDA as Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation | 54,533.04 (Schedule G, line 461, page 23 of the filing PDF) | 42 |
| 462 | Benlysta 200 mg PFS 449401008847Listed by the FDA as Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC | 54,376.51 (Schedule G, line 462, page 23 of the filing PDF) | 15 |
| 463 | Advate Baxject III 5 mL 3,601- 4,800 IU00944304710Listed by the FDA as Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 54,129.48 (Schedule G, line 463, page 23 of the filing PDF) | fewer than 6 (the count is not shown) |
| 464 | Aristada 441 mg SYG 1.6 mL65757040103Listed by the FDA as Aristadaaripiprazole lauroxil441 mg/1.6 mLinjection, suspension, extended releaseAlkermes, Inc. | 54,116.02 (Schedule G, line 464, page 23 of the filing PDF) | 43 |
| 465 | Gamunex-C 5 g VL 50 mL13533080020Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC | 53,706.87 (Schedule G, line 465, page 23 of the filing PDF) | 107 |
| 466 | Lupron Depot 30 mg PED kit00074969403Listed by the FDA as Lupron Depot-PEDleuprolide acetatekitAbbVie Inc. | 53,126.97 (Schedule G, line 466, page 23 of the filing PDF) | 25 |
| 467 | Dasatinib 100 mg tab 3060505363103Listed by the FDA as Dasatinib100 mgtablet, film coatedApotex Corp. | 53,078.19 (Schedule G, line 467, page 23 of the filing PDF) | 50 |
| 468 | Yonsa 125 mg tab 12047335040181Listed by the FDA as Yonsaabiraterone acetate125 mgtabletSun Pharmaceutical Industries, Inc. | 52,737.55 (Schedule G, line 468, page 23 of the filing PDF) | 11 |
| 469 | Zenpep 25,000 units DR cap 10073562011601Listed by the FDA as Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase25,000 USP units; 79,000 USP units; 105,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc. | 50,468.18 (Schedule G, line 469, page 23 of the filing PDF) | 11 |
| 470 | Xpovio 40 mg once wkly tab (10 mg x 16)72237010601Listed by the FDA as Xpovioselinexor10 mgtablet, film coatedKaryopharm Therapeutics Inc. | 50,363.37 (Schedule G, line 470, page 23 of the filing PDF) | fewer than 6 (the count is not shown) |
| 471 | Skytrofa 11 mg HGH 1x4BX73362001001Listed by the FDA as Skytrofalonapegsomatropin-tcgd11 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc. | 50,360.19 (Schedule G, line 471, page 23 of the filing PDF) | 18 |
| 472 | Hemofil M NF AHF 1,501-2,000 IU in 10 mL00944394602Listed by the FDA as Hemofil Mantihemophilic factor humankitTakeda Pharmaceuticals America, Inc. | 50,000.50 (Schedule G, line 472, page 23 of the filing PDF) | 0 |
| 473 | Padcev 30 mg SDV51144003001Listed by the FDA as Padcev EJFVenfortumab vedotin30 mg/3 mLinjection, powder, lyophilized, for solutionSeagen Inc. | 49,477.14 (Schedule G, line 473, page 23 of the filing PDF) | 11 |
| 474 | Aranesp 25 mcg PFS 4x0.42 mL55513005704Listed by the FDA as Aranespdarbepoetin alfa25 mcg/0.42 mLinjection, solutionAmgen, Inc | 49,285.56 (Schedule G, line 474, page 23 of the filing PDF) | 724 |
| 475 | Zoladex 10.8 mg PFS DS70720095130Listed by the FDA as Zoladexgoserelin10.8 mgimplantTerSera Therapeutics LLC | 49,255.05 (Schedule G, line 475, page 23 of the filing PDF) | 20 |
| 476 | Aristada 1,064 mg SYG 3.9 mL65757040403Listed by the FDA as Aristadaaripiprazole lauroxil1,064 mg/3.9 mLinjection, suspension, extended releaseAlkermes, Inc. | 48,800.02 (Schedule G, line 476, page 24 of the filing PDF) | 17 |
| 477 | Pancreaze 37,000 units DR cap 10062541040610Listed by the FDA as Pancreazepancrelipase lipase, pancrelipase amylase, and pancrelipase protease37,000 USP units; 149,900 USP units; 97,300 USP unitscapsule, delayed releaseVivus LLC | 48,790.56 (Schedule G, line 477, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 478 | Advate Baxject III 2 mL 1,201- 1,800 IU00944305402Listed by the FDA as Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 48,751.36 (Schedule G, line 478, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 479 | Sogroya 15 mg PFP 1.5 mL00169203711Listed by the FDA as Sogroyasomapacitan-beco10 mg/mLinjection, solutionNovo Nordisk | 47,913.60 (Schedule G, line 479, page 24 of the filing PDF) | 34 |
| 480 | Taltz 80 mg/mL auto inj 3x1 mL00002144509Listed by the FDA as Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company | 47,549.17 (Schedule G, line 480, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 481 | Budesonide-Formot 160-4.5 mcg inh 10.2 g00310737020Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 47,312.77 (Schedule G, line 481, page 24 of the filing PDF) | 427 |
| 482 | Wegovy 0.25 mg PFP 4x0.5 mL00169452514Listed by the FDA as Wegovysemaglutide0.25 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 46,739.80 (Schedule G, line 482, page 24 of the filing PDF) | 81 |
| 483 | Trelegy Ellipta 200-62.5-25 mcg pwd 6000173089310Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC | 46,607.77 (Schedule G, line 483, page 24 of the filing PDF) | 220 |
| 484 | Eltrombopag 25 mg tab 3031722084230Listed by the FDA as Eltrombopag25 mgtablet, film coatedCamber Pharmaceuticals, Inc. | 46,591.03 (Schedule G, line 484, page 24 of the filing PDF) | 13 |
| 485 | Mirena 52 mg SYS IUD50419042301Listed by the FDA as Mirenalevonorgestrel52 mgintrauterine deviceBayer HealthCare Pharmaceuticals Inc. | 46,253.54 (Schedule G, line 485, page 24 of the filing PDF) | 94 |
| 486 | Revlimid DS 5 mg cap 2859572040528Listed by the FDA as Revlimidlenalidomide5 mgcapsuleCelgene Corporation | 46,220.75 (Schedule G, line 486, page 24 of the filing PDF) | 7 |
| 487 | Kengreal 50 mg VL 10x10 mL10122062010Listed by the FDA as Kengrealcangrelor50 mginjection, powder, lyophilized, for solutionChiesi USA, Inc. | 46,174.30 (Schedule G, line 487, page 24 of the filing PDF) | 59 |
| 488 | Lynparza 150 mg tab 6000310067960Listed by the FDA as Lynparzaolaparib150 mgtablet, film coatedAstraZeneca Pharmaceuticals LP | 46,131.90 (Schedule G, line 488, page 24 of the filing PDF) | 8 |
| 489 | Iclusig 15 mg (30 tablets ea)63020053530Listed by the FDA as Iclusigponatinib hydrochloride15 mgtablet, film coatedTakeda Pharmaceuticals America, Inc. | 45,970.26 (Schedule G, line 489, page 24 of the filing PDF) | 35 |
| 490 | Entresto FCT 97/ 103 mg tab 6000078069620Listed by the FDA as Entrestosacubitril and valsartan97 mg; 103 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 45,845.79 (Schedule G, line 490, page 24 of the filing PDF) | 168 |
| 491 | Activase Cathflo 2 mg SDV50242004164Listed by the FDA as Cathflo Activasealteplase2.2 mg/2 mLinjection, powder, lyophilized, for solutionGenentech, Inc. | 45,609.78 (Schedule G, line 491, page 24 of the filing PDF) | 742 |
| 492 | Eltrombopag 75 mg tab 3031722084430Listed by the FDA as Eltrombopag75 mgtablet, film coatedCamber Pharmaceuticals, Inc. | 45,516.90 (Schedule G, line 492, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 493 | Bimzelx 160 mg inj 1 mL50474078184Listed by the FDA as Bimzelxbimekizumab160 mg/mLinjection, solutionUCB, Inc. | 45,495.42 (Schedule G, line 493, page 24 of the filing PDF) | 13 |
| 494 | Phesgo 1,200 mg-600 mg SDV 15 mL50242024501Listed by the FDA as Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf1,200 mg/15 mL; 600 mg/15 mL; 30,000 units/15 mLinjection, solutionGenentech, Inc. | 45,000.00 (Schedule G, line 494, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 495 | Tremfya 200 mg PFP 2x2 mL57894065104Listed by the FDA as Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc. | 44,823.39 (Schedule G, line 495, page 24 of the filing PDF) | 6 |
| 496 | Suboxone FL 8-2 mg 30 SL C312496120803Listed by the FDA as Suboxonebuprenorphine hydrochloride, naloxone hydrochloride8 mg; 2 mgfilm, solubleIndivior Inc. | 44,820.63 (Schedule G, line 496, page 24 of the filing PDF) | 142 |
| 497 | Cimzia 2x200 mg/mL PFS kit50474071079Listed by the FDA as Cimziacertolizumab pegol200 mg/mLinjection, solutionUCB, Inc. | 44,701.11 (Schedule G, line 497, page 24 of the filing PDF) | 270 |
| 498 | Fluorouracil 2.5 g PBP VL 50 mL63323011751Listed by the FDA as Fluorouracil50 mg/mLinjection, solutionFresenius Kabi USA, LLC | 44,545.93 (Schedule G, line 498, page 24 of the filing PDF) | 2,865 |
| 499 | Alphanate AHF 2,110 IU RCOF 2,360 IU VL68516462002Listed by the FDA as Alphanateantihemophilic factor/von willebrand factor complex (human)kitGrifols USA, LLC | 44,106.39 (Schedule G, line 499, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 500 | Zosyn 4.5 g bag 12x100 mL DS00338963812Listed by the FDA as Zosynpiperacillin sodium and tazobactam sodium4 g/100 mL; 0.5 g/100 mLinjection, solutionBaxter Healthcare Corporation | 43,967.31 (Schedule G, line 500, page 24 of the filing PDF) | 4,544 |
| 501 | Nilotinib 150 mg cap 112 (4x28) BP60505380102Listed by the FDA as Nilotinib150 mgcapsuleApotex Corp. | 43,939.70 (Schedule G, line 501, page 24 of the filing PDF) | 21 |
| 502 | Sotyktu 6 mg tab 3000003089511Listed by the FDA as Sotyktudeucravacitinib6 mgtablet, film coatedE.R. Squibb & Sons, L.L.C. | 43,378.70 (Schedule G, line 502, page 24 of the filing PDF) | 22 |
| 503 | Adbry 150 mg PFS 4x1 mL50222034604Listed by the FDA as Adbrytralokinumab-ldrm150 mg/mLinjection, solutionLEO Pharma Inc. | 43,334.37 (Schedule G, line 503, page 24 of the filing PDF) | 20 |
| 504 | Steqeyma 90 mg PFS 1 mL72606002801Listed by the FDA as Steqeymaustekinumab-stba90 mg/mLinjection, solutionCELLTRION USA, Inc. | 43,294.70 (Schedule G, line 504, page 24 of the filing PDF) | 41 |
| 505 | Sofosbuvir Velpatasvr 400 mg-100 mg tab 2872626270101Listed by the FDA as Sofosbuvir and Velpatasvirvelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedAsegua Therapeutics LLC | 42,805.56 (Schedule G, line 505, page 24 of the filing PDF) | 9 |
| 506 | Ninlaro 4 mg cap 1x363020040002Listed by the FDA as Ninlaroixazomib4 mgcapsuleTakeda Pharmaceuticals America, Inc. | 42,737.11 (Schedule G, line 506, page 24 of the filing PDF) | fewer than 6 (the count is not shown) |
| 507 | Leukine 250 mcg SDV 571837584305Listed by the FDA as Leukinesargramostim250 mcg/mLinjection, powder, lyophilized, for solutionPartner Therapeutics, Inc. | 42,287.69 (Schedule G, line 507, page 24 of the filing PDF) | 24 |
| 508 | Azacitidine 100 mg SDV71288011530Listed by the FDA as Azacitidine100 mginjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc. | 42,238.57 (Schedule G, line 508, page 24 of the filing PDF) | 1,032 |
| 509 | Xpovio 40 mg once wkly tab (40 mg x 4)72237010207Listed by the FDA as Xpovioselinexor40 mgtablet, film coatedKaryopharm Therapeutics Inc. | 41,964.44 (Schedule G, line 509, page 24 of the filing PDF) | 0 |
| 510 | Rytelo 47 mg SDV82959011201Listed by the FDA as Ryteloimetelstat sodium47 mginjection, powder, lyophilized, for solutionGeron Corporation | 41,648.06 (Schedule G, line 510, page 24 of the filing PDF) | 24 |
| 511 | Eliquis 5 mg tab 6000003089421Listed by the FDA as Eliquisapixaban5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C. | 41,601.92 (Schedule G, line 511, page 24 of the filing PDF) | 2,857 |
| 512 | Pemetrexed 500 mg LYO pwd SDV71288016750Listed by the FDA as Pemetrexedpemetrexed disodium500 mg/50 mLinjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc. | 41,562.28 (Schedule G, line 512, page 24 of the filing PDF) | 1,057 |
| 513 | Omvoh 100 mg PFP 2x1 mL00002801127Listed by the FDA as Omvohmirikizumab-mrkz100 mg/mLinjection, solutionEli Lilly and Company | 41,461.16 (Schedule G, line 513, page 24 of the filing PDF) | 7 |
| 514 | Testopel 75 mg PEL 10 DS66887000410Listed by the FDA as Testopeltestosterone75 mgpelletEndo USA, Inc. | 41,389.70 (Schedule G, line 514, page 25 of the filing PDF) | 57 |
| 515 | Altuviiio 500 IU LFP VL71104097901Listed by the FDA as Altuviiioantihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlkitBioverativ Therapeutics Inc. | 41,197.08 (Schedule G, line 515, page 25 of the filing PDF) | 6 |
| 516 | Xifaxan 550 mg tab 6065649030302Listed by the FDA as Xifaxanrifaximin550 mgtabletSalix Pharmaceuticals, Inc. | 40,966.08 (Schedule G, line 516, page 25 of the filing PDF) | 52 |
| 517 | Phenylephrine HCl 2.5% O/S 2 mL70756062925Listed by the FDA as Phenylephrine Hydrochloride25 mg/mLsolution/ dropsLifestar Pharma LLC | 40,935.21 (Schedule G, line 517, page 25 of the filing PDF) | 2,617 |
| 518 | Envarsus XR 1 mg tab 10068992301001Listed by the FDA as Envarsus XRtacrolimus1 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc | 40,799.03 (Schedule G, line 518, page 25 of the filing PDF) | 149 |
| 519 | Lupron 3 mo 11.25 mg PE kit00074377903Listed by the FDA as Lupron Depot-PEDleuprolide acetatekitAbbVie Inc. | 40,568.69 (Schedule G, line 519, page 25 of the filing PDF) | 15 |
| 520 | Leukeran 2 mg tab 2580725061025Listed by the FDA as Leukeranchlorambucil2 mgtablet, film coatedWaylis Therapeutics LLC | 40,177.23 (Schedule G, line 520, page 25 of the filing PDF) | 9 |
| 521 | Wegovy 0.5 mg PFP 4x0.5 mL00169450514Listed by the FDA as Wegovysemaglutide0.5 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 39,616.02 (Schedule G, line 521, page 25 of the filing PDF) | 72 |
| 522 | AlbuRx 5% VL 250 mL44206031025Listed by the FDA as Alburxalbumin (human)12.5 g/250 mLsolutionCSL Behring AG | 39,594.67 (Schedule G, line 522, page 25 of the filing PDF) | 226 |
| 523 | Trelegy Ellipta 100/62.5/25 mcg inh 60 BP00173088710Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate100 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC | 39,585.15 (Schedule G, line 523, page 25 of the filing PDF) | 167 |
| 524 | Simponi auto 100 mg/mL inj 1 mL57894007102Listed by the FDA as Simponigolimumab100 mg/mLinjection, solutionJanssen Biotech, Inc. | 39,504.76 (Schedule G, line 524, page 25 of the filing PDF) | 32 |
| 525 | Iclusig 45 mg (30 tablets ea)63020053430Listed by the FDA as Iclusigponatinib hydrochloride45 mgtablet, film coatedTakeda Pharmaceuticals America, Inc. | 39,313.78 (Schedule G, line 525, page 25 of the filing PDF) | 6 |
| 526 | Lupron Depot 3 mo 22.5 mg SYG kit00074334603Listed by the FDA as Lupron Depotleuprolide acetatekitAbbVie Inc. | 39,233.23 (Schedule G, line 526, page 25 of the filing PDF) | 100 |
| 527 | Austedo 6 mg tab 6068546017060Listed by the FDA as Austedodeutetrabenazine6 mgtablet, coatedTeva Neuroscience, Inc. | 39,131.17 (Schedule G, line 527, page 25 of the filing PDF) | 33 |
| 528 | Dasatinib 80 mg tab 3060505381603Listed by the FDA as Dasatinib80 mgtablet, film coatedApotex Corp. | 39,012.70 (Schedule G, line 528, page 25 of the filing PDF) | 21 |
| 529 | Zolinza DS 100 mg cap 12000006056840Listed by the FDA as Zolinzavorinostat100 mgcapsuleMerck Sharp & Dohme LLC | 38,881.31 (Schedule G, line 529, page 25 of the filing PDF) | 12 |
| 530 | Tyenne 162 mg PFS 0.9 mL65219058604Listed by the FDA as Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC | 38,757.52 (Schedule G, line 530, page 25 of the filing PDF) | 37 |
| 531 | Valtoco 15 mg nasal SPY 5 (5x15 mg) BP72252051510Listed by the FDA as Valtocodiazepam7.5 mg/0.1 mLsprayNeurelis, Inc | 38,523.28 (Schedule G, line 531, page 25 of the filing PDF) | 52 |
| 532 | Doptelet 20 mg tab 1571369002015Listed by the FDA as Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc. | 38,402.62 (Schedule G, line 532, page 25 of the filing PDF) | 11 |
| 533 | Nurtec ODT 75 mg tab 872618300002Listed by the FDA as Nurtec ODTrimegepant sulfate75 mgtablet, orally disintegratingPfizer Laboratories Div Pfizer Inc | 38,354.90 (Schedule G, line 533, page 25 of the filing PDF) | 97 |
| 534 | Zydelig 150 mg tab 6061958170201Listed by the FDA as Zydeligidelalisib150 mgtablet, film coatedGilead Sciences, Inc. | 38,152.86 (Schedule G, line 534, page 25 of the filing PDF) | fewer than 6 (the count is not shown) |
| 535 | Abilify Maint 300 mg kit59148001871 | 37,777.47 (Schedule G, line 535, page 25 of the filing PDF) | 40 |
| 536 | Stivarga 40 mg tab 4x2150419017106Listed by the FDA as Stivargaregorafenib40 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc. | 37,772.04 (Schedule G, line 536, page 25 of the filing PDF) | 8 |
| 537 | Epclusa 400/100 mg tab 2861958220101Listed by the FDA as Epclusavelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedGilead Sciences, Inc. | 37,675.68 (Schedule G, line 537, page 25 of the filing PDF) | 8 |
| 538 | Valtoco 20 mg nasal SPY 5 (5x20 mg) BP72252052010Listed by the FDA as Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc | 37,600.84 (Schedule G, line 538, page 25 of the filing PDF) | 32 |
| 539 | Deferiprone 1,000 mg tab 5000054071119Listed by the FDA as Deferiprone1,000 mgtablet, coatedHikma Pharmaceuticals USA Inc. | 37,527.20 (Schedule G, line 539, page 25 of the filing PDF) | 7 |
| 540 | Zarxio 480 mcg PFS 10x0.8 mL61314032610Listed by the FDA as Zarxiofilgrastim-sndz480 mcg/0.8 mLinjection, solutionSandoz Inc. | 37,273.09 (Schedule G, line 540, page 25 of the filing PDF) | 202 |
| 541 | Neupogen 300 mcg SDV 10x1 mL55513053010Listed by the FDA as Neupogenfilgrastim300 mcg/mLinjection, solutionAmgen, Inc | 37,090.95 (Schedule G, line 541, page 25 of the filing PDF) | 37 |
| 542 | Eligard PSS 45 mg 6 month sus kit DS62935046150Listed by the FDA as Eligardleuprolide acetate45 mg/0.375 mLinjection, suspension, extended releaseTOLMAR Inc. | 36,690.23 (Schedule G, line 542, page 25 of the filing PDF) | 50 |
| 543 | Fensolvi 45 mg SYG kit DS62935016360Listed by the FDA as Fensolvileuprolide acetate45 mg/0.375 mLinjection, suspension, extended releaseTOLMAR Inc. | 36,573.67 (Schedule G, line 543, page 25 of the filing PDF) | fewer than 6 (the count is not shown) |
| 544 | Rubraca 300 mg tab 6082154078501Listed by the FDA as Rubracarucaparib300 mgtablet, film coatedpharmaand GmbH | 36,445.20 (Schedule G, line 544, page 25 of the filing PDF) | fewer than 6 (the count is not shown) |
| 545 | Fosaprepitant 150 mg SDV72205005401Listed by the FDA as Fosaprepitant150 mg/5 mLinjection, powder, lyophilized, for solutionNovadoz Pharmaceuticals LLC | 36,296.77 (Schedule G, line 545, page 25 of the filing PDF) | 3,660 |
| 546 | Tremfya 100 mg/mL PFS57894064001Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc. | 35,978.27 (Schedule G, line 546, page 25 of the filing PDF) | 9 |
| 547 | Adbry 300 mg PFP 2x2 mL50222035002Listed by the FDA as Adbrytralokinumab-ldrm300 mg/2 mLinjection, solutionLEO Pharma Inc. | 35,448.80 (Schedule G, line 547, page 25 of the filing PDF) | 16 |
| 548 | Jakafi 20 mg tab 6050881002060Listed by the FDA as Jakafiruxolitinib20 mgtabletIncyte Corporation | 35,407.80 (Schedule G, line 548, page 25 of the filing PDF) | 6 |
| 549 | Adalimumab-adaz 40 mg PFS 2x0.4 mL61314032764Listed by the FDA as Adalimumabadalimumab-adaz40 mg/0.4 mLinjection, solutionSandoz Inc | 35,134.29 (Schedule G, line 549, page 25 of the filing PDF) | 56 |
| 550 | Biktarvy TB50-200-25 mg 30CPLT BPK61958250103Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc. | 35,021.45 (Schedule G, line 550, page 25 of the filing PDF) | 87 |
| 551 | Carboplatin 450 mg MDV 45 mL61703033950Listed by the FDA as Carboplatin10 mg/mLinjection, solutionHospira, Inc. | 34,907.85 (Schedule G, line 551, page 25 of the filing PDF) | 1,571 |
| 552 | Retevmo 80 mg tab 6000002608260Listed by the FDA as Retevmoselpercatinib80 mgtablet, coatedEli Lilly and Company | 34,755.12 (Schedule G, line 552, page 26 of the filing PDF) | fewer than 6 (the count is not shown) |
| 553 | Taltz 80 mg/mL inj PFS 1 mL00002772411Listed by the FDA as Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company | 34,738.86 (Schedule G, line 553, page 26 of the filing PDF) | 12 |
| 554 | Tiopronin 300 mg DR tab 9000254303509Listed by the FDA as Tiopronin300 mgtablet, delayed releasePar Health USA, LLC | 34,307.54 (Schedule G, line 554, page 26 of the filing PDF) | 10 |
| 555 | Eloctate kit 3,200 IU VL71104080701Listed by the FDA as Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc. | 34,304.00 (Schedule G, line 555, page 26 of the filing PDF) | fewer than 6 (the count is not shown) |
| 556 | Indomethacin 50 mg SUP 3070710185207Listed by the FDA as Indomethacin50 mgsuppositoryZydus Pharmaceuticals USA Inc. | 34,147.77 (Schedule G, line 556, page 26 of the filing PDF) | 66 |
| 557 | Eloctate kit 499 IU VL71104080201Listed by the FDA as Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc. | 33,682.50 (Schedule G, line 557, page 26 of the filing PDF) | fewer than 6 (the count is not shown) |
| 558 | Ebglyss 250 mg PFP 2 mL00002777211Listed by the FDA as Ebglysslebrikizumab-lbkz250 mg/2 mLinjection, solutionEli Lilly and Company | 33,410.00 (Schedule G, line 558, page 26 of the filing PDF) | 6 |
| 559 | Invega Trinza 273 mg SYG 0.88 mL50458060601Listed by the FDA as Invega Trinzapaliperidone palmitate273 mg/0.88 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc | 33,252.13 (Schedule G, line 559, page 26 of the filing PDF) | 18 |
| 560 | Hylenex 150 USP VL 4x1 mL18657011704Listed by the FDA as Hylenex Recombinanthyaluronidase150 USP units/mLinjection, solutionAntares Pharma, Inc. | 33,100.18 (Schedule G, line 560, page 26 of the filing PDF) | 588 |
| 561 | Hadlima 40 mg PFS 2x0.4 mL78206018601Listed by the FDA as Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC | 33,071.27 (Schedule G, line 561, page 26 of the filing PDF) | 50 |
| 562 | Koselugo 25 mg cap 6000310062560Listed by the FDA as Koselugoselumetinib25 mgcapsuleAstraZeneca Pharmaceuticals LP | 33,063.87 (Schedule G, line 562, page 26 of the filing PDF) | fewer than 6 (the count is not shown) |
| 563 | Austedo 12 mg ER tab 3068546047156Listed by the FDA as Austedo XRdeutetrabenazine12 mgtablet, film coated, extended releaseTeva Neuroscience, Inc. | 32,660.82 (Schedule G, line 563, page 26 of the filing PDF) | 11 |
| 564 | Skytrofa 7.6 mg HGH 1x4BX73362000801Listed by the FDA as Skytrofalonapegsomatropin-tcgd7.6 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc. | 32,179.04 (Schedule G, line 564, page 26 of the filing PDF) | 9 |
| 565 | Kevzara 150 mg PFP 2x1.14 mL00024592001Listed by the FDA as Kevzarasarilumab150 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC | 31,955.41 (Schedule G, line 565, page 26 of the filing PDF) | 16 |
| 566 | Norepinephrine 8 mg bag 10x250 mL81298965503Listed by the FDA as Norepinephrinenorepinephrine bitartrate32 mcg/mLsolutionLong Grove Pharmaceuticals, LLC | 31,751.09 (Schedule G, line 566, page 26 of the filing PDF) | 1,320 |
| 567 | Pertzye DR cap 24000USP UN 8059767002401Listed by the FDA as Pertzyepancrelipase24,000 USP units; 90,750 USP units; 86,250 USP unitscapsule, delayed releaseDigestive Care, Inc. | 31,194.24 (Schedule G, line 567, page 26 of the filing PDF) | 9 |
| 568 | Thyrogen VL 2 DS58468003002Listed by the FDA as Thyrogenthyrotropin alfa0.9 mg/mLinjection, powder, lyophilized, for solutionGenzyme Corporation | 31,066.54 (Schedule G, line 568, page 26 of the filing PDF) | 90 |
| 569 | Triptodur 22.5 mg kit24338015020Listed by the FDA as TriptodurtriptorelinkitAzurity Pharmaceuticals, Inc. | 30,704.70 (Schedule G, line 569, page 26 of the filing PDF) | 6 |
| 570 | Brixadi 64 mg ER PFS kit 0.18 mL58284026401Listed by the FDA as Brixadibuprenorphine64 mg/0.18 mLinjectionBraeburn Inc. | 30,682.75 (Schedule G, line 570, page 26 of the filing PDF) | 30 |
| 571 | Sapropterin Dihcl 100 mg tab 12049884072008Listed by the FDA as Sapropterin Dihydrochloride100 mgtabletPar Health USA, LLC | 30,591.35 (Schedule G, line 571, page 26 of the filing PDF) | 10 |
| 572 | Venclexta Starter pack00074057928Listed by the FDA as VenclextavenetoclaxkitAbbVie Inc. | 30,306.72 (Schedule G, line 572, page 26 of the filing PDF) | 12 |
| 573 | Nexplanon IMP 68 mg78206014501Listed by the FDA as Nexplanonetonogestrel68 mgimplantOrganon LLC | 30,220.63 (Schedule G, line 573, page 26 of the filing PDF) | 55 |
| 574 | Nuzyra 150 mg tab 3071715000227Listed by the FDA as Nuzyraomadacycline150 mgtablet, film coatedParatek Pharmaceuticals, Inc. | 29,898.95 (Schedule G, line 574, page 26 of the filing PDF) | 8 |
| 575 | Lonsurf 15 mg tab 2064842102501Listed by the FDA as Lonsurftrifluridine and tipiracil15 mg; 6.14 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd. | 29,863.33 (Schedule G, line 575, page 26 of the filing PDF) | 7 |
| 576 | Imdelltra 1 mg VL55513005901Listed by the FDA as Imdelltra (AMG757)tarlatamab-dllekitAmgen, Inc | 28,506.30 (Schedule G, line 576, page 26 of the filing PDF) | 19 |
| 577 | Afinitor 10 mg tab 2800078056751Listed by the FDA as Afinitoreverolimus10 mgtabletNovartis Pharmaceuticals Corporation | 28,089.44 (Schedule G, line 577, page 26 of the filing PDF) | 0 |
| 578 | Myfortic 360 mg DR tab 12000078038666Listed by the FDA as Myforticmycophenolic acid360 mgtablet, delayed releaseNovartis Pharmaceuticals Corporation | 27,975.77 (Schedule G, line 578, page 26 of the filing PDF) | 73 |
| 579 | Lazcluze 80 mg tab 6057894008060Listed by the FDA as Lazcluzelazertinib80 mgtablet, film coatedJanssen Biotech, Inc. | 27,857.30 (Schedule G, line 579, page 26 of the filing PDF) | fewer than 6 (the count is not shown) |
| 580 | Infumorph 25 mg/mL amp 20 mL00641604001Listed by the FDA as Infumorph 500morphine sulfate25 mg/mLinjection, solutionHikma Pharmaceuticals USA Inc. | 27,828.39 (Schedule G, line 580, page 26 of the filing PDF) | 86 |
| 581 | Prograf 1 mg cap 10000469061773Listed by the FDA as Prograftacrolimus1 mgcapsule, gelatin coatedAstellas Pharma US, Inc. | 27,802.81 (Schedule G, line 581, page 26 of the filing PDF) | 112 |
| 582 | Vemlidy 25 mg tab 3061958230101Listed by the FDA as Vemlidytenofovir alafenamide25 mgtabletGilead Sciences, Inc. | 27,686.92 (Schedule G, line 582, page 26 of the filing PDF) | 28 |
| 583 | Kineret 100 mg PFS 7x0.67 mL66658023407Listed by the FDA as Kineretanakinra100 mg/0.67 mLinjection, solutionSwedish Orphan Biovitrum AB (publ) | 27,647.34 (Schedule G, line 583, page 26 of the filing PDF) | 60 |
| 584 | Baclofen 10 mg-5 mL oral sol 237 mL52817062008Listed by the FDA as Baclofen10 mg/5 mLsolutionTrupharma, LLC | 27,442.33 (Schedule G, line 584, page 26 of the filing PDF) | 39 |
| 585 | Brilinta 90 mg tab 6000186077760Listed by the FDA as Brilintaticagrelor90 mgtabletAstraZeneca Pharmaceuticals LP | 27,174.91 (Schedule G, line 585, page 26 of the filing PDF) | 193 |
| 586 | Caplyta 42 mg cap 3072060014240Listed by the FDA as Caplytalumateperone42 mgcapsuleIntra-Cellular Therapies, Inc | 27,171.36 (Schedule G, line 586, page 26 of the filing PDF) | 18 |
| 587 | Xcopri 100 mg tab 3071699010030Listed by the FDA as Xcopricenobamate100 mgtablet, film coatedSK Life Science, Inc. | 27,104.16 (Schedule G, line 587, page 26 of the filing PDF) | 38 |
| 588 | Balversa 3 mg tab 5659676003056Listed by the FDA as Balversaerdafitinib3 mgtablet, film coatedJanssen Products LP | 27,061.68 (Schedule G, line 588, page 26 of the filing PDF) | fewer than 6 (the count is not shown) |
| 589 | Tecvayli 30 mg SDV 3 mL SD57894044901Listed by the FDA as Tecvayliteclistamab-cqyv10 mg/mLinjectionJanssen Biotech, Inc. | 27,004.02 (Schedule G, line 589, page 26 of the filing PDF) | 32 |
| 590 | Orencia 50 mg/0.4 mL SYG 400003281411Listed by the FDA as Orenciaabatacept50 mg/0.4 mLinjection, solutionE.R. Squibb & Sons, L.L.C. | 26,884.40 (Schedule G, line 590, page 27 of the filing PDF) | 13 |
| 591 | Zarxio 300 mcg PFS 10x0.5 mL61314031810Listed by the FDA as Zarxiofilgrastim-sndz300 mcg/0.5 mLinjection, solutionSandoz Inc. | 26,852.04 (Schedule G, line 591, page 27 of the filing PDF) | 205 |
| 592 | Inbrija 42 mg cap 6010144034260Listed by the FDA as Inbrijalevodopa42 mgcapsuleMerz Pharmaceuticals, LLC | 26,844.44 (Schedule G, line 592, page 27 of the filing PDF) | 22 |
| 593 | Tetracaine HCl 0.5% O/S 12x4 mL00065074114Listed by the FDA as Tetracaine Hydrochloride5 mg/mLsolutionAlcon Laboratories, Inc. | 26,784.98 (Schedule G, line 593, page 27 of the filing PDF) | 2,340 |
| 594 | Hizentra 4 g PFS 20 mL44206045824Listed by the FDA as Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG | 26,413.72 (Schedule G, line 594, page 27 of the filing PDF) | 22 |
| 595 | Diazepam 10 mg C/J 10x2 mL LL00409127332Listed by the FDA as Diazepam5 mg/mLinjection, solutionHospira, Inc. | 26,301.15 (Schedule G, line 595, page 27 of the filing PDF) | 3,422 |
| 596 | Lenvima 20 mg cap 6062856072030Listed by the FDA as Lenvimalenvatinib10 mgcapsuleEisai Inc. | 26,290.00 (Schedule G, line 596, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 597 | Zonisade 20 mg/mL sus 150 mL52652800101Listed by the FDA as Zonisadezonisamide100 mg/5 mLsuspensionAzurity Pharmaceuticals, Inc. | 26,260.28 (Schedule G, line 597, page 27 of the filing PDF) | 51 |
| 598 | Itovebi 3 mg tab 2850242008408Listed by the FDA as Itovebiinavolisib3 mgtablet, film coatedGenentech, Inc. | 26,146.92 (Schedule G, line 598, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 599 | Rybelsus 7 mg tab 3000169430730Listed by the FDA as Rybelsusoral semaglutide7 mgtabletNovo Nordisk Pharmaceutical Industries, LP | 25,742.86 (Schedule G, line 599, page 27 of the filing PDF) | 51 |
| 600 | Emgality 120 mg PFP00002143611Listed by the FDA as Emgalitygalcanezumab-gnlm120 mg/mLinjection, solutionEli Lilly and Company | 25,641.04 (Schedule G, line 600, page 27 of the filing PDF) | 30 |
| 601 | Skytrofa 4.3 mg HGH 1x4 BX73362000501Listed by the FDA as Skytrofalonapegsomatropin-tcgd4.3 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc. | 25,414.69 (Schedule G, line 601, page 27 of the filing PDF) | 23 |
| 602 | Humate-P PDS 1,200 RCOF VL 500 IU FVIII63833061602Listed by the FDA as Humate-Pantihemophilic factor/von willebrand factor complex (human)kitCSL Behring GmbH | 25,264.47 (Schedule G, line 602, page 27 of the filing PDF) | 7 |
| 603 | Odomzo 200 mg cap 3047335030383Listed by the FDA as Odomzosonidegib200 mgcapsuleSun Pharmaceutical Industries, Inc. | 25,192.86 (Schedule G, line 603, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 604 | Dificid 200 mg tab 2052015008001Listed by the FDA as Dificidfidaxomicin200 mgtablet, film coatedMerck Sharp & Dohme LLC | 25,162.43 (Schedule G, line 604, page 27 of the filing PDF) | 45 |
| 605 | Cibinqo 200 mg tab 3000069043530Listed by the FDA as Cibinqoabrocitinib200 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 25,076.18 (Schedule G, line 605, page 27 of the filing PDF) | 11 |
| 606 | Idelvion 2,095 IU VL69911086702Listed by the FDA as Idelvioncoagulation factor IX recombinant humankitCSL Behring Lengnau AG | 24,867.60 (Schedule G, line 606, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 607 | Procrit 20M UN/mL MDV 4x1 mL59676032004Listed by the FDA as Procriterythropoietin20,000 IU/mLinjection, solutionJanssen Products, LP | 24,740.30 (Schedule G, line 607, page 27 of the filing PDF) | 127 |
| 608 | Paxlovid 300/100 mg tab 30 (3x10) BP00069532130Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc | 24,684.95 (Schedule G, line 608, page 27 of the filing PDF) | 24 |
| 609 | Gleevec 100 mg tab 9000078040134Listed by the FDA as Gleevecimatinib mesylate100 mgtabletNovartis Pharmaceuticals Corporation | 24,346.71 (Schedule G, line 609, page 27 of the filing PDF) | 11 |
| 610 | Afinitor Disperz 2 mg tab 28 (4x7)00078062651Listed by the FDA as Afinitor Disperzeverolimus2 mgtablet, for suspensionNovartis Pharmaceuticals Corporation | 24,099.34 (Schedule G, line 610, page 27 of the filing PDF) | 8 |
| 611 | Skytrofa 13.3 mg HGH-6XNDL/4XSD cartridge73362001101Listed by the FDA as Skytrofalonapegsomatropin-tcgd13.3 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc. | 24,095.27 (Schedule G, line 611, page 27 of the filing PDF) | 7 |
| 612 | Cyltezo 40 mg-0.4 mL PFP kit 200597049550Listed by the FDA as Cyltezoadalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc. | 23,910.39 (Schedule G, line 612, page 27 of the filing PDF) | 44 |
| 613 | Alphanate AHF 1,070 IU RCOF 1,120 IU VL68516461802Listed by the FDA as Alphanateantihemophilic factor/von willebrand factor complex (human)kitGrifols USA, LLC | 23,593.50 (Schedule G, line 613, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 614 | Valtoco 10 mg nasal SPY 2 BP72252051002Listed by the FDA as Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc | 23,514.54 (Schedule G, line 614, page 27 of the filing PDF) | 33 |
| 615 | Creon 12,000 DR cap 10000032004770Listed by the FDA as Creonpancrelipase60,000 USP units; 12,000 USP units; 38,000 USP unitscapsule, delayed release pelletsAbbVie Inc. | 23,185.33 (Schedule G, line 615, page 27 of the filing PDF) | 173 |
| 616 | Advate Baxject III 2 mL 801-1,200 IU00944305302Listed by the FDA as Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 23,122.55 (Schedule G, line 616, page 27 of the filing PDF) | 15 |
| 617 | Omvoh 200 mg-2 mL-100 mg-mL PFP 200002771711Listed by the FDA as Omvohmirikizumab-mrkzkitEli Lilly and Company | 22,984.91 (Schedule G, line 617, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 618 | DigiFab 40 mg VL 150633012011Listed by the FDA as DigiFabovine digoxin immune fab40 mginjection, powder, lyophilized, for solutionBTG International Inc. | 22,930.15 (Schedule G, line 618, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 619 | Tremfya 100 mg PFP 1 mL57894064006Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc. | 22,638.83 (Schedule G, line 619, page 27 of the filing PDF) | 7 |
| 620 | Winrevair 90 mg pwd kit 200006508701Listed by the FDA as Winrevairsotatercept-csrkkitMerck Sharp & Dohme LLC | 22,491.26 (Schedule G, line 620, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 621 | Zejula 100 mg tab 3000173090913Listed by the FDA as Zejulaniraparib100 mgtablet, film coatedGlaxoSmithKline LLC | 22,356.83 (Schedule G, line 621, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 622 | Dasatinib 140 mg tab 3060505381703Listed by the FDA as Dasatinib140 mgtablet, film coatedApotex Corp. | 22,336.01 (Schedule G, line 622, page 27 of the filing PDF) | 9 |
| 623 | Rituxan 100 mg SDV 10 mL50242005121Listed by the FDA as Rituxanrituximab10 mg/mLinjection, solutionGenentech, Inc. | 22,274.16 (Schedule G, line 623, page 27 of the filing PDF) | 19 |
| 624 | Kevzara 200 mg PFS 2x1.14 mL00024591001Listed by the FDA as Kevzarasarilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC | 22,240.75 (Schedule G, line 624, page 27 of the filing PDF) | fewer than 6 (the count is not shown) |
| 625 | Cefazolin-Dext 2 g/50 mL DUP bag 24x50 mL00264310511Listed by the FDA as Cefazolin Sodium2 g/50 mLsolutionB. Braun Medical Inc. | 22,159.93 (Schedule G, line 625, page 27 of the filing PDF) | 2,614 |
| 626 | Procrit 10 MU SDV 6x1 mL59676031001Listed by the FDA as Procriterythropoietin10,000 IU/mLinjection, solutionJanssen Products, LP | 22,099.56 (Schedule G, line 626, page 27 of the filing PDF) | 173 |
| 627 | Simulect 20 mg SDV00078033184Listed by the FDA as Simulectbasiliximab20 mg/5 mLinjection, powder, for solutionNovartis Pharmaceuticals Corporation | 22,085.21 (Schedule G, line 627, page 27 of the filing PDF) | 18 |
| 628 | Omvoh 300 mg SDV 15 mL00002757501Listed by the FDA as Omvohmirikizumab-mrkz20 mg/mLinjection, solutionEli Lilly and Company | 21,996.30 (Schedule G, line 628, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 629 | Siklos 1,000 mg tab 3071770012030Listed by the FDA as Sikloshydroxyurea1,000 mgtablet, film coatedMedunik | 21,987.15 (Schedule G, line 629, page 28 of the filing PDF) | 18 |
| 630 | Phenobarbital 130 mg VL 25x1 mL42494041625Listed by the FDA as Phenobarbital Sodium130 mg/mLinjectionCameron Pharmaceuticals | 21,950.00 (Schedule G, line 630, page 28 of the filing PDF) | 252 |
| 631 | Dactinomycin 500 mcg SDV55150043101Listed by the FDA as Dactinomycin0.5 mg/mLinjection, powder, lyophilized, for solutionEugia US LLC | 21,851.30 (Schedule G, line 631, page 28 of the filing PDF) | 20 |
| 632 | Budesonide-Formot 80-4.5 mcg inh 10.2 g00310737220Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 21,766.44 (Schedule G, line 632, page 28 of the filing PDF) | 246 |
| 633 | Fulvestrant 250 mg PFS 2x5 mL00143902202Listed by the FDA as Fulvestrant50 mg/mLinjectionHikma Pharmaceuticals USA Inc. | 21,698.78 (Schedule G, line 633, page 28 of the filing PDF) | 420 |
| 634 | Kalydeco PED gran 25 mg 5651167060001Listed by the FDA as Kalydecoivacaftor25 mggranuleVertex Pharmaceuticals Incorporated | 21,566.50 (Schedule G, line 634, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 635 | Ceftriaxone-Dext 1 g bag 24x50 mL DS00338500241Listed by the FDA as Ceftriaxoneceftriaxone sodium1 g/50 mLinjection, solutionBaxter Healthcare Company | 21,480.32 (Schedule G, line 635, page 28 of the filing PDF) | 2,403 |
| 636 | Temsirolimus 25 mg-mL SDV kit72611078502Listed by the FDA as Temsirolimustemsirolimus injectionkitAlmaject, Inc. | 21,348.75 (Schedule G, line 636, page 28 of the filing PDF) | 27 |
| 637 | Xcopri 150 mg tab 3071699015030Listed by the FDA as Xcopricenobamate150 mgtablet, film coatedSK Life Science, Inc. | 21,243.25 (Schedule G, line 637, page 28 of the filing PDF) | 23 |
| 638 | Isoproterenol HCl 1 mg SDV 5x5 mL23155066142Listed by the FDA as Isoproterenol Hydrochloride0.2 mg/mLinjection, solutionHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 21,242.95 (Schedule G, line 638, page 28 of the filing PDF) | 387 |
| 639 | Albuterol Sulf HFA 90 mcg inh 18 g66993001968Listed by the FDA as Albuterol Sulfate HFA90 mcgaerosol, meteredPrasco Laboratories | 21,114.02 (Schedule G, line 639, page 28 of the filing PDF) | 958 |
| 640 | Xolair 150 mg auto inj 1 mL50242021555Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc. | 21,079.08 (Schedule G, line 640, page 28 of the filing PDF) | 19 |
| 641 | Rasuvo auto 20 mg inj 4x0.4 mL59137053004Listed by the FDA as Rasuvomethotrexate20 mg/0.4 mLinjection, solutionMedexus Pharma Inc. | 20,943.21 (Schedule G, line 641, page 28 of the filing PDF) | 90 |
| 642 | Lantus Solostar 100 units/mL PFP 5x3 mL00088221905Listed by the FDA as Lantus Solostarinsulin glargine100 IU/mLinjection, solutionsanofi-aventis U.S. LLC | 20,796.22 (Schedule G, line 642, page 28 of the filing PDF) | 1,059 |
| 643 | Eliquis 2.5 mg tab 6000003089321Listed by the FDA as Eliquisapixaban2.5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C. | 20,758.45 (Schedule G, line 643, page 28 of the filing PDF) | 788 |
| 644 | Herceptin Hylecta 600 mg SDV50242007701Listed by the FDA as Herceptin Hylectatrastuzumab and hyaluronidase-oysk600 mg/5 mL; 10,000 units/5 mLinjection, solutionGenentech, Inc. | 20,718.82 (Schedule G, line 644, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 645 | Omnitrope 10 mg /1.5 mL CRT00781300407Listed by the FDA as Omnitropesomatropin10 mg/1.5 mLinjection, solutionSandoz Inc | 20,644.41 (Schedule G, line 645, page 28 of the filing PDF) | 65 |
| 646 | Leucovorin Calcium 350 mg 50 mL SDV00143955201Listed by the FDA as Leucovorin Calcium350 mg/17.5 mLinjection, powder, lyophilized, for solutionHikma Pharmaceuticals USA Inc. | 20,339.34 (Schedule G, line 646, page 28 of the filing PDF) | 750 |
| 647 | Ceftriaxone-Dext 2 g bag 24x50 mL DS00338500341Listed by the FDA as Ceftriaxoneceftriaxone sodium2 g/50 mLinjection, solutionBaxter Healthcare Company | 20,324.97 (Schedule G, line 647, page 28 of the filing PDF) | 933 |
| 648 | Abiraterone Acetate 250 mg tab 12071921017820Listed by the FDA as Abiraterone Acetate250 mgtabletFlorida Pharmaceutical Products, LLC. | 20,305.62 (Schedule G, line 648, page 28 of the filing PDF) | 465 |
| 649 | Ondansetron 4 mg oral sol 30x5 mL60687025286Listed by the FDA as Ondansetron4 mg/5 mLsolutionAmerican Health Packaging | 19,960.52 (Schedule G, line 649, page 28 of the filing PDF) | 1,796 |
| 650 | Prednisolone Acetate 1% OPH DRP 5 mL61314063705Listed by the FDA as Prednisolone Acetate10 mg/mLsuspension/ dropsSandoz Inc | 19,736.90 (Schedule G, line 650, page 28 of the filing PDF) | 1,465 |
| 651 | Eylea 2 mg VL kit PAP61755000502Listed by the FDA as Eyleaaflibercept40 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc. | 19,561.16 (Schedule G, line 651, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 652 | Xpovio 100 mg once wkly tab (50 mg x 8) BP72237010305Listed by the FDA as Xpovioselinexor50 mgtablet, film coatedKaryopharm Therapeutics Inc. | 19,541.13 (Schedule G, line 652, page 28 of the filing PDF) | 0 |
| 653 | Vonvendi 1,320 IU VL 10 mL00944755302Listed by the FDA as Vonvendivon willebrand factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 19,453.50 (Schedule G, line 653, page 28 of the filing PDF) | 16 |
| 654 | Stelara IV 130 mg SDV 26 mL57894005427Listed by the FDA as Stelaraustekinumab130 mg/26 mLsolutionJanssen Biotech, Inc. | 19,442.38 (Schedule G, line 654, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 655 | Gleostine 100 mg cap 558181304205Listed by the FDA as Gleostinelomustine100 mgcapsule, gelatin coatedNextSource Biotechnology, LLC | 19,417.62 (Schedule G, line 655, page 28 of the filing PDF) | 14 |
| 656 | Bosulif 500 mg tab 3000069013601Listed by the FDA as Bosulifbosutinib500 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 19,413.03 (Schedule G, line 656, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 657 | Docetaxel 80 mg MDV 4 mL00409036701Listed by the FDA as Docetaxel20 mg/mLinjection, solutionHospira, Inc. | 19,267.40 (Schedule G, line 657, page 28 of the filing PDF) | 634 |
| 658 | Sodium Ferric 62.5 mg 10x5 mL SDV00143957010Listed by the FDA as Sodium Ferric Gluconate Complex in Sucrose12.5 mg/mLinjectionHikma Pharmaceuticals USA Inc. | 19,237.57 (Schedule G, line 658, page 28 of the filing PDF) | 1,191 |
| 659 | Vijoice 50 mg PKT 2800078117551Listed by the FDA as Vijoicealpelisib50 mggranuleNovartis Pharmaceuticals Corporation | 18,864.65 (Schedule G, line 659, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 660 | Adalimumab-adbm 40 mg-0.4 mL PFP kit 200597057550Listed by the FDA as Adalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc. | 18,841.69 (Schedule G, line 660, page 28 of the filing PDF) | 43 |
| 661 | Orencia 125 mg/mL PFS 4x1 mL00003218811Listed by the FDA as Orenciaabatacept125 mg/mLinjection, solutionE.R. Squibb & Sons, L.L.C. | 18,633.80 (Schedule G, line 661, page 28 of the filing PDF) | 71 |
| 662 | Dexamethasone 4 mg SDV 25x1 mL67457042312Listed by the FDA as Dexamethasone Sodium Phosphate4 mg/mLinjection, solutionMylan Institutional LLC | 18,494.21 (Schedule G, line 662, page 28 of the filing PDF) | 19,543 |
| 663 | Eltrombopag 12.5 mg tab 3031722084130Listed by the FDA as Eltrombopag12.5 mgtablet, film coatedCamber Pharmaceuticals, Inc. | 18,255.31 (Schedule G, line 663, page 28 of the filing PDF) | fewer than 6 (the count is not shown) |
| 664 | Balversa 4 mg tab 5659676004056Listed by the FDA as Balversaerdafitinib4 mgtablet, film coatedJanssen Products LP | 18,043.95 (Schedule G, line 664, page 28 of the filing PDF) | 0 |
| 665 | Lokelma 10 g PKT 3000310111030Listed by the FDA as Lokelmasodium zirconium cyclosilicate10 g/10 gpowder, for suspensionAstraZeneca Pharmaceuticals LP | 17,942.13 (Schedule G, line 665, page 28 of the filing PDF) | 523 |
| 666 | Humira 80 mg-0.8 mL PFP kit 300074012403Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 17,863.04 (Schedule G, line 666, page 29 of the filing PDF) | fewer than 6 (the count is not shown) |
| 667 | Ambrisentan 10 mg tab 3000591240630Listed by the FDA as Ambrisentan10 mgtablet, film coatedActavis Pharma, Inc. | 17,748.65 (Schedule G, line 667, page 29 of the filing PDF) | 30 |
| 668 | Teriparatide 560 mcg PFP 2.24 mL47781065289Listed by the FDA as Teriparatide250 mcg/mLinjection, solutionAlvogen, Inc. | 17,722.00 (Schedule G, line 668, page 29 of the filing PDF) | 15 |
| 669 | Humira 40 mg-0.8 mL PFP kit 200074433902Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 17,720.54 (Schedule G, line 669, page 29 of the filing PDF) | 135 |
| 670 | Adalimumab-adaz 80 mg PFP 2x0.8 mL61314032520Listed by the FDA as Adalimumabadalimumab-adaz80 mg/0.8 mLinjection, solutionSandoz Inc | 17,521.33 (Schedule G, line 670, page 29 of the filing PDF) | 16 |
| 671 | Desmopressin Acetate 40 mcg MDV 10 mL83634045110Listed by the FDA as Desmopressin Acetate4 mcg/mLinjection, solutionAvenacy, LLC | 17,516.72 (Schedule G, line 671, page 29 of the filing PDF) | 154 |
| 672 | Incruse Ellipta inh 3000173087310Listed by the FDA as Incruse Elliptaumeclidinium62.5 mcgaerosol, powderGlaxoSmithKline LLC | 17,498.18 (Schedule G, line 672, page 29 of the filing PDF) | 175 |
| 673 | Diprivan 200 mg VL 10x20 mL63323026929Listed by the FDA as Diprivanpropofol10 mg/mLinjection, emulsionFresenius Kabi USA, LLC | 17,481.36 (Schedule G, line 673, page 29 of the filing PDF) | 35,823 |
| 674 | Retevmo 160 mg tab 6000002556260Listed by the FDA as Retevmoselpercatinib160 mgtablet, coatedEli Lilly and Company | 17,377.55 (Schedule G, line 674, page 29 of the filing PDF) | fewer than 6 (the count is not shown) |
| 675 | Cosentyx PFS 150 mg/mL 200078063998Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation | 16,973.62 (Schedule G, line 675, page 29 of the filing PDF) | 12 |
| 676 | Jaypirca 50 mg tab 3000002690230Listed by the FDA as Jaypircapirtobrutinib50 mgtablet, coatedEli Lilly and Company | 16,843.72 (Schedule G, line 676, page 29 of the filing PDF) | fewer than 6 (the count is not shown) |
| 677 | Somatuline Depot 60 mg PFS 0.2 mL15054106004Listed by the FDA as Somatuline Depotlanreotide acetate60 mg/0.2 mLinjectionIpsen Biopharmaceuticals, Inc. | 16,760.97 (Schedule G, line 677, page 29 of the filing PDF) | 9 |
| 678 | Xolair 75 mg PFS 0.5 mL50242021401Listed by the FDA as Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc.the product is listed, not this package | 16,736.30 (Schedule G, line 678, page 29 of the filing PDF) | 54 |
| 679 | Cefazolin 1 g VL 2500143992490Listed by the FDA as Cefazolin330 mg/mLinjection, powder, for solutionHikma Pharmaceuticals USA Inc. | 16,728.05 (Schedule G, line 679, page 29 of the filing PDF) | 10,503 |
| 680 | Gablofen 20 MU mcg PFS 20 mL DS66794015601Listed by the FDA as Gablofenbaclofen injection1,000 mcg/mLinjection, solutionPiramal Critical Care Inc | 16,709.00 (Schedule G, line 680, page 29 of the filing PDF) | 40 |
| 681 | Hernexeos 60 mg tab 6000597925786Listed by the FDA as Hernexeoszongertinib60 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc. | 16,620.28 (Schedule G, line 681, page 29 of the filing PDF) | fewer than 6 (the count is not shown) |
| 682 | Zenpep 10,000 units DR cap 10073562011001Listed by the FDA as Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase10,000 USP units; 32,000 USP units; 42,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc. | 16,541.05 (Schedule G, line 682, page 29 of the filing PDF) | 18 |
| 683 | Aranesp 10 mcg PFS 4x0.4 mL55513009804Listed by the FDA as Aranespdarbepoetin alfa10 mcg/0.4 mLinjection, solutionAmgen, Inc | 16,455.99 (Schedule G, line 683, page 29 of the filing PDF) | 1,106 |
| 684 | Zymfentra 120 mg-mL PFP kit 272606002502Listed by the FDA as Zymfentrainfliximab-dyybkitCELLTRION USA Inc. | 16,411.42 (Schedule G, line 684, page 29 of the filing PDF) | 11 |
| 685 | Dapagliflozin 5 mg tab 3066993045630Listed by the FDA as Dapagliflozin5 mgtablet, film coatedPrasco Laboratories | 16,249.65 (Schedule G, line 685, page 29 of the filing PDF) | 57 |
| 686 | Uzedy 125 mg ER PFS 0.35 mL51759063010Listed by the FDA as Uzedyrisperidone125 mg/0.35 mLinjection, suspension, extended releaseTeva Pharmaceuticals USA, Inc. | 16,141.09 (Schedule G, line 686, page 29 of the filing PDF) | 11 |
| 687 | Konvomep 2-84 mg-mL kit 150 mL65628027205Listed by the FDA as Konvomepomeprazole and sodium bicarbonatekitAzurity Pharmaceuticals, Inc. | 16,124.40 (Schedule G, line 687, page 29 of the filing PDF) | 88 |
| 688 | Gonal-F Redi-ject 900 IU PFP44087111701Listed by the FDA as Gonal-f RFF Redi-jectfollitropin900 IU/1.5 mLinjection, solutionEMD Serono, Inc. | 16,031.19 (Schedule G, line 688, page 29 of the filing PDF) | 21 |
| 689 | Xolair 75 mg PFS 0.5 mL50242021403Listed by the FDA as Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc. | 15,989.90 (Schedule G, line 689, page 29 of the filing PDF) | 36 |
| 690 | Zoledronic Acid 5 mg sol 100 mL71288080651Listed by the FDA as Zoledronic Acid5 mg/100 mLinjection, solutionMeitheal Pharmaceuticals Inc. | 15,969.73 (Schedule G, line 690, page 29 of the filing PDF) | 681 |
| 691 | Humate-P PDS 600 RCOF VL 250 IU FVIII63833061502Listed by the FDA as Humate-Pantihemophilic factor/von willebrand factor complex (human)kitCSL Behring GmbH | 15,969.14 (Schedule G, line 691, page 29 of the filing PDF) | 11 |
| 692 | Hydromorphone HCl 500 mg SDV 50 mL00409263450Listed by the FDA as Hydromorphone Hydrochloride10 mg/mLinjection, solutionHospira, Inc. | 15,768.92 (Schedule G, line 692, page 29 of the filing PDF) | 18 |
| 693 | Prevymis 480 mg tab 28 BP DS00006307602Listed by the FDA as Prevymisletermovir480 mgtablet, film coatedMerck Sharp & Dohme LLC | 15,758.01 (Schedule G, line 693, page 29 of the filing PDF) | fewer than 6 (the count is not shown) |
| 694 | Vonjo 100 mg cap 12072482010012Listed by the FDA as Vonjopacritinib100 mgcapsuleSobi, Inc. | 15,672.52 (Schedule G, line 694, page 29 of the filing PDF) | fewer than 6 (the count is not shown) |
| 695 | Nuplazid 34 mg cap 3063090034030Listed by the FDA as Nuplazidpimavanserin tartrate34 mgcapsuleAcadia Pharmaceuticals Inc. | 15,593.80 (Schedule G, line 695, page 29 of the filing PDF) | 7 |
| 696 | Cosentyx syringe 150 mg/mL00078063997Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation | 15,560.25 (Schedule G, line 696, page 29 of the filing PDF) | 14 |
| 697 | Oxaliplatin 50 mg SDV 10 mL60505613206Listed by the FDA as Oxaliplatin5 mg/mLinjection, solutionApotex Corp. | 15,529.19 (Schedule G, line 697, page 29 of the filing PDF) | 1,741 |
| 698 | Enbrel Mini 50 mg/mL CRT 458406004404Listed by the FDA as Enbreletanercept50 mg/mLsolutionImmunex Corporation | 15,521.53 (Schedule G, line 698, page 29 of the filing PDF) | 170 |
| 699 | Dalvance 500 mg VL57970010001Listed by the FDA as Dalvancedalbavancin500 mg/25 mLinjection, powder, for solutionAllergan, Inc. | 15,499.60 (Schedule G, line 699, page 29 of the filing PDF) | 7 |
| 700 | Rytary 36.25 mg/145 mg cap 10064896066201Listed by the FDA as Rytarycarbidopa and levodopa145 mg; 36.25 mgcapsule, extended releaseAmneal Pharmaceuticals LLC | 15,418.64 (Schedule G, line 700, page 29 of the filing PDF) | 40 |
| 701 | Acetaminophen 1,000 mg bag 20x100 mL63323043400Listed by the FDA as Acetaminophen10 mg/mLinjectionFresenius Kabi USA, LLC | 15,414.17 (Schedule G, line 701, page 29 of the filing PDF) | 3,446 |
| 702 | Promacta 12.5 mg tab 3000078068415Listed by the FDA as Promactaeltrombopag olamine12.5 mgtablet, film coatedNovartis Pharmaceuticals Corporation | 15,312.15 (Schedule G, line 702, page 29 of the filing PDF) | 11 |
| 703 | Risperdal Con 37.5 mg ER SYG 2 mL kit50458030711Listed by the FDA as Risperdal ConstarisperidonekitJanssen Pharmaceuticals, Inc. | 15,190.22 (Schedule G, line 703, page 29 of the filing PDF) | 31 |
| 704 | Depo Medrol 40 mg SDV 25x1 mL00009307303Listed by the FDA as Depo-Medrolmethylprednisolone acetate40 mg/mLinjection, suspensionPharmacia & Upjohn Company LLC | 15,111.19 (Schedule G, line 704, page 30 of the filing PDF) | 2,788 |
| 705 | Praluent 150 mg/mL PFP 261755002102Listed by the FDA as Praluentalirocumab150 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc. | 15,099.60 (Schedule G, line 705, page 30 of the filing PDF) | 57 |
| 706 | BeneFIX-RT PDS 2,080 IU VL58394063603Listed by the FDA as BeneFIXcoagulation factor ix (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 15,015.51 (Schedule G, line 706, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 707 | Lumakras 120 mg tab 24055513048824Listed by the FDA as Lumakrassotorasib120 mgtablet, coatedAmgen, Inc | 14,966.67 (Schedule G, line 707, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 708 | Admelog Solostar 100 units/mL PFP 5x3 mL00024592505Listed by the FDA as Admeloginsulin lispro100 units/mLinjection, solutionSanofi-Aventis U.S. LLC | 14,909.64 (Schedule G, line 708, page 30 of the filing PDF) | 140 |
| 709 | Tremfya 200 mg PFS 2 mL57894065122Listed by the FDA as Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc. | 14,713.92 (Schedule G, line 709, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 710 | Proparacaine HCl 0.5% O/S 15 mL24208073006Listed by the FDA as Proparacaine Hydrochloride5 mg/mLsolution/ dropsBausch & Lomb Incorporated | 14,697.74 (Schedule G, line 710, page 30 of the filing PDF) | 1,653 |
| 711 | Lupron Depot 3.75 mg kit00074364103Listed by the FDA as Lupron Depotleuprolide acetatekitAbbVie Inc. | 14,687.13 (Schedule G, line 711, page 30 of the filing PDF) | 217 |
| 712 | Mesna 400 mg tab 1050742035401Listed by the FDA as Mesna400 mgtablet, film coatedIngenus Pharmaceuticals, LLC | 14,665.64 (Schedule G, line 712, page 30 of the filing PDF) | 30 |
| 713 | Dexrazoxane-Sod Lac 250 mg SDV kit55150043401Listed by the FDA as DexrazoxanekitEugia US LLC | 14,640.52 (Schedule G, line 713, page 30 of the filing PDF) | 128 |
| 714 | Eribulin Mesylate 1 mg SDV 2 mL60505628900Listed by the FDA as Eribulin Mesylate0.5 mg/mLinjectionApotex Corp. | 14,617.08 (Schedule G, line 714, page 30 of the filing PDF) | 16 |
| 715 | Aristada 662 mg SYG 2.4 mL65757040203Listed by the FDA as Aristadaaripiprazole lauroxil662 mg/2.4 mLinjection, suspension, extended releaseAlkermes, Inc. | 14,589.99 (Schedule G, line 715, page 30 of the filing PDF) | 6 |
| 716 | Lumakras 240 mg tab 12055513051260Listed by the FDA as Lumakrassotorasib240 mgtablet, coatedAmgen, Inc | 14,421.04 (Schedule G, line 716, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 717 | Buprenorphine 10 mcg-hr pat 442858049340Listed by the FDA as Buprenorphine10 mcg/hourpatchRhodes Pharmaceuticals LLC | 14,402.05 (Schedule G, line 717, page 30 of the filing PDF) | 568 |
| 718 | Lenalidomide 20 mg cap 21 DS00480124521Listed by the FDA as Lenalidomide20 mgcapsuleTeva Pharmaceuticals, Inc. | 14,352.56 (Schedule G, line 718, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 719 | Abilify Maintena 300 mg syringe59148004580Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc. | 14,350.92 (Schedule G, line 719, page 30 of the filing PDF) | 11 |
| 720 | Sprycel 80 mg tab 3000003085522Listed by the FDA as Spryceldasatinib80 mgtabletE.R. Squibb & Sons, L.L.C. | 14,306.93 (Schedule G, line 720, page 30 of the filing PDF) | 29 |
| 721 | Radicava ORS 105 mg/5 mL sus kit 2x35 mL70510232102Listed by the FDA as Radicava ORSedaravonekitShionogi Inc. | 14,276.88 (Schedule G, line 721, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 722 | Valtoco 15 mg nasal SPY 2 (2x7.5 mg) BP72252051504Listed by the FDA as Valtocodiazepam7.5 mg/0.1 mLsprayNeurelis, Inc | 14,251.52 (Schedule G, line 722, page 30 of the filing PDF) | 28 |
| 723 | Toujeo Max Solostar 300 units/mL PFP 2x3 mL00024587102Listed by the FDA as Toujeo Maxinsulin glargine300 units/mLinjection, solutionSanofi-Aventis U.S. LLC | 14,189.86 (Schedule G, line 723, page 30 of the filing PDF) | 95 |
| 724 | Monjuvi 200 mg/5 mL SDV73535020801Listed by the FDA as Monjuvitafasitamab-cxix200 mg/5 mLinjection, powder, lyophilized, for solutionIncyte Corporation | 14,161.14 (Schedule G, line 724, page 30 of the filing PDF) | 10 |
| 725 | Descovy 200-25 mg tab 3061958200201Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc. | 14,142.19 (Schedule G, line 725, page 30 of the filing PDF) | 10 |
| 726 | Myfortic 180 mg DR tab 12000078038566Listed by the FDA as Myforticmycophenolic acid180 mgtablet, delayed releaseNovartis Pharmaceuticals Corporation | 14,078.97 (Schedule G, line 726, page 30 of the filing PDF) | 51 |
| 727 | Talzenna 0.35 mg SGC 3000069045430Listed by the FDA as Talzennatalazoparib0.35 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc | 13,952.08 (Schedule G, line 727, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 728 | Rasuvo auto 15 mg inj 4x0.3 mL59137052004Listed by the FDA as Rasuvomethotrexate15 mg/0.3 mLinjection, solutionMedexus Pharma Inc. | 13,763.23 (Schedule G, line 728, page 30 of the filing PDF) | 64 |
| 729 | Synagis 100 mg-mL SDV66658023101 | 13,751.68 (Schedule G, line 729, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 730 | Envarsus XR 1 mg tab 3068992301003Listed by the FDA as Envarsus XRtacrolimus1 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc | 13,736.29 (Schedule G, line 730, page 30 of the filing PDF) | 635 |
| 731 | Rybelsus 14 mg tab 3000169431430Listed by the FDA as Rybelsusoral semaglutide14 mgtabletNovo Nordisk Pharmaceutical Industries, LP | 13,670.54 (Schedule G, line 731, page 30 of the filing PDF) | 43 |
| 732 | Provayblue 50 mg amp 5x10 mL00517037405Listed by the FDA as Provaybluemethylene blue5 mg/mLinjectionAmerican Regent, Inc. | 13,635.47 (Schedule G, line 732, page 30 of the filing PDF) | 74 |
| 733 | Abilify Maintena 400 mg syringe59148007280Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc. | 13,622.48 (Schedule G, line 733, page 30 of the filing PDF) | 10 |
| 734 | AlbuRx 25% VL 50 mL44206025105Listed by the FDA as AlbuRxalbumin (human)12.5 g/50 mLsolutionCSL Behring AG | 13,557.62 (Schedule G, line 734, page 30 of the filing PDF) | 207 |
| 735 | Revlimid DS 5 mg cap 10059572040500Listed by the FDA as Revlimidlenalidomide5 mgcapsuleCelgene Corporation | 13,528.44 (Schedule G, line 735, page 30 of the filing PDF) | 0 |
| 736 | Buprenorphine-Naloxone 8-2 mg FLM 3000378876793Listed by the FDA as Buprenorphine and Naloxone8 mg; 2 mgfilmMylan Pharmaceuticals Inc. | 13,509.38 (Schedule G, line 736, page 30 of the filing PDF) | 277 |
| 737 | Rasuvo auto inj 4 25 mg/0.50 mL59137054004Listed by the FDA as Rasuvomethotrexate25 mg/0.5 mLinjection, solutionMedexus Pharma Inc. | 13,376.68 (Schedule G, line 737, page 30 of the filing PDF) | 64 |
| 738 | Skytrofa 5.2 mg HGH 1x4BX73362000601Listed by the FDA as Skytrofalonapegsomatropin-tcgd5.2 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc. | 13,284.82 (Schedule G, line 738, page 30 of the filing PDF) | 8 |
| 739 | BeneFIX-RT PDS 1,080 IU VL58394063503Listed by the FDA as BeneFIXcoagulation factor ix (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 13,268.58 (Schedule G, line 739, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 740 | Zejula 300 mg tab 3000173091513Listed by the FDA as Zejulaniraparib300 mgtablet, film coatedGlaxoSmithKline LLC | 13,207.09 (Schedule G, line 740, page 30 of the filing PDF) | fewer than 6 (the count is not shown) |
| 741 | Activase 50 mg VL50242004413Listed by the FDA as ActivasealteplasekitGenentech, Inc. | 13,202.58 (Schedule G, line 741, page 30 of the filing PDF) | 10 |
| 742 | Motegrity 2 mg tab 3054092054701Listed by the FDA as Motegrityprucalopride2 mgtablet, film coatedTakeda Pharmaceuticals America, Inc. | 13,185.46 (Schedule G, line 742, page 31 of the filing PDF) | 32 |
| 743 | Gvoke HypoPen 1 mg auto inj 2x0.2 mL72065012112Listed by the FDA as Gvoke HypoPen 1 mg Auto-Injectorglucagon injection, solution1 mg/0.2 mLinjection, solutionXeris Pharmaceuticals, Inc. | 13,063.20 (Schedule G, line 743, page 31 of the filing PDF) | 30 |
| 744 | Ledipasvir-Sofosbuvir 90-400 mg tab 2872626260101Listed by the FDA as Ledipasvir and Sofosbuvir90 mg; 400 mgtablet, film coatedAsegua Therapeutics LLC | 13,024.00 (Schedule G, line 744, page 31 of the filing PDF) | 0 |
| 745 | Katerzia 1 mg/mL sus 150 mL52652500101Listed by the FDA as Katerziaamlodipine1 mg/mLsuspensionAzurity Pharmaceuticals, Inc. | 13,020.52 (Schedule G, line 745, page 31 of the filing PDF) | 64 |
| 746 | Xiaflex 0.9 mg SDV DS66887000301Listed by the FDA as Xiaflexcollagenase clostridium histolyticumkitEndo USA, Inc. | 12,906.72 (Schedule G, line 746, page 31 of the filing PDF) | fewer than 6 (the count is not shown) |
| 747 | Yesintek 90 mg PFS 1 mL83257002541Listed by the FDA as Yesintekustekinumab90 mg/mLinjection, solutionBiocon Biologics Inc. | 12,786.45 (Schedule G, line 747, page 31 of the filing PDF) | 46 |
| 748 | Paclitaxel 300 mg MDV 50 mL25021025550Listed by the FDA as Paclitaxel6 mg/mLinjection, solutionSagent Pharmaceuticals | 12,768.41 (Schedule G, line 748, page 31 of the filing PDF) | 1,303 |
| 749 | Symbicort 120 160-4.5 mcg inh 10.2 g00186037020Listed by the FDA as Symbicortbudesonide and formoterol fumarate dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 12,709.68 (Schedule G, line 749, page 31 of the filing PDF) | 169 |
| 750 | Vonvendi 765 IU VL 5 mL00944755102Listed by the FDA as Vonvendivon willebrand factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 12,703.07 (Schedule G, line 750, page 31 of the filing PDF) | 14 |
| 751 | Veklury 100 mg LYPH pwd SDV61958290102Listed by the FDA as Vekluryremdesivir100 mginjection, powder, lyophilized, for solutionGilead Sciences, Inc. | 12,678.49 (Schedule G, line 751, page 31 of the filing PDF) | 18 |
| 752 | Eltrombopag 25 mg oral sus 30 PKT kit31722030132Listed by the FDA as Eltrombopageltrombopag olamine25 mgpowder, for suspensionCamber Pharmaceuticals, Inc. | 12,627.27 (Schedule G, line 752, page 31 of the filing PDF) | fewer than 6 (the count is not shown) |
| 753 | Ondansetron 4 mg SDV 25x2 mL00641607825Listed by the FDA as Ondansetron2 mg/mLinjectionHikma Pharmaceuticals USA Inc. | 12,626.71 (Schedule G, line 753, page 31 of the filing PDF) | 29,437 |
| 754 | Dovato TB 50-300 mg 30 BPK49702024633Listed by the FDA as Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company | 12,511.12 (Schedule G, line 754, page 31 of the filing PDF) | 9 |
| 755 | Rytary 48.75 mg/195 mg cap 10064896066301Listed by the FDA as Rytarycarbidopa and levodopa195 mg; 48.75 mgcapsule, extended releaseAmneal Pharmaceuticals LLC | 12,412.74 (Schedule G, line 755, page 31 of the filing PDF) | 25 |
| 756 | Zoledronic 4 mg bag 1x100 mL25021082682Listed by the FDA as Zoledronic Acid0.04 mg/mLinjection, solutionSagent Pharmaceuticals | 12,318.46 (Schedule G, line 756, page 31 of the filing PDF) | 915 |
| 757 | Fluticasone Prop 44 mcg inh aer 10.6 g66993007896Listed by the FDA as Fluticasone Propionate HFA44 mcgaerosol, meteredPrasco Laboratories | 12,264.61 (Schedule G, line 757, page 31 of the filing PDF) | 175 |
| 758 | Fluticasone Prop 110 mcg inh aer 12 g66993007996Listed by the FDA as Fluticasone Propionate HFA110 mcgaerosol, meteredPrasco Laboratories | 12,250.50 (Schedule G, line 758, page 31 of the filing PDF) | 121 |
| 759 | Envarsus 0.75 mg tab 10068992307501Listed by the FDA as Envarsus XRtacrolimus0.75 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc | 12,210.95 (Schedule G, line 759, page 31 of the filing PDF) | 290 |
| 760 | Kovaltry Adapter 2,142 IU VL00026382650Listed by the FDA as Kovaltryantihemophilic factor (recombinant)kitBayer HealthCare LLC | 12,175.16 (Schedule G, line 760, page 31 of the filing PDF) | fewer than 6 (the count is not shown) |
| 761 | Buprenorphine 20 mcg-hr pat 442858083940Listed by the FDA as Buprenorphine20 mcg/hourpatchRhodes Pharmaceuticals LLC | 12,137.85 (Schedule G, line 761, page 31 of the filing PDF) | 165 |
| 762 | Tacrolimus 1 mg cap 10055111052601Listed by the FDA as Tacrolimus1 mgcapsuleDr. Reddy's Laboratories Limited | 12,121.07 (Schedule G, line 762, page 31 of the filing PDF) | 991 |
| 763 | Mavyret 50/20 mg PEL 2800074260028Listed by the FDA as Mavyretglecaprevir and pibrentasvir20 mg; 50 mgpelletAbbVie Inc. | 12,070.16 (Schedule G, line 763, page 31 of the filing PDF) | fewer than 6 (the count is not shown) |
| 764 | Aimovig 140 mg auto inj 1 mL55513084301Listed by the FDA as Aimovigerenumab-aooe140 mg/mLinjection, solutionAmgen, Inc | 11,869.18 (Schedule G, line 764, page 31 of the filing PDF) | 87 |
| 765 | Novolog Insulin FLX 100 units/mL PFS 5x3 mL00169633910Listed by the FDA as Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk | 11,821.33 (Schedule G, line 765, page 31 of the filing PDF) | 207 |
| 766 | Abilify Asimtufii 720 mg ER PFS 2.4 mL59148010280Listed by the FDA as Abilify Asimtufiiaripiprazole720 mg/2.4 mLinjection, suspension, extended releaseOtsuka America Pharmaceutical, Inc | 11,749.68 (Schedule G, line 766, page 31 of the filing PDF) | 0 |
| 767 | Santyl 250 units/g ONT 30 g50484001030Listed by the FDA as Collagenase Santyl250 units/gointmentSmith & Nephew, Inc | 11,696.46 (Schedule G, line 767, page 31 of the filing PDF) | 35 |
| 768 | Yuflyma 40 mg-0.4 mL auto inj kit 272606003010Listed by the FDA as Yuflymaadalimumab-aatykitCELLTRION USA, Inc. | 11,627.66 (Schedule G, line 768, page 31 of the filing PDF) | 32 |
| 769 | Everolimus 5 mg tab 3000054048113Listed by the FDA as Everolimus5 mgtabletHikma Pharmaceuticals USA Inc. | 11,599.25 (Schedule G, line 769, page 31 of the filing PDF) | 24 |
| 770 | Risperdal Con 50 mg ER SYG 2 mL kit50458030811Listed by the FDA as Risperdal ConstarisperidonekitJanssen Pharmaceuticals, Inc. | 11,598.56 (Schedule G, line 770, page 31 of the filing PDF) | 26 |
| 771 | Talvey 3 mg SDV 1.5 mL57894046901Listed by the FDA as Talveytalquetamab-tgvs3 mg/1.5 mLinjectionJanssen Biotech, Inc. | 11,515.91 (Schedule G, line 771, page 31 of the filing PDF) | 12 |
| 772 | Ambrisentan 5 mg tab 3000591240530Listed by the FDA as Ambrisentan5 mgtablet, film coatedActavis Pharma, Inc. | 11,475.45 (Schedule G, line 772, page 31 of the filing PDF) | 17 |
| 773 | Insulin Lispro 100 units/mL VL 10 mL00002773701Listed by the FDA as Insulin Lispro100 IU/mLinjection, solutionEli Lilly and Company | 11,448.27 (Schedule G, line 773, page 31 of the filing PDF) | 232 |
| 774 | Renflexis 100 mg SDV78206016201Listed by the FDA as Renflexisinfliximab100 mginjection, powder, lyophilized, for solutionOrganon LLC | 11,383.09 (Schedule G, line 774, page 31 of the filing PDF) | 10 |
| 775 | Aprepitant 80 mg cap 668462058476Listed by the FDA as Aprepitant80 mgcapsuleGlenmark Pharmaceuticals Inc., USA | 11,308.10 (Schedule G, line 775, page 31 of the filing PDF) | 237 |
| 776 | Auvi-Q 0.1 mg auto inj 2x0.1 mL60842002102Listed by the FDA as Auvi-Qepinephrine0.1 mg/0.1 mLinjection, solutionkaleo, Inc | 11,215.39 (Schedule G, line 776, page 31 of the filing PDF) | 19 |
| 777 | Hizentra 2 g/10 mL PFS44206045722Listed by the FDA as Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG | 11,210.64 (Schedule G, line 777, page 31 of the filing PDF) | 11 |
| 778 | Adalimumab-aacf 40 mg-0.8 mL PFP kit 265219061299Listed by the FDA as Adalimumab-aacfadalimumabkitFresenius Kabi USA, LLC | 11,194.32 (Schedule G, line 778, page 31 of the filing PDF) | 17 |
| 779 | Novolog 100 units/mL VL 10 mL00169750111Listed by the FDA as Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk | 11,149.32 (Schedule G, line 779, page 31 of the filing PDF) | 136 |
| 780 | Invega Susten 78 mg SYG 0.50 mL50458056101Listed by the FDA as Invega Sustennapaliperidone palmitate78 mg/0.5 mLinjectionJanssen Pharmaceuticals, Inc. | 11,127.70 (Schedule G, line 780, page 32 of the filing PDF) | 26 |
| 781 | Nyvepria 6 mg PFS 0.6 mL00069032401Listed by the FDA as Nyvepriapegfilgrastim-apgf6 mg/0.6 mLinjection, solutionPfizer Laboratories Div Pfizer Inc | 11,100.81 (Schedule G, line 781, page 32 of the filing PDF) | 10 |
| 782 | Xeomin DS 100 units SDV 100259161001Listed by the FDA as XeominincobotulinumtoxinA100 USP unitsinjection, powder, lyophilized, for solutionMerz Pharmaceuticals, LLC | 11,050.15 (Schedule G, line 782, page 32 of the filing PDF) | 17 |
| 783 | Hemlibra 30 mg SDV50242092001Listed by the FDA as Hemlibraemicizumab30 mg/mLinjection, solutionGenentech, Inc. | 11,014.48 (Schedule G, line 783, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 784 | Anoro 62.5/25 mcg inh 60 (2x30)00173086910Listed by the FDA as Anoro Elliptaumeclidinium bromide and vilanterol trifenatate62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC | 11,013.23 (Schedule G, line 784, page 32 of the filing PDF) | 222 |
| 785 | Envarsus XR 4 mg tab 3068992304003Listed by the FDA as Envarsus XRtacrolimus4 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc | 11,008.12 (Schedule G, line 785, page 32 of the filing PDF) | 23 |
| 786 | Doxil 20 mg SDV 10 mL00338966701Listed by the FDA as Doxildoxorubicin hydrochloride2 mg/mLinjection, suspension, liposomalBaxter Healthcare Corporation | 10,987.32 (Schedule G, line 786, page 32 of the filing PDF) | 44 |
| 787 | Lenvima 18 mg cap 9062856071830Listed by the FDA as LenvimalenvatinibkitEisai Inc. | 10,957.18 (Schedule G, line 787, page 32 of the filing PDF) | 0 |
| 788 | Fentanyl Cit PF 100 mcg SDV 25x2 mL00409909422Listed by the FDA as Fentanyl Citrate50 mcg/mLinjection, solutionHospira, Inc. | 10,880.24 (Schedule G, line 788, page 32 of the filing PDF) | 27,726 |
| 789 | Doxil 20 mg SDV 10 mL00338006301Listed by the FDA as Doxildoxorubicin hydrochloride2 mg/mLinjection, suspension, liposomalBaxter Healthcare Company | 10,800.32 (Schedule G, line 789, page 32 of the filing PDF) | 43 |
| 790 | Ampicillin-Sulbactam 3 g SDV 1071288003221Listed by the FDA as Ampicillin and Sulbactamampicillin sodium and sulbactam sodium2 g; 1 ginjection, powder, for solutionMeitheal Pharmaceuticals Inc. | 10,714.45 (Schedule G, line 790, page 32 of the filing PDF) | 3,327 |
| 791 | Spiriva Respimat 2.5 mcg inh 4 g00597010061Listed by the FDA as Spiriva Respimattiotropium bromide inhalation spray3.124 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc. | 10,711.00 (Schedule G, line 791, page 32 of the filing PDF) | 230 |
| 792 | Esperoct 1,082 IU VL00169810001Listed by the FDA as Esperoctantihemophilic factor (recombinant), glycopegylated-exeikitNovo Nordisk | 10,674.66 (Schedule G, line 792, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 793 | Etoposide 50 mg cap 20 BP00378326694Listed by the FDA as Etoposide50 mgcapsuleMylan Pharmaceuticals Inc. | 10,662.06 (Schedule G, line 793, page 32 of the filing PDF) | 15 |
| 794 | Plaquenil TB 200 mg 10059212056210Listed by the FDA as Plaquenilhydroxychloroquine sulfate200 mgtabletAdvanz Pharma (US) Corp. | 10,659.02 (Schedule G, line 794, page 32 of the filing PDF) | 17 |
| 795 | Breztri Aerosphere inh aer 10.7 g00310461612Listed by the FDA as Breztribudesonide, glycopyrrolate, and formoterol fumarate160 mcg; 9 mcg; 4.8 mcgaerosol, meteredAstraZeneca Pharmaceuticals LP | 10,652.59 (Schedule G, line 795, page 32 of the filing PDF) | 50 |
| 796 | Tropicamide 1% O/S 15 mL70069012101Listed by the FDA as Tropicamide10 mg/mLsolution/ dropsSomerset Therapeutics, LLC | 10,641.04 (Schedule G, line 796, page 32 of the filing PDF) | 1,785 |
| 797 | Albuked 5% VL 250 mL76125079025Listed by the FDA as Albukedalbumin (human)2.5 g/50 mLsolutionKedrion Biopharma, Inc. | 10,635.35 (Schedule G, line 797, page 32 of the filing PDF) | 154 |
| 798 | Praxbind 2.5 g SDV 2x50 mL00597019705Listed by the FDA as Praxbindidarucizumab50 mg/mLinjectionBoehringer Ingelheim Pharmaceuticals, Inc. | 10,589.01 (Schedule G, line 798, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 799 | Glatiramer Acetate 40 mg-mL PFS 12x1 mL00378696112Listed by the FDA as Glatiramer Acetateglatiramer40 mg/mLinjection, solutionMylan Pharmaceuticals Inc. | 10,490.38 (Schedule G, line 799, page 32 of the filing PDF) | 13 |
| 800 | Dexamethasone 6 mg tab 100(10x10)60687072901Listed by the FDA as Dexamethasone6 mgtabletAmerican Health Packaging | 10,458.15 (Schedule G, line 800, page 32 of the filing PDF) | 4,232 |
| 801 | Activase 100 mg VL50242008527Listed by the FDA as ActivasealteplasekitGenentech, Inc. | 10,367.83 (Schedule G, line 801, page 32 of the filing PDF) | 6 |
| 802 | Neupogen 480 mcg SDV 10x1.6 mL55513054610Listed by the FDA as Neupogenfilgrastim480 mcg/1.6 mLinjection, solutionAmgen, Inc | 10,340.25 (Schedule G, line 802, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 803 | Elitek W/DIL 1.5 mg SDV 300024515010Listed by the FDA as ElitekrasburicasekitSanofi-Aventis U.S. LLC | 10,332.11 (Schedule G, line 803, page 32 of the filing PDF) | 6 |
| 804 | Cardene IV 40 mg bag 10x200 mL43066001610Listed by the FDA as Cardene IVnicardipine hydrochloride0.2 mg/mLinjection, solutionBaxter Healthcare Corporation | 10,251.09 (Schedule G, line 804, page 32 of the filing PDF) | 559 |
| 805 | Onyda XR 0.1 mg ER sus 30 mL24478014803Listed by the FDA as Onyda XRclonidine hydrochloride0.1 mg/mLsuspension, extended releaseNextWave Pharmaceuticals, Inc | 10,223.55 (Schedule G, line 805, page 32 of the filing PDF) | 25 |
| 806 | Admelog 100 units/mL VL 3 mL00024592605Listed by the FDA as Admeloginsulin lispro100 units/mLinjection, solutionSanofi-Aventis U.S. LLC | 10,179.23 (Schedule G, line 806, page 32 of the filing PDF) | 5,811 |
| 807 | Magnesium Sulfate 2 g bag 24x50 mL63323010605Listed by the FDA as Magnesium Sulfatemagnesium sulfate heptahydrate40 mg/mLinjection, solutionFresenius Kabi USA, LLC | 10,145.12 (Schedule G, line 807, page 32 of the filing PDF) | 5,194 |
| 808 | Belbuca 600 mcg FLM 6059385002560Listed by the FDA as Belbucabuprenorphine hydrochloride600 mcgfilm, solubleBioDelivery Sciences International Inc | 10,115.15 (Schedule G, line 808, page 32 of the filing PDF) | 41 |
| 809 | Ingrezza Sprinkle 40 mg cap 3070370404001Listed by the FDA as Ingrezza Sprinklevalbenazine40 mgcapsuleNeurocrine Biosciences, Inc. | 10,091.94 (Schedule G, line 809, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 810 | Columvi 2.5 mg SDV 2.5 mL50242012501Listed by the FDA as Columviglofitamab2.5 mg/2.5 mLsolution, concentrateGenentech, Inc. | 10,090.12 (Schedule G, line 810, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 811 | Vascepa 1 g cap 12052937000120Listed by the FDA as Vascepaicosapent ethyl1,000 mgcapsuleAmarin Pharma Inc. | 10,081.36 (Schedule G, line 811, page 32 of the filing PDF) | 22 |
| 812 | Ketorolac Trometh 15 mg-mL SDV 25x1 mL63323016101Listed by the FDA as Ketorolac Tromethamine15 mg/mLinjection, solutionFresenius Kabi USA, LLC | 9,999.16 (Schedule G, line 812, page 32 of the filing PDF) | 11,463 |
| 813 | Risperidone 37.5 mg ER inj sus kit00480134208Listed by the FDA as RisperidonekitTeva Pharmaceuticals, Inc. | 9,916.00 (Schedule G, line 813, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 814 | Hizentra 10 g/50 mL PFS44206045525Listed by the FDA as Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG | 9,871.23 (Schedule G, line 814, page 32 of the filing PDF) | 10 |
| 815 | Somatuline Depot 90 mg PFS 0.3 mL15054109004Listed by the FDA as Somatuline Depotlanreotide acetate90 mg/0.3 mLinjectionIpsen Biopharmaceuticals, Inc. | 9,730.89 (Schedule G, line 815, page 32 of the filing PDF) | fewer than 6 (the count is not shown) |
| 816 | Anecream 4% TEGA patch kit 5x5 g24357070107Listed by the FDA as Anecreamlidocaine 4%4 g/100 gcreamFocus Health Group | 9,718.13 (Schedule G, line 816, page 32 of the filing PDF) | 2,165 |
| 817 | Mercaptopurine 2,000 mg oral sus 100 mL00054087949Listed by the FDA as Mercaptopurine20 mg/mLsuspensionHikma Pharmaceuticals USA Inc. | 9,680.72 (Schedule G, line 817, page 32 of the filing PDF) | 55 |
| 818 | Albuterol Sulf 90 mcg inh aer 6.7 g60687066291Listed by the FDA as Albuterol Sulfate90 mcginhalantAmerican Health Packaging | 9,572.41 (Schedule G, line 818, page 33 of the filing PDF) | 2,176 |
| 819 | Diprivan 1,000 mg EML VL 10x100 mL63323026965Listed by the FDA as Diprivanpropofol10 mg/mLinjection, emulsionFresenius Kabi USA, LLC | 9,533.81 (Schedule G, line 819, page 33 of the filing PDF) | 2,177 |
| 820 | Veozah TB 45 mg 3000469266030Listed by the FDA as Veozahfezolinetant45 mgtablet, film coatedAstellas Pharma US, Inc. | 9,483.57 (Schedule G, line 820, page 33 of the filing PDF) | 28 |
| 821 | Creon 24,000 DR cap 10000032263601Listed by the FDA as Creonpancrelipase24,000 USP units; 76,000 USP units; 120,000 USP unitscapsule, delayed release pelletsAbbVie Inc. | 9,444.37 (Schedule G, line 821, page 33 of the filing PDF) | 342 |
| 822 | Leucovorin Calcium 350 mg SDV67457053035Listed by the FDA as Leucovorin Calcium350 mg/17.5 mLinjection, powder, lyophilized, for suspensionMylan Institutional LLC | 9,151.28 (Schedule G, line 822, page 33 of the filing PDF) | 195 |
| 823 | Insulin Glargine-yfgn 100 units/mL PFP 5x3 mL83257001532Listed by the FDA as Insulin Glargineinsulin glargine-yfgn100 IU/mLinjection, solutionBiocon Biologics Inc. | 9,065.30 (Schedule G, line 823, page 33 of the filing PDF) | 164 |
| 824 | Morphine Sulfate PF 4 mg/mL CJ LL 10x1 mL00409189101Listed by the FDA as Morphine Sulfate4 mg/mLinjection, solutionHospira, Inc. | 9,063.44 (Schedule G, line 824, page 33 of the filing PDF) | 9,462 |
| 825 | Irinotecan HCl 100 mg SDV 5 mL60505612801Listed by the FDA as Irinotecan Hydrochloride20 mg/mLinjection, solutionApotex Corp. | 9,056.07 (Schedule G, line 825, page 33 of the filing PDF) | 977 |
| 826 | Abiraterone Acet 250 mg tab 12068462013508Listed by the FDA as Abiraterone Acetate250 mgtabletGlenmark Pharmaceuticals Inc., USA | 9,031.32 (Schedule G, line 826, page 33 of the filing PDF) | 162 |
| 827 | Protamine Sulfate 10 mg-mL VL 25x5 mL63323022905Listed by the FDA as Protamine Sulfate10 mg/mLinjection, solutionFresenius Kabi USA, LLC | 9,005.34 (Schedule G, line 827, page 33 of the filing PDF) | 1,914 |
| 828 | Tresiba Flex Touch 100 units-mL PFP 5x3 mL00169266015Listed by the FDA as Tresibainsulin degludec100 units/mLinjection, solutionNovo Nordisk | 8,983.15 (Schedule G, line 828, page 33 of the filing PDF) | 72 |
| 829 | Cefepime-Dext 2 g IVPB 12x100 mL DS00338130148Listed by the FDA as Cefepime1 g/50 mLinjection, solutionBaxter Healthcare Corporation | 8,935.65 (Schedule G, line 829, page 33 of the filing PDF) | 689 |
| 830 | Revlimid DS 15 mg cap 2159572041521Listed by the FDA as Revlimidlenalidomide15 mgcapsuleCelgene Corporation | 8,894.66 (Schedule G, line 830, page 33 of the filing PDF) | 9 |
| 831 | Saxenda 18 mg/3 mL PF inj 500169280015Listed by the FDA as Saxendaliraglutide6 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 8,883.85 (Schedule G, line 831, page 33 of the filing PDF) | 15 |
| 832 | Gliadel WAF 8 DS24338005008Listed by the FDA as Gliadelcarmustine7.7 mgwaferAzurity Pharmaceuticals, Inc. | 8,868.51 (Schedule G, line 832, page 33 of the filing PDF) | fewer than 6 (the count is not shown) |
| 833 | Eltrombopag 50 mg tab 3031722084330Listed by the FDA as Eltrombopag50 mgtablet, film coatedCamber Pharmaceuticals, Inc. | 8,813.18 (Schedule G, line 833, page 33 of the filing PDF) | fewer than 6 (the count is not shown) |
| 834 | Adalimumab-adbm 40 mg-0.8 mL PFP kit 200597054522Listed by the FDA as Adalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc. | 8,790.70 (Schedule G, line 834, page 33 of the filing PDF) | 17 |
| 835 | Etoposide 1 g MDV 50 mL16729011411Listed by the FDA as Etoposide20 mg/mLinjectionAccord Healthcare Inc. | 8,780.72 (Schedule G, line 835, page 33 of the filing PDF) | 842 |
| 836 | Albuterol Sulf HFA 90 mcg inh aer 6.7 g00781729685Listed by the FDA as Albuterol Sulfate108 mcgaerosol, meteredSandoz Inc | 8,752.21 (Schedule G, line 836, page 33 of the filing PDF) | 1,041 |
| 837 | Heparin 5% Dextrose 50 units-mL bag 24x500 mL63323052277Listed by the FDA as Heparin Sodium5,000 USP units/100 mLinjection, solutionFresenius Kabi USA, LLC | 8,687.20 (Schedule G, line 837, page 33 of the filing PDF) | 965 |
| 838 | Cyltezo 40 mg-0.8 mL PFP kit 200597037597Listed by the FDA as Cyltezoadalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc. | 8,646.14 (Schedule G, line 838, page 33 of the filing PDF) | 16 |
| 839 | Ninlaro 3 mg cap 1x363020039002Listed by the FDA as Ninlaroixazomib3 mgcapsuleTakeda Pharmaceuticals America, Inc. | 8,560.60 (Schedule G, line 839, page 33 of the filing PDF) | 15 |
| 840 | Kepivance 5.16 mg VL 366658011303Listed by the FDA as Kepivancepalifermin5.16 mg/1.2 mLinjection, powder, lyophilized, for solutionSwedish Orphan Biovitrum AB (publ) | 8,529.52 (Schedule G, line 840, page 33 of the filing PDF) | fewer than 6 (the count is not shown) |
| 841 | Ninlaro 2.3 mg cap 3 (1x3)63020023002Listed by the FDA as Ninlaroixazomib2.3 mgcapsuleTakeda Pharmaceuticals America, Inc. | 8,519.32 (Schedule G, line 841, page 33 of the filing PDF) | fewer than 6 (the count is not shown) |
| 842 | Calcium Glucon-NaCl 2,000 mg bag 24x100 mL44567062124Listed by the FDA as Calcium Gluconate in Sodium Chloridecalcium gluconate20 mg/mLinjection, solutionWG Critical Care, LLC | 8,493.20 (Schedule G, line 842, page 33 of the filing PDF) | 463 |
| 843 | Eprontia 25 mg oral sol 473 mL52652900101Listed by the FDA as Eprontiatopiramate25 mg/mLsolutionAzurity Pharmaceuticals, Inc. | 8,481.97 (Schedule G, line 843, page 33 of the filing PDF) | 37 |
| 844 | Lidocaine 2% Glydo Jelly 10x11 mL25021067377Listed by the FDA as Glydolidocaine hydrochloride20 mg/mLjellySagent Pharmaceuticals | 8,474.95 (Schedule G, line 844, page 33 of the filing PDF) | 1,718 |
| 845 | Steglatro 15 mg tab 3000006536403Listed by the FDA as Steglatroertugliflozin15 mgtablet, film coatedMerck Sharp & Dohme LLC | 8,432.59 (Schedule G, line 845, page 33 of the filing PDF) | 25 |
| 846 | Pentam Lyophz 300 mg SDV 10x15 mL63323011310Listed by the FDA as Pentam 300pentamidine isethionate300 mg/3 mLinjection, powder, lyophilized, for solutionFresenius Kabi USA, LLC | 8,340.36 (Schedule G, line 846, page 33 of the filing PDF) | 184 |
| 847 | Rytary 23.75 mg/95 mg cap 10064896066101Listed by the FDA as Rytarycarbidopa and levodopa95 mg; 23.75 mgcapsule, extended releaseAmneal Pharmaceuticals LLC | 8,329.88 (Schedule G, line 847, page 33 of the filing PDF) | 20 |
| 848 | Sevelamer Carbonate 800 mg tab 27065162005827Listed by the FDA as Sevelamer Carbonate800 mgtablet, film coatedAmneal Pharmaceuticals LLC | 8,296.13 (Schedule G, line 848, page 33 of the filing PDF) | 334 |
| 849 | Envarsus XR 0.75 mg tab 3068992307503Listed by the FDA as Envarsus XRtacrolimus0.75 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc | 8,263.70 (Schedule G, line 849, page 33 of the filing PDF) | 67 |
| 850 | Pegasys 180 mcg VL 1 mL82154044901Listed by the FDA as Pegasyspeginterferon alfa-2a180 mcg/mLinjection, solutionpharmaand GmbH | 8,260.08 (Schedule G, line 850, page 33 of the filing PDF) | 30 |
| 851 | Auvi-Q 0.15 mg auto inj 2x0.15 mL60842002202Listed by the FDA as Auvi-Qepinephrine0.15 mg/0.15 mLinjection, solutionkaleo, Inc | 8,227.41 (Schedule G, line 851, page 33 of the filing PDF) | 15 |
| 852 | Ngenla 60 mg PFP 1.2 mL00069052002Listed by the FDA as Ngenlasomatrogon-ghla60 mg/1.2 mLinjection, solutionPfizer Laboratories Div Pfizer Inc | 8,183.15 (Schedule G, line 852, page 33 of the filing PDF) | 8 |
| 853 | Mycophenolic Acid 360 mg DR tab 12016729018929Listed by the FDA as Mycophenolic Acid360 mgtablet, delayed releaseAccord Healthcare Inc. | 8,146.98 (Schedule G, line 853, page 33 of the filing PDF) | 973 |
| 854 | Lokelma 10 g PKT 1100310111039Listed by the FDA as Lokelmasodium zirconium cyclosilicate10 g/10 gpowder, for suspensionAstraZeneca Pharmaceuticals LP | 8,127.79 (Schedule G, line 854, page 33 of the filing PDF) | 24 |
| 855 | Eohilia 2 mg sus PKT 60x10 mL64764010560Listed by the FDA as Eohiliabudesonide2 mg/10 mLsuspensionTakeda Pharmaceuticals America, Inc. | 8,091.51 (Schedule G, line 855, page 33 of the filing PDF) | 10 |
| 856 | Diazepam rectal gel 10 mg kit 268682065220Listed by the FDA as Diazepam10 mg/2 mLgelOceanside Pharmaceuticals | 8,077.70 (Schedule G, line 856, page 34 of the filing PDF) | 58 |
| 857 | Combivent Respim inh 4 g00597002402Listed by the FDA as Combivent Respimatipratropium bromide and albuterol20 mcg; 100 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc. | 8,067.81 (Schedule G, line 857, page 34 of the filing PDF) | 35 |
| 858 | Dysport 300 units VL15054053006Listed by the FDA as Dysportbotulinum toxin type A300 unitsinjection, powder, lyophilized, for solutionIpsen Biopharmaceuticals, Inc. | 8,066.50 (Schedule G, line 858, page 34 of the filing PDF) | 29 |
| 859 | Esbriet 267 mg cap 27050242012101 | 7,934.36 (Schedule G, line 859, page 34 of the filing PDF) | 0 |
| 860 | Leucovorin Calcium 350 mg LYO SDV25021081630Listed by the FDA as Leucovorin Calcium350 mg/17.5 mLinjection, powder, lyophilized, for solutionSagent Pharmaceuticals | 7,929.77 (Schedule G, line 860, page 34 of the filing PDF) | 1,082 |
| 861 | Octagam 10% 20 g 200 mL VL68982085004Listed by the FDA as Octagam Immune Globulin (Human)immune globulin100 mg/mLsolutionOctapharma USA Inc | 7,922.22 (Schedule G, line 861, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 862 | Stiolto Respimat 2.5/2.5 mcg inh 60x4 g00597015561Listed by the FDA as Stiolto Respimattiotropium bromide and olodaterol3.124 mcg; 2.736 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc. | 7,905.96 (Schedule G, line 862, page 34 of the filing PDF) | 97 |
| 863 | Vancomycin-Sod 1 g bag 6x200 mL DS00338358301Listed by the FDA as Vancomycin Hydrochloride1 g/200 mLinjection, solutionBaxter Healthcare Corporation | 7,886.19 (Schedule G, line 863, page 34 of the filing PDF) | 952 |
| 864 | Baqsimi 3 mg pwd00548835101Listed by the FDA as Baqsimiglucagon3 mgpowderAmphastar Pharmaceuticals, Inc. | 7,870.71 (Schedule G, line 864, page 34 of the filing PDF) | 22 |
| 865 | Otulfi 45 mg PFS 0.5 mL65219082401Listed by the FDA as Otulfiustekinumab-aauz45 mg/0.5 mLinjection, solutionFresenius Kabi USA, LLC | 7,817.95 (Schedule G, line 865, page 34 of the filing PDF) | 10 |
| 866 | Pancreaze CP 21,000 units 100 DR62541040510Listed by the FDA as Pancreazepancrelipase lipase, pancrelipase amylase, and pancrelipase protease21,000 USP units; 83,900 USP units; 54,700 USP unitscapsule, delayed releaseVivus LLC | 7,816.44 (Schedule G, line 866, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 867 | Leucovorin Calcium 200 mg LYO SDV00143955301Listed by the FDA as Leucovorin Calcium200 mg/20 mLinjection, powder, lyophilized, for solutionHikma Pharmaceuticals USA Inc. | 7,813.00 (Schedule G, line 867, page 34 of the filing PDF) | 294 |
| 868 | Afrin Original spray 30 mL11523116705Listed by the FDA as Afrin Originaloxymetazoline hydrochloride0.05 g/100 mLsprayBayer HealthCare LLC. | 7,787.68 (Schedule G, line 868, page 34 of the filing PDF) | 1,029 |
| 869 | Ambrisentan 10 mg tab 3000378427193Listed by the FDA as Ambrisentan10 mgtablet, film coatedMylan Pharmaceuticals Inc. | 7,778.26 (Schedule G, line 869, page 34 of the filing PDF) | 47 |
| 870 | Opzelura 1.5% crm 60 g50881000705Listed by the FDA as Opzeluraruxolitinib15 mg/gcreamIncyte Corporation | 7,765.62 (Schedule G, line 870, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 871 | Breo Ellipta 200-25 mcg inh 60 (2x30) BP00173088210Listed by the FDA as Breo Elliptafluticasone furoate and vilanterol trifenatate200 mcg; 25 mcgpowderGlaxoSmithKline LLC | 7,677.99 (Schedule G, line 871, page 34 of the filing PDF) | 94 |
| 872 | Epinephrine 0.3 mg inj PFS 249502010202Listed by the FDA as Epinephrine0.3 mg/0.3 mLinjectionViatris Specialty LLC | 7,636.04 (Schedule G, line 872, page 34 of the filing PDF) | 268 |
| 873 | Inlyta 1 mg tab 18000069014501Listed by the FDA as Inlytaaxitinib1 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 7,627.16 (Schedule G, line 873, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 874 | Abiraterone Acetate 250 mg tab 12072205003092Listed by the FDA as Abirateroneabiraterone acetate250 mgtabletNovadoz Pharmaceuticals LLC | 7,614.19 (Schedule G, line 874, page 34 of the filing PDF) | 124 |
| 875 | Truxima 100 mg SDV 10 mL63459010310Listed by the FDA as Truximarituximab-abbs10 mg/mLinjection, solutionCephalon, Inc. | 7,613.80 (Schedule G, line 875, page 34 of the filing PDF) | 31 |
| 876 | Humalog 100 units/mL VL 10 mL00002751001Listed by the FDA as Humaloginsulin lispro100 IU/mLinjection, solutionEli Lilly and Company | 7,607.66 (Schedule G, line 876, page 34 of the filing PDF) | 182 |
| 877 | Vraylar 1.5 mg cap 3061874011530Listed by the FDA as Vraylarcariprazine1.5 mgcapsule, gelatin coatedAllergan, Inc. | 7,582.26 (Schedule G, line 877, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 878 | Hadlima Pushtouch 40 mg auto inj 2x0.8 mL78206018401Listed by the FDA as Hadlimaadalimumab-bwwd40 mg/0.8 mLsolutionOrganon LLC | 7,580.85 (Schedule G, line 878, page 34 of the filing PDF) | 13 |
| 879 | Cibinqo 100 mg tab 3000069033530Listed by the FDA as Cibinqoabrocitinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc | 7,549.10 (Schedule G, line 879, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 880 | Rybelsus 3 mg tab 3000169430330Listed by the FDA as Rybelsusoral semaglutide3 mgtabletNovo Nordisk Pharmaceutical Industries, LP | 7,545.00 (Schedule G, line 880, page 34 of the filing PDF) | 18 |
| 881 | Venclexta 50 mg tab 7 Wallet00074056607Listed by the FDA as Venclextavenetoclax50 mgtablet, film coatedAbbVie Inc. | 7,532.55 (Schedule G, line 881, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 882 | Gvoke HypoPen 2-pack 0.5 mg per 0.1 mL72065012012Listed by the FDA as Gvoke HypoPen 0.5 mg Auto-Injectorglucagon injection, solution0.5 mg/0.1 mLinjection, solutionXeris Pharmaceuticals, Inc. | 7,487.98 (Schedule G, line 882, page 34 of the filing PDF) | 23 |
| 883 | Qvar Redihaler 80 mcg inh 10.6 g59310030480Listed by the FDA as Qvar Redihalerbeclomethasone dipropionate HFA80 mcgaerosol, meteredTeva Respiratory, LLC | 7,429.53 (Schedule G, line 883, page 34 of the filing PDF) | 62 |
| 884 | Ajovy 225 mg auto inj 1.5 mL51759020210Listed by the FDA as Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc. | 7,417.49 (Schedule G, line 884, page 34 of the filing PDF) | 23 |
| 885 | Norepinephrine-Dext 8 mg-5% bag 20x250 mL00338010820Listed by the FDA as Norepinephrine Bitartrate8 mg/250 mLinjection, solutionBaxter Healthcare Corporation | 7,414.68 (Schedule G, line 885, page 34 of the filing PDF) | 1,002 |
| 886 | Teriparatide 560 mcg PFP 2.24 mL66993049528Listed by the FDA as Teriparatide250 mcg/mLinjection, solutionPrasco Laboratories | 7,355.63 (Schedule G, line 886, page 34 of the filing PDF) | 26 |
| 887 | Santyl OI 250 units/g 90 g tube PF50484001090Listed by the FDA as Collagenase Santyl250 units/gointmentSmith & Nephew, Inc | 7,346.13 (Schedule G, line 887, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 888 | Dexamethasone 4 mg tab 100 (10x10)60687071801Listed by the FDA as Dexamethasone4 mgtabletAmerican Health Packaging | 7,284.17 (Schedule G, line 888, page 34 of the filing PDF) | 5,127 |
| 889 | Avastin 100 mg SDV 4 mL50242006001Listed by the FDA as Avastinbevacizumab100 mg/4 mLinjection, solutionGenentech, Inc. | 7,262.34 (Schedule G, line 889, page 34 of the filing PDF) | 14 |
| 890 | Iclusig 30 mg (30 tablets ea)63020053330Listed by the FDA as Iclusigponatinib hydrochloride30 mgtablet, film coatedTakeda Pharmaceuticals America, Inc. | 7,228.59 (Schedule G, line 890, page 34 of the filing PDF) | fewer than 6 (the count is not shown) |
| 891 | Azathioprine 75 mg tab 10068682023101Listed by the FDA as Azathioprine75 mgtabletOceanside Pharmaceuticals | 7,208.92 (Schedule G, line 891, page 34 of the filing PDF) | 21 |
| 892 | Tiotropium Bromide 18 mcg cap 3068180096412Listed by the FDA as Tiotropium Bromide18 mcgcapsuleLupin Pharmaceuticals, Inc. | 7,181.68 (Schedule G, line 892, page 34 of the filing PDF) | 36 |
| 893 | Solu Medrol 125 mg AOV 25x2 mL00009004722Listed by the FDA as Solu-Medrolmethylprednisolone sodium succinate125 mg/2 mLinjection, powder, for solutionPharmacia & Upjohn Company LLC | 7,157.98 (Schedule G, line 893, page 34 of the filing PDF) | 3,670 |
| 894 | Prucalopride 1 mg tab 3070954059610Listed by the FDA as Prucalopride1 mgtabletANI Pharmaceuticals, Inc. | 7,152.01 (Schedule G, line 894, page 35 of the filing PDF) | 23 |
| 895 | Doxorubicin HCl Liposome 20 mg SDV 10 mL70710153001Listed by the FDA as Doxorubicin Hydrochloride2 mg/mLinjectable, liposomalZydus Pharmaceuticals USA Inc. | 7,139.48 (Schedule G, line 895, page 35 of the filing PDF) | 40 |
| 896 | Propofol 500 mg EML VL 20x50 mL23155034542Listed by the FDA as Propofol10 mg/mLinjection, emulsionHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7,117.96 (Schedule G, line 896, page 35 of the filing PDF) | 7,332 |
| 897 | Cimzia Start 2x200 mg/mL kit 350474071081Listed by the FDA as Cimziacertolizumab pegol200 mg/mLinjection, solutionUCB, Inc. | 6,907.28 (Schedule G, line 897, page 35 of the filing PDF) | 15 |
| 898 | Sirolimus 1 mg tab 10068462068301Listed by the FDA as Sirolimus1 mgtablet, film coatedGlenmark Pharmaceuticals Inc., USA | 6,892.88 (Schedule G, line 898, page 35 of the filing PDF) | 208 |
| 899 | Methylprednisolone ACE 40 mg SDV 25x1 mL70121157305Listed by the FDA as Methylprednisolone acetate40 mg/mLinjection, suspensionAmneal Pharmaceuticals LLC | 6,886.66 (Schedule G, line 899, page 35 of the filing PDF) | 831 |
| 900 | Lidocaine HCl 2% Viscous sol 40x15 mL00121495040Listed by the FDA as Lidocaine Hydrochloride20 mg/mLsolutionPAI Holdings, LLC dba PAI Pharma | 6,796.73 (Schedule G, line 900, page 35 of the filing PDF) | 2,403 |
| 901 | Esperoct 2,235 IU VL00169820001Listed by the FDA as Esperoctantihemophilic factor (recombinant), glycopegylated-exeikitNovo Nordisk | 6,749.70 (Schedule G, line 901, page 35 of the filing PDF) | fewer than 6 (the count is not shown) |
| 902 | Palonosetron HCl 0.25 mg SDV 5 mL68001035525Listed by the FDA as Palonosetron0.05 mg/mLinjection, solutionBluePoint Laboratories | 6,717.94 (Schedule G, line 902, page 35 of the filing PDF) | 1,248 |
| 903 | Tresiba Flex Touch 200 units-mL PFP 3x3 mL00169255013Listed by the FDA as Tresibainsulin degludec200 units/mLinjection, solutionNovo Nordisk | 6,637.02 (Schedule G, line 903, page 35 of the filing PDF) | 17 |
| 904 | Glatopa 20 mg PFS 30x1 mL00781323434Listed by the FDA as Glatopaglatiramer acetate20 mg/mLinjection, solutionSandoz Inc | 6,619.38 (Schedule G, line 904, page 35 of the filing PDF) | 12 |
| 905 | Sogroya 10 mg PFP 1.5 mL00169203011Listed by the FDA as Sogroyasomapacitan-beco6.7 mg/mLinjection, solutionNovo Nordisk | 6,573.71 (Schedule G, line 905, page 35 of the filing PDF) | 15 |
| 906 | Harvoni 90 mg/400 mg tab 2861958180101Listed by the FDA as Harvoniledipasvir and sofosbuvir90 mg; 400 mgtablet, film coatedGilead Sciences, Inc | 6,538.22 (Schedule G, line 906, page 35 of the filing PDF) | 0 |
| 907 | Mesnex 400 mg tab 1067108356509Listed by the FDA as Mesnexmesna400 mgtablet, film coatedBaxter Healthcare Company | 6,466.11 (Schedule G, line 907, page 35 of the filing PDF) | 18 |
| 908 | Zemplar 5 mcg FTV 25x1 mL00074165801Listed by the FDA as Zemplarparicalcitol5 mcg/mLinjection, solutionAbbVie Inc. | 6,419.10 (Schedule G, line 908, page 35 of the filing PDF) | 537 |
| 909 | Risperdal Con 25 mg ER SYG 2 mL kit50458030611Listed by the FDA as Risperdal ConstarisperidonekitJanssen Pharmaceuticals, Inc. | 6,408.90 (Schedule G, line 909, page 35 of the filing PDF) | 24 |
| 910 | Rydapt 25 mg SGC 56 (2x28)00078069899Listed by the FDA as Rydapt25 mgcapsule, liquid filledNovartis Pharmaceuticals Corporation | 6,399.25 (Schedule G, line 910, page 35 of the filing PDF) | fewer than 6 (the count is not shown) |
| 911 | Valganciclovir 450 mg tab 6031722083260Listed by the FDA as Valganciclovir450 mgtablet, film coatedCamber Pharmaceuticals, Inc. | 6,374.35 (Schedule G, line 911, page 35 of the filing PDF) | 132 |
| 912 | DR Vigabatrin 500 mg pwd5043598069750Listed by the FDA as Vigabatrin50 mg/mLpowder, for solutionDr. Reddy's Laboratories Inc. | 6,345.92 (Schedule G, line 912, page 35 of the filing PDF) | 24 |
| 913 | Sogroya 5 mg PFP 1.5 mL00169203511Listed by the FDA as Sogroyasomapacitan-beco3.3 mg/mLinjection, solutionNovo Nordisk | 6,338.42 (Schedule G, line 913, page 35 of the filing PDF) | 28 |
| 914 | Capecitabine 500 mg tab 12055111049704Listed by the FDA as Capecitabine500 mgtabletDr. Reddy's Laboratories Limited | 6,336.18 (Schedule G, line 914, page 35 of the filing PDF) | 293 |
| 915 | Spiriva Respimat 1.25 mcg inh 4 g00597016061Listed by the FDA as Spiriva Respimattiotropium bromide inhalation spray1.562 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc. | 6,315.36 (Schedule G, line 915, page 35 of the filing PDF) | 100 |
| 916 | Xyntha PDS 3,040 IU Solofuse kit SYG58394001603Listed by the FDA as Xynthaantihemophilic factor (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 6,300.00 (Schedule G, line 916, page 35 of the filing PDF) | fewer than 6 (the count is not shown) |
| 917 | Qbrelis 1 mg/mL sol 150 mL52652300101Listed by the FDA as Qbrelislisinopril1 mg/mLsolutionAzurity Pharmaceuticals, Inc. | 6,218.43 (Schedule G, line 917, page 35 of the filing PDF) | 7 |
| 918 | Ventolin HFA 90 mcg inh 18 g00173068220Listed by the FDA as Ventolin HFAalbuterol sulfate90 mcgaerosol, meteredGlaxoSmithKline LLC | 6,205.42 (Schedule G, line 918, page 35 of the filing PDF) | 404 |
| 919 | Revlimid DS 10 mg cap 10059572041000Listed by the FDA as Revlimidlenalidomide10 mgcapsuleCelgene Corporation | 6,119.76 (Schedule G, line 919, page 35 of the filing PDF) | fewer than 6 (the count is not shown) |
| 920 | Afinitor Disperz 3 mg tab 28 (4x7)00078062751Listed by the FDA as Afinitor Disperzeverolimus3 mgtablet, for suspensionNovartis Pharmaceuticals Corporation | 6,106.58 (Schedule G, line 920, page 35 of the filing PDF) | fewer than 6 (the count is not shown) |
| 921 | Aminocaproic Acid 0.25 g-mL sol 236.5 mL31722003523Listed by the FDA as Aminocaproic Acid0.25 g/mLsolutionCamber Pharmaceuticals, Inc. | 6,099.21 (Schedule G, line 921, page 35 of the filing PDF) | 34 |
| 922 | Symbicort INS 160/ 4.5 mcg inh 6 g00186037028Listed by the FDA as Symbicortbudesonide and formoterol fumarate dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 6,075.29 (Schedule G, line 922, page 35 of the filing PDF) | 340 |
| 923 | Epkinly 4 mg SDV 0.8 mL82705000201Listed by the FDA as Epkinlyepcoritamab-bysp4 mg/0.8 mLinjection, solutionGenmab US, Inc. | 6,027.42 (Schedule G, line 923, page 35 of the filing PDF) | 7 |
| 924 | Sunitinib Malate 12.5 mg cap 2800378667828Listed by the FDA as Sunitinib Malate12.5 mgcapsuleMylan Pharmaceuticals Inc. | 6,016.48 (Schedule G, line 924, page 35 of the filing PDF) | fewer than 6 (the count is not shown) |
| 925 | Breo Ellipta 100-25 mcg inh 60 (2x30) BP00173085910Listed by the FDA as Breo Elliptafluticasone furoate and vilanterol trifenatate100 mcg; 25 mcgpowderGlaxoSmithKline LLC | 5,982.47 (Schedule G, line 925, page 35 of the filing PDF) | 65 |
| 926 | Rexulti 3 mg tab 3059148003913Listed by the FDA as Rexultibrexpiprazole3 mgtabletOtsuka America Pharmaceutical, Inc. | 5,943.59 (Schedule G, line 926, page 35 of the filing PDF) | 11 |
| 927 | Motpoly XR 150 mg ER cap 6073289006402Listed by the FDA as Motpoly XRlacosamide150 mgcapsule, extended releaseAucta Pharmaceuticals, Inc. | 5,922.17 (Schedule G, line 927, page 35 of the filing PDF) | 9 |
| 928 | Revlimid DS 25 mg cap 2159572042521Listed by the FDA as Revlimidlenalidomide25 mgcapsuleCelgene Corporation | 5,879.71 (Schedule G, line 928, page 35 of the filing PDF) | 0 |
| 929 | Tyenne 162 mg auto inj 0.9 mL65219059601Listed by the FDA as Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC | 5,871.46 (Schedule G, line 929, page 35 of the filing PDF) | 10 |
| 930 | Decitabine 50 mg SDV71288011920Listed by the FDA as Decitabine50 mg/20 mLinjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc. | 5,868.43 (Schedule G, line 930, page 35 of the filing PDF) | 401 |
| 931 | Palonosetron HCl 0.25 mg SDV 5 mL71288040905Listed by the FDA as Palonosetron Hydrochloride0.25 mg/5 mLinjection, solutionMeitheal Pharmaceuticals Inc. | 5,815.34 (Schedule G, line 931, page 35 of the filing PDF) | 2,083 |
| 932 | Ciprofloxacin-Dexame 0.3-0.1% sus 7.5 mL72485062513Listed by the FDA as Ciprofloxacin and dexamethasone3 mg/mL; 1 mg/mLsuspension/ dropsArmas Pharmaceuticals Inc. | 5,795.90 (Schedule G, line 932, page 36 of the filing PDF) | 373 |
| 933 | Levetiracetam 500 mg-5 mL SDV 25x5 mL00409188602Listed by the FDA as Levetiracetam100 mg/mLinjection, solutionHospira, Inc. | 5,795.26 (Schedule G, line 933, page 36 of the filing PDF) | 1,436 |
| 934 | Auvi-Q 0.3 mg auto inj 2x0.3 mL60842002302Listed by the FDA as Auvi-Qepinephrine0.3 mg/0.3 mLinjection, solutionkaleo, Inc | 5,791.89 (Schedule G, line 934, page 36 of the filing PDF) | 18 |
| 935 | Wixela Inhub in 250-50 mcg 6000378932132Listed by the FDA as Wixela Inhubfluticasone propionate and salmeterol250 mcg; 50 mcgpowderMylan Pharmaceuticals Inc. | 5,766.72 (Schedule G, line 935, page 36 of the filing PDF) | 152 |
| 936 | Repatha 140 mg PFS 1 mL L/F72511050101Listed by the FDA as Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc. | 5,762.48 (Schedule G, line 936, page 36 of the filing PDF) | 27 |
| 937 | Buprenorphine 5 mcg-hr pat 442858075040Listed by the FDA as Buprenorphine5 mcg/hourpatchRhodes Pharmaceuticals LLC | 5,735.38 (Schedule G, line 937, page 36 of the filing PDF) | 466 |
| 938 | Advate Baxject III 2 mL 200-400 IU00944305102Listed by the FDA as Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc. | 5,683.99 (Schedule G, line 938, page 36 of the filing PDF) | 7 |
| 939 | Genotropin M/Q 2 mg SYG 700013265802Listed by the FDA as GenotropinsomatropinkitPfizer Laboratories Div Pfizer Inc | 5,680.91 (Schedule G, line 939, page 36 of the filing PDF) | 8 |
| 940 | Lunsumio 1 mg SDV 1 mL50242015901Listed by the FDA as Lunsumiomosunetuzumab1 mg/mLconcentrateGenentech, Inc. | 5,670.94 (Schedule G, line 940, page 36 of the filing PDF) | fewer than 6 (the count is not shown) |
| 941 | Humalog Kwik pen 200 units 2x3 mL00002771227Listed by the FDA as Humalog KwikPeninsulin lispro200 IU/mLinjection, solutionEli Lilly and Company | 5,649.29 (Schedule G, line 941, page 36 of the filing PDF) | 12 |
| 942 | Januvia 100 mg tab 9000006027754Listed by the FDA as Januviasitagliptin100 mgtablet, film coatedMerck Sharp & Dohme LLC | 5,593.40 (Schedule G, line 942, page 36 of the filing PDF) | 36 |
| 943 | Tasimelteon 20 mg cap 3000480449056Listed by the FDA as Tasimelteon20 mgcapsule, gelatin coatedTeva Pharmaceuticals, Inc. | 5,584.56 (Schedule G, line 943, page 36 of the filing PDF) | 8 |
| 944 | Genotropin 5 mg SYG CRT 100013262681Listed by the FDA as GenotropinsomatropinkitPfizer Laboratories Div Pfizer Inc | 5,576.64 (Schedule G, line 944, page 36 of the filing PDF) | 37 |
| 945 | Zenpep 40,000 USP DR cap 10073562011401Listed by the FDA as Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase40,000 USP units; 126,000 USP units; 168,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc. | 5,546.79 (Schedule G, line 945, page 36 of the filing PDF) | fewer than 6 (the count is not shown) |
| 946 | Olanzapine 10 mg SDV31722030801Listed by the FDA as Olanzapine10 mg/2 mLinjection, powder, for solutionCamber Pharmaceuticals, Inc. | 5,532.71 (Schedule G, line 946, page 36 of the filing PDF) | 690 |
| 947 | Abiraterone Acetate 250 mg tab 12060505432701Listed by the FDA as Abiraterone Acetate250 mgtabletApotex Corp. | 5,512.03 (Schedule G, line 947, page 36 of the filing PDF) | 39 |
| 948 | Humira 80 mg/0.8 mL 40 mg/0.4 mL kit 300074153903Listed by the FDA as HumiraadalimumabkitAbbVie Inc. | 5,502.24 (Schedule G, line 948, page 36 of the filing PDF) | 0 |
| 949 | Vinblastine 10 mg MDV 10 mL63323027810Listed by the FDA as Vinblastine Sulfate1 mg/mLinjectionFresenius Kabi USA, LLC | 5,492.66 (Schedule G, line 949, page 36 of the filing PDF) | 141 |
| 950 | Uzedy 250 mg ER PFS 0.7 mL51759096010Listed by the FDA as Uzedyrisperidone250 mg/0.7 mLinjection, suspension, extended releaseTeva Pharmaceuticals USA, Inc. | 5,477.90 (Schedule G, line 950, page 36 of the filing PDF) | fewer than 6 (the count is not shown) |
| 951 | Sunitinib Malate 50 mg cap 2800378668028Listed by the FDA as Sunitinib Malate50 mgcapsuleMylan Pharmaceuticals Inc. | 5,468.56 (Schedule G, line 951, page 36 of the filing PDF) | fewer than 6 (the count is not shown) |
| 952 | Atropine Sulf 0.4 mg SDV 25x1 mL00517100425Listed by the FDA as Atropine Sulfate0.4 mg/mLinjection, solutionAmerican Regent, Inc. | 5,445.19 (Schedule G, line 952, page 36 of the filing PDF) | 1,079 |
| 953 | Epinephrine 1 mg PFS 10x10 mL76329331801Listed by the FDA as Epinephrine0.1 mg/mLinjectionInternational Medication Systems, Limited | 5,410.49 (Schedule G, line 953, page 36 of the filing PDF) | 695 |
| 954 | Yusimry 40 mg PFP 2x0.8 mL70114022002Listed by the FDA as Yusimryadalimumab-aqvh40 mg/0.8 mLinjection, solutionCoherus BioSciences Inc | 5,410.14 (Schedule G, line 954, page 36 of the filing PDF) | 0 |
| 955 | Retacrit 10,000 units/mL VL 10x1 mL00069130810Listed by the FDA as Retacritepoetin alfa-epbx10,000 IU/mLinjection, solutionPfizer Laboratories Div Pfizer Inc | 5,392.43 (Schedule G, line 955, page 36 of the filing PDF) | 238 |
| 956 | Heparin Sod 5,000 units-mL VL 25x1 mL63323026206Listed by the FDA as Heparin Sodium5,000 USP units/mLinjection, solutionFresenius Kabi USA, LLC | 5,330.92 (Schedule G, line 956, page 36 of the filing PDF) | 5,808 |
| 957 | Xolair 75 mg auto inj 0.5 mL50242021455Listed by the FDA as Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc. | 5,306.16 (Schedule G, line 957, page 36 of the filing PDF) | 6 |
| 958 | Purixan 2,000 mg 100 mL EA62484002002Listed by the FDA as Purixan20 mg/mLsuspensionNova Laboratories, Ltd | 5,302.26 (Schedule G, line 958, page 36 of the filing PDF) | 28 |
| 959 | Everolimus 10 mg tab 3000054048213Listed by the FDA as Everolimus10 mgtabletHikma Pharmaceuticals USA Inc. | 5,289.34 (Schedule G, line 959, page 36 of the filing PDF) | 6 |
| 960 | Symbicort 120 80-4.5 mcg inh 10.2 g00186037220Listed by the FDA as Symbicortbudesonide and formoterol fumarate dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 5,230.37 (Schedule G, line 960, page 36 of the filing PDF) | 114 |
| 961 | Pot Chl 10 mEq P-B 24x100 mL00338070948Listed by the FDA as Potassium Chloride7.46 g/1,000 mLinjection, solutionBaxter Healthcare Corporation | 5,200.63 (Schedule G, line 961, page 36 of the filing PDF) | 2,430 |
| 962 | Myxredlin Sod Chl 0.9% bag 12x100 mL00338012612Listed by the FDA as Myxredlininsulin human1 IU/mLinjection, solutionBaxter Healthcare Corporation | 5,186.23 (Schedule G, line 962, page 36 of the filing PDF) | 486 |
| 963 | Adrenalin 4 mg bag 10x250 mL42023031510Listed by the FDA as Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride16 mcg/mLinjectionPar Health USA, LLC | 5,183.47 (Schedule G, line 963, page 36 of the filing PDF) | 163 |
| 964 | Mitomycin 20 mg LYO VL00143927901Listed by the FDA as Mitomycin20 mg/40 mLinjection, powder, lyophilized, for solutionHikma Pharmaceuticals USA Inc. | 5,162.05 (Schedule G, line 964, page 36 of the filing PDF) | 51 |
| 965 | Cobenfy 100-20 mg cap 6000003110060Listed by the FDA as Cobenfyxanomeline and trospium chloride100 mg; 20 mgcapsule, coated pelletsE.R. Squibb & Sons, L.L.C. | 5,147.55 (Schedule G, line 965, page 36 of the filing PDF) | fewer than 6 (the count is not shown) |
| 966 | Lidocaine HCl 1% MDV 25x20 mL00409427601Listed by the FDA as Lidocaine Hydrochloride10 mg/mLinjection, solutionHospira, Inc. | 5,133.68 (Schedule G, line 966, page 36 of the filing PDF) | 6,974 |
| 967 | Xyosted SY 75 mg/0.5 mL 4x0.5 mL C354436027504Listed by the FDA as Xyostedtestosterone enanthate75 mg/0.5 mLinjectionAntares Pharma, Inc. | 5,121.48 (Schedule G, line 967, page 36 of the filing PDF) | 21 |
| 968 | Humatrope 12 mg CRT00002814801Listed by the FDA as HumatropesomatropinkitEli Lilly and Company | 5,116.08 (Schedule G, line 968, page 36 of the filing PDF) | 0 |
| 969 | Sacubitril-Valsartan 24-26 mg tab 6062332055660Listed by the FDA as Sacubitril and Valsartan24 mg; 26 mgtablet, film coatedAlembic Pharmaceuticals Inc. | 5,101.40 (Schedule G, line 969, page 36 of the filing PDF) | 83 |
| 970 | Lidocaine-Epineph 1%-1:100K MDV 10x20 mL00409000710Listed by the FDA as Lidocaine Hydrochloride and Epinephrine10 mg/mL; 10 mcg/mLinjection, solutionHospira, Inc. | 5,093.82 (Schedule G, line 970, page 37 of the filing PDF) | 5,329 |
| 971 | Symbicort INS 80/ 4.5 mcg inh 6.9 g00186037228Listed by the FDA as Symbicortbudesonide and formoterol fumarate dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 5,051.20 (Schedule G, line 971, page 37 of the filing PDF) | 168 |
| 972 | Vasostrict 20 units SDV 10x100 mL42023023710Listed by the FDA as Vasostrictvasopressin0.2 USP units/mLinjectionPar Health USA, LLC | 5,049.88 (Schedule G, line 972, page 37 of the filing PDF) | 168 |
| 973 | Thiamine 200 mg MDV 25x2 mL63323001302Listed by the FDA as Thiaminethiamine hydrochloride100 mg/mLinjection, solutionFresenius Kabi USA, LLC | 5,000.61 (Schedule G, line 973, page 37 of the filing PDF) | 670 |
No row matches. | |||
| Total Prescription Drugs individually under $5,000 | 1,588,416.20 (Schedule G, row for amounts under $5,000, page 37 of the filing PDF) | 547,295 (Schedule G, claims on the row for amounts under $5,000, page 37 of the filing PDF) | |
| Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement | 357,096,076.09 (Schedule G, printed total, page 37 of the filing PDF) | 982,072 (Schedule G, printed claims total, page 37 of the filing PDF) | |
The rows at the foot of the table are always shown. The sum above does not include them.
What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.
Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.
Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.
“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. 968 of the 973 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched
Source
- Filing PDF
- Open Schedule G on the State of Rhode Island's website
- SHA-256
- d57d066726562ac3d1cb3ddfa8a661519bfe38ffee912ae222c7c6e4bdab2661
- Retrieved
- 11 November 2026
- Pages used
- 11 to 37 of 40